id	sid	tid	token	lemma	pos
iajs-2127	1	1	12	12	NUM
iajs-2127	1	2	ibn	ibn	PROPN
iajs-2127	1	3	al	al	PROPN
iajs-2127	1	4	-	-	PUNCT
iajs-2127	1	5	haitham	haitham	PROPN
iajs-2127	1	6	jour	jour	X
iajs-2127	1	7	.	.	PROPN
iajs-2127	1	8	for	for	ADP
iajs-2127	1	9	pure	pure	ADJ
iajs-2127	1	10	&	&	CCONJ
iajs-2127	1	11	appl	appl	PROPN
iajs-2127	1	12	.	.	PUNCT
iajs-2127	2	1	sci	sci	PROPN
iajs-2127	2	2	.	.	PROPN
iajs-2127	2	3	32	32	NUM
iajs-2127	2	4	(	(	PUNCT
iajs-2127	2	5	2	2	NUM
iajs-2127	2	6	)	)	PUNCT
iajs-2127	2	7	2019	2019	NUM
iajs-2127	2	8	abstract	abstract	ADJ
iajs-2127	2	9	hepatitis	hepatitis	NOUN
iajs-2127	2	10	-	-	PUNCT
iajs-2127	2	11	b	b	NOUN
iajs-2127	2	12	(	(	PUNCT
iajs-2127	2	13	hbv	hbv	NOUN
iajs-2127	2	14	)	)	PUNCT
iajs-2127	2	15	is	be	AUX
iajs-2127	2	16	a	a	DET
iajs-2127	2	17	viral	viral	ADJ
iajs-2127	2	18	disease	disease	NOUN
iajs-2127	2	19	cause	cause	VERB
iajs-2127	2	20	liver	liver	NOUN
iajs-2127	2	21	damage	damage	NOUN
iajs-2127	2	22	,	,	PUNCT
iajs-2127	2	23	cirrhosis	cirrhosis	NOUN
iajs-2127	2	24	,	,	PUNCT
iajs-2127	2	25	fibrosis	fibrosis	NOUN
iajs-2127	2	26	and	and	CCONJ
iajs-2127	2	27	hepatocellular	hepatocellular	ADJ
iajs-2127	2	28	carcinoma	carcinoma	NOUN
iajs-2127	2	29	.	.	PUNCT
iajs-2127	3	1	present	present	ADJ
iajs-2127	3	2	study	study	NOUN
iajs-2127	3	3	attempted	attempt	VERB
iajs-2127	3	4	to	to	PART
iajs-2127	3	5	elucidate	elucidate	VERB
iajs-2127	3	6	the	the	DET
iajs-2127	3	7	biochemical	biochemical	ADJ
iajs-2127	3	8	and	and	CCONJ
iajs-2127	3	9	haematological	haematological	ADJ
iajs-2127	3	10	markers	marker	NOUN
iajs-2127	3	11	other	other	ADJ
iajs-2127	3	12	than	than	ADP
iajs-2127	3	13	australia	australia	PROPN
iajs-2127	3	14	antigen	antigen	ADV
iajs-2127	3	15	,	,	PUNCT
iajs-2127	3	16	of	of	ADP
iajs-2127	3	17	hepatitis	hepatitis	NOUN
iajs-2127	3	18	,	,	PUNCT
iajs-2127	3	19	b	b	NOUN
iajs-2127	3	20	,	,	PUNCT
iajs-2127	3	21	vairusv	vairusv	INTJ
iajs-2127	3	22	(	(	PUNCT
iajs-2127	3	23	hbsag	hbsag	NOUN
iajs-2127	3	24	)	)	PUNCT
iajs-2127	3	25	for	for	ADP
iajs-2127	3	26	better	well	ADJ
iajs-2127	3	27	assessment	assessment	NOUN
iajs-2127	3	28	of	of	ADP
iajs-2127	3	29	hbv	hbv	NOUN
iajs-2127	3	30	infection	infection	NOUN
iajs-2127	3	31	.	.	PUNCT
iajs-2127	4	1	the	the	DET
iajs-2127	4	2	present	present	ADJ
iajs-2127	4	3	study	study	NOUN
iajs-2127	4	4	was	be	AUX
iajs-2127	4	5	conducted	conduct	VERB
iajs-2127	4	6	on	on	ADP
iajs-2127	4	7	76	76	NUM
iajs-2127	4	8	men	man	NOUN
iajs-2127	4	9	,	,	PUNCT
iajs-2127	4	10	50	50	NUM
iajs-2127	4	11	of	of	ADP
iajs-2127	4	12	them	they	PRON
iajs-2127	4	13	were	be	AUX
iajs-2127	4	14	found	find	VERB
iajs-2127	4	15	to	to	PART
iajs-2127	4	16	be	be	AUX
iajs-2127	4	17	hbeag	hbeag	ADV
iajs-2127	4	18	positive	positive	ADJ
iajs-2127	4	19	and	and	CCONJ
iajs-2127	4	20	26	26	NUM
iajs-2127	4	21	were	be	AUX
iajs-2127	4	22	negative	negative	ADJ
iajs-2127	4	23	,	,	PUNCT
iajs-2127	4	24	mean	mean	ADJ
iajs-2127	4	25	age	age	NOUN
iajs-2127	4	26	was53±5.7years	was53±5.7year	NOUN
iajs-2127	4	27	.	.	PUNCT
iajs-2127	5	1	haematological	haematological	ADJ
iajs-2127	5	2	parameters	parameter	NOUN
iajs-2127	5	3	such	such	ADJ
iajs-2127	5	4	as	as	ADP
iajs-2127	5	5	absolute	absolute	ADJ
iajs-2127	5	6	erythrocyte	erythrocyte	NOUN
iajs-2127	5	7	(	(	PUNCT
iajs-2127	5	8	abs	ab	NOUN
iajs-2127	5	9	eryt	eryt	VERB
iajs-2127	5	10	)	)	PUNCT
iajs-2127	5	11	,	,	PUNCT
iajs-2127	5	12	absolute	absolute	ADJ
iajs-2127	5	13	leukocyte	leukocyte	NOUN
iajs-2127	5	14	(	(	PUNCT
iajs-2127	5	15	abs	ab	NOUN
iajs-2127	5	16	leuk	leuk	NOUN
iajs-2127	5	17	)	)	PUNCT
iajs-2127	5	18	,	,	PUNCT
iajs-2127	5	19	haemoglobin	haemoglobin	NOUN
iajs-2127	5	20	(	(	PUNCT
iajs-2127	5	21	hb	hb	PROPN
iajs-2127	5	22	)	)	PUNCT
iajs-2127	5	23	,	,	PUNCT
iajs-2127	5	24	packed	pack	VERB
iajs-2127	5	25	cell	cell	NOUN
iajs-2127	5	26	volume(pcv),mean	volume(pcv),mean	ADJ
iajs-2127	5	27	corpuscular	corpuscular	NOUN
iajs-2127	5	28	volume	volume	NOUN
iajs-2127	5	29	(	(	PUNCT
iajs-2127	5	30	mcv	mcv	PROPN
iajs-2127	5	31	)	)	PUNCT
iajs-2127	5	32	,	,	PUNCT
iajs-2127	5	33	red	red	ADJ
iajs-2127	5	34	cell	cell	NOUN
iajs-2127	5	35	distribution	distribution	NOUN
iajs-2127	5	36	width	width	NOUN
iajs-2127	5	37	(	(	PUNCT
iajs-2127	5	38	rdw	rdw	ADJ
iajs-2127	5	39	)	)	PUNCT
iajs-2127	5	40	,	,	PUNCT
iajs-2127	5	41	mean	mean	VERB
iajs-2127	5	42	corpuscular	corpuscular	ADJ
iajs-2127	5	43	haemoglobin	haemoglobin	NOUN
iajs-2127	5	44	(	(	PUNCT
iajs-2127	5	45	mch	mch	PROPN
iajs-2127	5	46	)	)	PUNCT
iajs-2127	5	47	,	,	PUNCT
iajs-2127	5	48	mch	mch	PROPN
iajs-2127	5	49	concentration	concentration	NOUN
iajs-2127	5	50	(	(	PUNCT
iajs-2127	5	51	mchc	mchc	NOUN
iajs-2127	5	52	)	)	PUNCT
iajs-2127	5	53	,	,	PUNCT
iajs-2127	5	54	neutrophils	neutrophil	NOUN
iajs-2127	5	55	(	(	PUNCT
iajs-2127	5	56	neut	neut	NOUN
iajs-2127	5	57	)	)	PUNCT
iajs-2127	5	58	,	,	PUNCT
iajs-2127	5	59	lymphocyte	lymphocyte	NOUN
iajs-2127	5	60	(	(	PUNCT
iajs-2127	5	61	lymph	lymph	NOUN
iajs-2127	5	62	)	)	PUNCT
iajs-2127	5	63	,	,	PUNCT
iajs-2127	5	64	monocyte	monocyte	NOUN
iajs-2127	5	65	(	(	PUNCT
iajs-2127	5	66	mono	mono	PROPN
iajs-2127	5	67	)	)	PUNCT
iajs-2127	5	68	,	,	PUNCT
iajs-2127	5	69	eosinophil	eosinophil	ADJ
iajs-2127	5	70	(	(	PUNCT
iajs-2127	5	71	eosin	eosin	NOUN
iajs-2127	5	72	)	)	PUNCT
iajs-2127	5	73	,	,	PUNCT
iajs-2127	5	74	basophil	basophil	NOUN
iajs-2127	5	75	(	(	PUNCT
iajs-2127	5	76	baso	baso	PROPN
iajs-2127	5	77	)	)	PUNCT
iajs-2127	5	78	,	,	PUNCT
iajs-2127	5	79	absolut	absolut	PROPN
iajs-2127	5	80	platelet	platelet	NOUN
iajs-2127	5	81	(	(	PUNCT
iajs-2127	5	82	abs.plt	abs.plt	NOUN
iajs-2127	5	83	)	)	PUNCT
iajs-2127	5	84	,	,	PUNCT
iajs-2127	5	85	red	red	ADJ
iajs-2127	5	86	blood	blood	NOUN
iajs-2127	5	87	distribution	distribution	NOUN
iajs-2127	5	88	(	(	PUNCT
iajs-2127	5	89	rbd	rbd	NOUN
iajs-2127	5	90	)	)	PUNCT
iajs-2127	5	91	and	and	CCONJ
iajs-2127	5	92	biochemical	biochemical	ADJ
iajs-2127	5	93	markers	marker	NOUN
iajs-2127	5	94	such	such	ADJ
iajs-2127	5	95	as	as	ADP
iajs-2127	5	96	alanine	alanine	NOUN
iajs-2127	5	97	aminotransferase	aminotransferase	NOUN
iajs-2127	5	98	(	(	PUNCT
iajs-2127	5	99	alt	alt	PROPN
iajs-2127	5	100	)	)	PUNCT
iajs-2127	5	101	,	,	PUNCT
iajs-2127	5	102	aspartate	aspartate	NOUN
iajs-2127	5	103	aminotransferase	aminotransferase	NOUN
iajs-2127	5	104	(	(	PUNCT
iajs-2127	5	105	ast	ast	PROPN
iajs-2127	5	106	)	)	PUNCT
iajs-2127	5	107	,	,	PUNCT
iajs-2127	5	108	alkaline	alkaline	NOUN
iajs-2127	5	109	phosphatase	phosphatase	NOUN
iajs-2127	5	110	(	(	PUNCT
iajs-2127	5	111	alp	alp	PROPN
iajs-2127	5	112	)	)	PUNCT
iajs-2127	5	113	,	,	PUNCT
iajs-2127	5	114	gamma	gamma	PROPN
iajs-2127	5	115	glutamyl	glutamyl	PROPN
iajs-2127	5	116	transpeptidase	transpeptidase	NOUN
iajs-2127	5	117	(	(	PUNCT
iajs-2127	5	118	ggt	ggt	NOUN
iajs-2127	5	119	)	)	PUNCT
iajs-2127	5	120	,	,	PUNCT
iajs-2127	5	121	total	total	ADJ
iajs-2127	5	122	bilirubin	bilirubin	NOUN
iajs-2127	5	123	(	(	PUNCT
iajs-2127	5	124	t.bil	t.bil	VERB
iajs-2127	5	125	)	)	PUNCT
iajs-2127	5	126	,	,	PUNCT
iajs-2127	5	127	albumin	albumin	NOUN
iajs-2127	5	128	(	(	PUNCT
iajs-2127	5	129	alb	alb	PROPN
iajs-2127	5	130	)	)	PUNCT
iajs-2127	5	131	,	,	PUNCT
iajs-2127	5	132	creactive	creactive	ADJ
iajs-2127	5	133	protein	protein	NOUN
iajs-2127	5	134	(	(	PUNCT
iajs-2127	5	135	crp	crp	NOUN
iajs-2127	5	136	)	)	PUNCT
iajs-2127	5	137	,	,	PUNCT
iajs-2127	5	138	amylase	amylase	NOUN
iajs-2127	5	139	(	(	PUNCT
iajs-2127	5	140	amy	amy	PROPN
iajs-2127	5	141	)	)	PUNCT
iajs-2127	5	142	,	,	PUNCT
iajs-2127	5	143	creatinine	creatinine	NOUN
iajs-2127	5	144	(	(	PUNCT
iajs-2127	5	145	crea	crea	NUM
iajs-2127	5	146	)	)	PUNCT
iajs-2127	5	147	,	,	PUNCT
iajs-2127	5	148	sodium	sodium	NOUN
iajs-2127	5	149	(	(	PUNCT
iajs-2127	5	150	na	na	NOUN
iajs-2127	5	151	)	)	PUNCT
iajs-2127	5	152	,	,	PUNCT
iajs-2127	5	153	potassium	potassium	NOUN
iajs-2127	5	154	(	(	PUNCT
iajs-2127	5	155	k	k	NOUN
iajs-2127	5	156	)	)	PUNCT
iajs-2127	5	157	,	,	PUNCT
iajs-2127	5	158	were	be	AUX
iajs-2127	5	159	estimated	estimate	VERB
iajs-2127	5	160	for	for	ADP
iajs-2127	5	161	hbv	hbv	NOUN
iajs-2127	5	162	patients	patient	NOUN
iajs-2127	5	163	and	and	CCONJ
iajs-2127	5	164	healthy	healthy	ADJ
iajs-2127	5	165	groups	group	NOUN
iajs-2127	5	166	.	.	PUNCT
iajs-2127	6	1	statically	statically	ADV
iajs-2127	6	2	at	at	ADP
iajs-2127	6	3	(	(	PUNCT
iajs-2127	6	4	p≤	p≤	NOUN
iajs-2127	6	5	0.05	0.05	NUM
iajs-2127	6	6	)	)	PUNCT
iajs-2127	6	7	abs	ab	NOUN
iajs-2127	6	8	plt	plt	NOUN
iajs-2127	6	9	was	be	AUX
iajs-2127	6	10	highly	highly	ADV
iajs-2127	6	11	significant	significant	ADJ
iajs-2127	6	12	elevated	elevate	VERB
iajs-2127	6	13	,	,	PUNCT
iajs-2127	6	14	hb	hb	X
iajs-2127	6	15	,	,	PUNCT
iajs-2127	6	16	abs	ab	NOUN
iajs-2127	6	17	leuk	leuk	NOUN
iajs-2127	6	18	,	,	PUNCT
iajs-2127	6	19	neut%	neut%	X
iajs-2127	6	20	,	,	PUNCT
iajs-2127	6	21	lymph%	lymph%	PUNCT
iajs-2127	6	22	and	and	CCONJ
iajs-2127	6	23	eosin%	eosin%	NUM
iajs-2127	6	24	were	be	AUX
iajs-2127	6	25	significant	significant	ADJ
iajs-2127	6	26	increases	increase	NOUN
iajs-2127	6	27	while	while	SCONJ
iajs-2127	6	28	other	other	ADJ
iajs-2127	6	29	haematological	haematological	ADJ
iajs-2127	6	30	parameters	parameter	NOUN
iajs-2127	6	31	showed	show	VERB
iajs-2127	6	32	no	no	DET
iajs-2127	6	33	differences	difference	NOUN
iajs-2127	6	34	in	in	ADP
iajs-2127	6	35	hbv	hbv	NOUN
iajs-2127	6	36	patients	patient	NOUN
iajs-2127	6	37	compared	compare	VERB
iajs-2127	6	38	with	with	ADP
iajs-2127	6	39	controls	control	NOUN
iajs-2127	6	40	.	.	PUNCT
iajs-2127	7	1	liver	liver	NOUN
iajs-2127	7	2	enzymes	enzyme	NOUN
iajs-2127	7	3	(	(	PUNCT
iajs-2127	7	4	alt	alt	ADJ
iajs-2127	7	5	,	,	PUNCT
iajs-2127	7	6	ast	ast	ADJ
iajs-2127	7	7	,	,	PUNCT
iajs-2127	7	8	ggt	ggt	NOUN
iajs-2127	7	9	)	)	PUNCT
iajs-2127	7	10	and	and	CCONJ
iajs-2127	7	11	t.	t.	PROPN
iajs-2127	7	12	bil	bil	PROPN
iajs-2127	7	13	were	be	AUX
iajs-2127	7	14	highly	highly	ADV
iajs-2127	7	15	significant	significant	ADJ
iajs-2127	7	16	increased	increase	VERB
iajs-2127	7	17	,	,	PUNCT
iajs-2127	7	18	alb	alb	PROPN
iajs-2127	7	19	,	,	PUNCT
iajs-2127	7	20	crp	crp	PROPN
iajs-2127	7	21	and	and	CCONJ
iajs-2127	7	22	amyl	amyl	NOUN
iajs-2127	7	23	were	be	AUX
iajs-2127	7	24	moderately	moderately	ADV
iajs-2127	7	25	increased	increase	VERB
iajs-2127	7	26	,	,	PUNCT
iajs-2127	7	27	niether	niether	PROPN
iajs-2127	7	28	crea	crea	PROPN
iajs-2127	7	29	,	,	PUNCT
iajs-2127	7	30	na	na	ADP
iajs-2127	7	31	nor	nor	CCONJ
iajs-2127	7	32	k	k	PROPN
iajs-2127	7	33	levels	level	NOUN
iajs-2127	7	34	have	have	VERB
iajs-2127	7	35	differences	difference	NOUN
iajs-2127	7	36	in	in	ADP
iajs-2127	7	37	hbv	hbv	NOUN
iajs-2127	7	38	patients	patient	NOUN
iajs-2127	7	39	compared	compare	VERB
iajs-2127	7	40	with	with	ADP
iajs-2127	7	41	controls	control	NOUN
iajs-2127	7	42	.	.	PUNCT
iajs-2127	8	1	alt	alt	PROPN
iajs-2127	8	2	has	have	VERB
iajs-2127	8	3	strong	strong	ADJ
iajs-2127	8	4	positive	positive	ADJ
iajs-2127	8	5	correlation	correlation	NOUN
iajs-2127	8	6	with	with	ADP
iajs-2127	8	7	leuk	leuk	NOUN
iajs-2127	8	8	and	and	CCONJ
iajs-2127	8	9	with	with	ADP
iajs-2127	8	10	abs	ab	NOUN
iajs-2127	8	11	plt	plt	NOUN
iajs-2127	8	12	in	in	ADP
iajs-2127	8	13	hbv	hbv	NOUN
iajs-2127	8	14	patients	patient	NOUN
iajs-2127	8	15	.	.	PUNCT
iajs-2127	9	1	liver	liver	NOUN
iajs-2127	9	2	enzymes	enzyme	NOUN
iajs-2127	9	3	alt	alt	ADJ
iajs-2127	9	4	,	,	PUNCT
iajs-2127	9	5	ast	ast	PROPN
iajs-2127	9	6	,	,	PUNCT
iajs-2127	9	7	alp	alp	PROPN
iajs-2127	9	8	,	,	PUNCT
iajs-2127	9	9	ggt	ggt	NOUN
iajs-2127	9	10	,	,	PUNCT
iajs-2127	9	11	t.	t.	PROPN
iajs-2127	9	12	bil	bil	PROPN
iajs-2127	9	13	and	and	CCONJ
iajs-2127	9	14	abs	ab	NOUN
iajs-2127	9	15	plt	plt	NOUN
iajs-2127	9	16	can	can	AUX
iajs-2127	9	17	be	be	AUX
iajs-2127	9	18	used	use	VERB
iajs-2127	9	19	as	as	ADP
iajs-2127	9	20	monitoring	monitor	VERB
iajs-2127	9	21	markers	marker	NOUN
iajs-2127	9	22	with	with	ADP
iajs-2127	9	23	the	the	DET
iajs-2127	9	24	strong	strong	ADJ
iajs-2127	9	25	correlation	correlation	NOUN
iajs-2127	9	26	between	between	ADP
iajs-2127	9	27	alt	alt	NOUN
iajs-2127	9	28	and	and	CCONJ
iajs-2127	9	29	abs	ab	VERB
iajs-2127	9	30	plt	plt	NOUN
iajs-2127	9	31	as	as	ADP
iajs-2127	9	32	an	an	DET
iajs-2127	9	33	assessment	assessment	NOUN
iajs-2127	9	34	tools	tool	NOUN
iajs-2127	9	35	for	for	ADP
iajs-2127	9	36	hbv	hbv	NOUN
iajs-2127	9	37	infection	infection	NOUN
iajs-2127	9	38	.	.	PUNCT
iajs-2127	10	1	keywords	keyword	NOUN
iajs-2127	10	2	:	:	PUNCT
iajs-2127	10	3	hepatitis	hepatitis	PROPN
iajs-2127	10	4	b	b	PROPN
iajs-2127	10	5	,	,	PUNCT
iajs-2127	10	6	haematological	haematological	ADJ
iajs-2127	10	7	parameters	parameter	NOUN
iajs-2127	10	8	,	,	PUNCT
iajs-2127	10	9	hepatic	hepatic	ADJ
iajs-2127	10	10	enzymes	enzyme	NOUN
iajs-2127	10	11	,	,	PUNCT
iajs-2127	10	12	liver	liver	NOUN
iajs-2127	10	13	function	function	NOUN
iajs-2127	10	14	tests	test	NOUN
iajs-2127	10	15	,	,	PUNCT
iajs-2127	10	16	electrolytes	electrolyte	NOUN
iajs-2127	10	17	.	.	PUNCT
iajs-2127	11	1	ibn	ibn	PROPN
iajs-2127	11	2	al	al	PROPN
iajs-2127	11	3	haitham	haitham	PROPN
iajs-2127	11	4	journal	journal	PROPN
iajs-2127	11	5	for	for	ADP
iajs-2127	11	6	pure	pure	ADJ
iajs-2127	11	7	and	and	CCONJ
iajs-2127	11	8	applied	apply	VERB
iajs-2127	11	9	science	science	NOUN
iajs-2127	11	10	journal	journal	PROPN
iajs-2127	11	11	homepage	homepage	NOUN
iajs-2127	11	12	:	:	PUNCT
iajs-2127	11	13	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	PROPN
iajs-2127	11	14	a	a	DET
iajs-2127	11	15	correlative	correlative	ADJ
iajs-2127	11	16	study	study	NOUN
iajs-2127	11	17	between	between	ADP
iajs-2127	11	18	haematological	haematological	ADJ
iajs-2127	11	19	and	and	CCONJ
iajs-2127	11	20	biochemical	biochemical	ADJ
iajs-2127	11	21	parameters	parameter	NOUN
iajs-2127	11	22	in	in	ADP
iajs-2127	11	23	hepatitis	hepatitis	PROPN
iajs-2127	11	24	b	b	PROPN
iajs-2127	11	25	susan	susan	PROPN
iajs-2127	11	26	jameel	jameel	PROPN
iajs-2127	11	27	ali	ali	PROPN
iajs-2127	11	28	department	department	PROPN
iajs-2127	11	29	of	of	ADP
iajs-2127	11	30	chemistry	chemistry	NOUN
iajs-2127	11	31	,	,	PUNCT
iajs-2127	11	32	faculty	faculty	NOUN
iajs-2127	11	33	of	of	ADP
iajs-2127	11	34	education	education	NOUN
iajs-2127	11	35	for	for	ADP
iajs-2127	11	36	pure	pure	ADJ
iajs-2127	11	37	sciences	science	NOUN
iajs-2127	11	38	,	,	PUNCT
iajs-2127	11	39	university	university	NOUN
iajs-2127	11	40	of	of	ADP
iajs-2127	11	41	tikrit	tikrit	NOUN
iajs-2127	11	42	,	,	PUNCT
iajs-2127	11	43	iraq	iraq	PROPN
iajs-2127	11	44	.	.	PUNCT
iajs-2127	12	1	susan.ali@tu.edu.iq	susan.ali@tu.edu.iq	PROPN
iajs-2127	12	2	article	article	NOUN
iajs-2127	12	3	history	history	NOUN
iajs-2127	12	4	:	:	PUNCT
iajs-2127	12	5	received	receive	VERB
iajs-2127	12	6	4	4	NUM
iajs-2127	12	7	july	july	PROPN
iajs-2127	12	8	2018	2018	NUM
iajs-2127	12	9	,	,	PUNCT
iajs-2127	12	10	accepted	accept	VERB
iajs-2127	12	11	24	24	NUM
iajs-2127	12	12	march	march	NOUN
iajs-2127	12	13	2019	2019	NUM
iajs-2127	12	14	,	,	PUNCT
iajs-2127	12	15	publish	publish	VERB
iajs-2127	12	16	may	may	AUX
iajs-2127	12	17	2019	2019	NUM
iajs-2127	12	18	10.30526/32.2.2127	10.30526/32.2.2127	PROPN
iajs-2127	12	19	doi	doi	NOUN
iajs-2127	12	20	:	:	PUNCT
iajs-2127	12	21	mailto:susan.ali@tu.edu.iq	mailto:susan.ali@tu.edu.iq	PROPN
iajs-2127	12	22	mailto:susan.ali@tu.edu.iq	mailto:susan.ali@tu.edu.iq	PROPN
iajs-2127	12	23	11	11	NUM
iajs-2127	12	24	ibn	ibn	PROPN
iajs-2127	12	25	al	al	PROPN
iajs-2127	12	26	-	-	PUNCT
iajs-2127	12	27	haitham	haitham	PROPN
iajs-2127	12	28	jour	jour	X
iajs-2127	12	29	.	.	PROPN
iajs-2127	12	30	for	for	ADP
iajs-2127	12	31	pure	pure	ADJ
iajs-2127	12	32	&	&	CCONJ
iajs-2127	12	33	appl	appl	PROPN
iajs-2127	12	34	.	.	PUNCT
iajs-2127	13	1	sci	sci	PROPN
iajs-2127	13	2	.	.	PROPN
iajs-2127	13	3	32	32	NUM
iajs-2127	13	4	(	(	PUNCT
iajs-2127	13	5	2	2	NUM
iajs-2127	13	6	)	)	PUNCT
iajs-2127	13	7	2019	2019	NUM
iajs-2127	13	8	1	1	NUM
iajs-2127	13	9	.	.	PUNCT
iajs-2127	14	1	introduction	introduction	NOUN
iajs-2127	14	2	hepatitis	hepatitis	NOUN
iajs-2127	14	3	-	-	PUNCT
iajs-2127	14	4	b	b	PROPN
iajs-2127	14	5	virus	virus	NOUN
iajs-2127	14	6	(	(	PUNCT
iajs-2127	14	7	hbv	hbv	NOUN
iajs-2127	14	8	)	)	PUNCT
iajs-2127	14	9	infection	infection	NOUN
iajs-2127	14	10	is	be	AUX
iajs-2127	14	11	a	a	DET
iajs-2127	14	12	continuous	continuous	ADJ
iajs-2127	14	13	global	global	ADJ
iajs-2127	14	14	health	health	NOUN
iajs-2127	14	15	problem	problem	NOUN
iajs-2127	14	16	that	that	PRON
iajs-2127	14	17	infected	infect	VERB
iajs-2127	14	18	about	about	ADV
iajs-2127	14	19	2	2	NUM
iajs-2127	14	20	billion	billion	NUM
iajs-2127	14	21	people	people	NOUN
iajs-2127	14	22	worldwide	worldwide	ADV
iajs-2127	14	23	.	.	PUNCT
iajs-2127	15	1	hbv	hbv	NOUN
iajs-2127	15	2	infection	infection	NOUN
iajs-2127	15	3	describes	describe	VERB
iajs-2127	15	4	a	a	DET
iajs-2127	15	5	form	form	NOUN
iajs-2127	15	6	of	of	ADP
iajs-2127	15	7	disease	disease	NOUN
iajs-2127	15	8	characterized	characterize	VERB
iajs-2127	15	9	by	by	ADP
iajs-2127	15	10	the	the	DET
iajs-2127	15	11	presence	presence	NOUN
iajs-2127	15	12	of	of	ADP
iajs-2127	15	13	detectable	detectable	ADJ
iajs-2127	15	14	hbsag	hbsag	NOUN
iajs-2127	15	15	in	in	ADP
iajs-2127	15	16	the	the	DET
iajs-2127	15	17	blood	blood	NOUN
iajs-2127	15	18	or	or	CCONJ
iajs-2127	15	19	serum	serum	NOUN
iajs-2127	15	20	[	[	X
iajs-2127	15	21	1	1	NUM
iajs-2127	15	22	]	]	PUNCT
iajs-2127	15	23	.	.	PUNCT
iajs-2127	16	1	the	the	DET
iajs-2127	16	2	infection	infection	NOUN
iajs-2127	16	3	accompanied	accompany	VERB
iajs-2127	16	4	with	with	ADP
iajs-2127	16	5	serious	serious	ADJ
iajs-2127	16	6	complication	complication	NOUN
iajs-2127	16	7	include	include	VERB
iajs-2127	16	8	inflammation	inflammation	NOUN
iajs-2127	16	9	,	,	PUNCT
iajs-2127	16	10	hepatofibrosis	hepatofibrosis	NOUN
iajs-2127	16	11	,	,	PUNCT
iajs-2127	16	12	cirrhosis	cirrhosis	NOUN
iajs-2127	16	13	and	and	CCONJ
iajs-2127	16	14	hepatocellular	hepatocellular	ADJ
iajs-2127	16	15	carcinoma	carcinoma	NOUN
iajs-2127	17	1	[	[	X
iajs-2127	17	2	2	2	NUM
iajs-2127	17	3	-	-	SYM
iajs-2127	17	4	4	4	NUM
iajs-2127	17	5	]	]	PUNCT
iajs-2127	17	6	.	.	PUNCT
iajs-2127	18	1	hepatic	hepatic	ADJ
iajs-2127	18	2	infection	infection	NOUN
iajs-2127	18	3	is	be	AUX
iajs-2127	18	4	assessed	assess	VERB
iajs-2127	18	5	directly	directly	ADV
iajs-2127	18	6	via	via	ADP
iajs-2127	18	7	liver	liver	NOUN
iajs-2127	18	8	biopsy	biopsy	NOUN
iajs-2127	18	9	specimens	specimen	NOUN
iajs-2127	18	10	,	,	PUNCT
iajs-2127	18	11	but	but	CCONJ
iajs-2127	18	12	since	since	SCONJ
iajs-2127	18	13	it	it	PRON
iajs-2127	18	14	is	be	AUX
iajs-2127	18	15	invasive	invasive	ADJ
iajs-2127	18	16	procedure	procedure	NOUN
iajs-2127	18	17	and	and	CCONJ
iajs-2127	18	18	companied	companie	VERB
iajs-2127	18	19	by	by	ADP
iajs-2127	18	20	poor	poor	ADJ
iajs-2127	18	21	patient	patient	ADJ
iajs-2127	18	22	compliance	compliance	NOUN
iajs-2127	18	23	,	,	PUNCT
iajs-2127	18	24	clinical	clinical	ADJ
iajs-2127	18	25	experience	experience	NOUN
iajs-2127	18	26	suggested	suggest	VERB
iajs-2127	18	27	that	that	SCONJ
iajs-2127	18	28	blood	blood	NOUN
iajs-2127	18	29	parameters	parameter	NOUN
iajs-2127	18	30	provide	provide	VERB
iajs-2127	18	31	valuable	valuable	ADJ
iajs-2127	18	32	information	information	NOUN
iajs-2127	18	33	for	for	ADP
iajs-2127	18	34	the	the	DET
iajs-2127	18	35	manifestation	manifestation	NOUN
iajs-2127	18	36	of	of	ADP
iajs-2127	18	37	hbv[5	hbv[5	NOUN
iajs-2127	18	38	]	]	PUNCT
iajs-2127	18	39	.	.	PUNCT
iajs-2127	19	1	liver	liver	NOUN
iajs-2127	19	2	disease	disease	NOUN
iajs-2127	19	3	is	be	AUX
iajs-2127	19	4	accompanied	accompany	VERB
iajs-2127	19	5	by	by	ADP
iajs-2127	19	6	derangement	derangement	NOUN
iajs-2127	19	7	of	of	ADP
iajs-2127	19	8	hepatocyte	hepatocyte	NOUN
iajs-2127	19	9	function	function	NOUN
iajs-2127	19	10	including	include	VERB
iajs-2127	19	11	the	the	DET
iajs-2127	19	12	synthesis	synthesis	NOUN
iajs-2127	19	13	of	of	ADP
iajs-2127	19	14	haemostatic	haemostatic	ADJ
iajs-2127	19	15	factors	factor	NOUN
iajs-2127	19	16	[	[	X
iajs-2127	19	17	6	6	NUM
iajs-2127	19	18	]	]	PUNCT
iajs-2127	19	19	.	.	PUNCT
iajs-2127	20	1	hbv	hbv	NOUN
iajs-2127	20	2	infection	infection	NOUN
iajs-2127	20	3	may	may	AUX
iajs-2127	20	4	result	result	VERB
iajs-2127	20	5	in	in	ADP
iajs-2127	20	6	abnormal	abnormal	ADJ
iajs-2127	20	7	haematological	haematological	ADJ
iajs-2127	20	8	parameters	parameter	NOUN
iajs-2127	20	9	such	such	ADJ
iajs-2127	20	10	as	as	ADP
iajs-2127	20	11	plt	plt	NOUN
iajs-2127	20	12	[	[	X
iajs-2127	20	13	7	7	NUM
iajs-2127	20	14	]	]	PUNCT
iajs-2127	20	15	.	.	PUNCT
iajs-2127	21	1	pcv	pcv	PROPN
iajs-2127	21	2	,	,	PUNCT
iajs-2127	21	3	hb	hb	PROPN
iajs-2127	21	4	and	and	CCONJ
iajs-2127	21	5	white	white	ADJ
iajs-2127	21	6	blood	blood	NOUN
iajs-2127	21	7	cell	cell	NOUN
iajs-2127	22	1	[	[	X
iajs-2127	22	2	8	8	NUM
iajs-2127	22	3	]	]	PUNCT
iajs-2127	22	4	.	.	PUNCT
iajs-2127	23	1	disorders	disorder	NOUN
iajs-2127	23	2	which	which	PRON
iajs-2127	23	3	include	include	VERB
iajs-2127	23	4	:	:	PUNCT
iajs-2127	23	5	absolute	absolute	ADJ
iajs-2127	23	6	changes	change	NOUN
iajs-2127	23	7	in	in	ADP
iajs-2127	23	8	leuk	leuk	NOUN
iajs-2127	23	9	numbers	number	NOUN
iajs-2127	23	10	,	,	PUNCT
iajs-2127	23	11	involving	involve	VERB
iajs-2127	23	12	neut	neut	NOUN
iajs-2127	23	13	,	,	PUNCT
iajs-2127	23	14	lym	lym	NOUN
iajs-2127	23	15	and	and	CCONJ
iajs-2127	23	16	eosin	eosin	NOUN
iajs-2127	23	17	in	in	ADP
iajs-2127	23	18	response	response	NOUN
iajs-2127	23	19	to	to	ADP
iajs-2127	23	20	bacterial	bacterial	ADJ
iajs-2127	23	21	,	,	PUNCT
iajs-2127	23	22	viral	viral	ADJ
iajs-2127	23	23	,	,	PUNCT
iajs-2127	23	24	or	or	CCONJ
iajs-2127	23	25	parasitic	parasitic	ADJ
iajs-2127	23	26	infections	infection	NOUN
iajs-2127	23	27	,	,	PUNCT
iajs-2127	23	28	tissue	tissue	NOUN
iajs-2127	23	29	injury	injury	NOUN
iajs-2127	23	30	,	,	PUNCT
iajs-2127	23	31	and	and	CCONJ
iajs-2127	23	32	inflammation	inflammation	NOUN
iajs-2127	23	33	[	[	X
iajs-2127	23	34	9	9	NUM
iajs-2127	23	35	]	]	PUNCT
iajs-2127	23	36	.	.	PUNCT
iajs-2127	24	1	viral	viral	ADJ
iajs-2127	24	2	infections	infection	NOUN
iajs-2127	24	3	that	that	PRON
iajs-2127	24	4	disrupt	disrupt	VERB
iajs-2127	24	5	liver	liver	NOUN
iajs-2127	24	6	function	function	NOUN
iajs-2127	24	7	also	also	ADV
iajs-2127	24	8	can	can	AUX
iajs-2127	24	9	be	be	AUX
iajs-2127	24	10	accompanied	accompany	VERB
iajs-2127	24	11	by	by	ADP
iajs-2127	24	12	changes	change	NOUN
iajs-2127	24	13	of	of	ADP
iajs-2127	24	14	liver	liver	NOUN
iajs-2127	24	15	enzymes	enzyme	NOUN
iajs-2127	24	16	level	level	NOUN
iajs-2127	24	17	,	,	PUNCT
iajs-2127	24	18	although	although	SCONJ
iajs-2127	24	19	it	it	PRON
iajs-2127	24	20	is	be	AUX
iajs-2127	24	21	not	not	PART
iajs-2127	24	22	specific	specific	ADJ
iajs-2127	24	23	for	for	ADP
iajs-2127	24	24	hbv	hbv	NOUN
iajs-2127	24	25	only	only	ADV
iajs-2127	24	26	.	.	PUNCT
iajs-2127	25	1	liver	liver	NOUN
iajs-2127	25	2	enzymes	enzyme	NOUN
iajs-2127	25	3	such	such	ADJ
iajs-2127	25	4	as	as	ADP
iajs-2127	25	5	amino	amino	NOUN
iajs-2127	25	6	transferases	transferase	NOUN
iajs-2127	25	7	i.e.	i.e.	X
iajs-2127	25	8	ast	ast	NOUN
iajs-2127	25	9	,	,	PUNCT
iajs-2127	25	10	alt	alt	ADJ
iajs-2127	25	11	,	,	PUNCT
iajs-2127	25	12	alp	alp	PROPN
iajs-2127	25	13	and	and	CCONJ
iajs-2127	25	14	ggt	ggt	PROPN
iajs-2127	25	15	,	,	PUNCT
iajs-2127	25	16	are	be	AUX
iajs-2127	25	17	sensitive	sensitive	ADJ
iajs-2127	25	18	and	and	CCONJ
iajs-2127	25	19	one	one	NUM
iajs-2127	25	20	of	of	ADP
iajs-2127	25	21	the	the	DET
iajs-2127	25	22	widely	widely	ADV
iajs-2127	25	23	used	use	VERB
iajs-2127	25	24	blood	blood	NOUN
iajs-2127	25	25	tests	test	NOUN
iajs-2127	25	26	for	for	ADP
iajs-2127	25	27	evaluating	evaluate	VERB
iajs-2127	25	28	patients	patient	NOUN
iajs-2127	25	29	with	with	ADP
iajs-2127	25	30	hbv	hbv	NOUN
iajs-2127	25	31	.	.	PUNCT
iajs-2127	26	1	these	these	DET
iajs-2127	26	2	enzymes	enzyme	NOUN
iajs-2127	26	3	are	be	AUX
iajs-2127	26	4	usually	usually	ADV
iajs-2127	26	5	contained	contain	VERB
iajs-2127	26	6	within	within	ADP
iajs-2127	26	7	the	the	DET
iajs-2127	26	8	hepatocytes	hepatocyte	NOUN
iajs-2127	26	9	and	and	CCONJ
iajs-2127	26	10	are	be	AUX
iajs-2127	26	11	spilled	spill	VERB
iajs-2127	26	12	into	into	ADP
iajs-2127	26	13	the	the	DET
iajs-2127	26	14	blood	blood	NOUN
iajs-2127	26	15	stream	stream	NOUN
iajs-2127	26	16	when	when	SCONJ
iajs-2127	26	17	the	the	DET
iajs-2127	26	18	liver	liver	NOUN
iajs-2127	26	19	is	be	AUX
iajs-2127	26	20	infected	infect	VERB
iajs-2127	26	21	[	[	PUNCT
iajs-2127	26	22	10	10	NUM
iajs-2127	26	23	]	]	PUNCT
iajs-2127	26	24	.	.	PUNCT
iajs-2127	27	1	amino	amino	NOUN
iajs-2127	27	2	transferase	transferase	NOUN
iajs-2127	27	3	,	,	PUNCT
iajs-2127	27	4	levels	level	NOUN
iajs-2127	27	5	usually	usually	ADV
iajs-2127	27	6	,	,	PUNCT
iajs-2127	27	7	fall	fall	VERB
iajs-2127	27	8	rapidly	rapidly	ADV
iajs-2127	27	9	before	before	ADP
iajs-2127	27	10	jaundice	jaundice	NOUN
iajs-2127	27	11	appearance	appearance	NOUN
iajs-2127	27	12	and	and	CCONJ
iajs-2127	27	13	have	have	VERB
iajs-2127	27	14	a	a	DET
iajs-2127	27	15	more	more	ADV
iajs-2127	27	16	gradual	gradual	ADJ
iajs-2127	27	17	,	,	PUNCT
iajs-2127	27	18	decline	decline	NOUN
iajs-2127	27	19	in	in	ADP
iajs-2127	27	20	cases	case	NOUN
iajs-2127	27	21	,	,	PUNCT
iajs-2127	27	22	of	of	ADP
iajs-2127	27	23	hbv	hbv	NOUN
iajs-2127	27	24	,	,	PUNCT
iajs-2127	27	25	and	and	CCONJ
iajs-2127	27	26	there	there	PRON
iajs-2127	27	27	is	be	VERB
iajs-2127	27	28	a	a	DET
iajs-2127	27	29	greater	great	ADJ
iajs-2127	27	30	increase	increase	NOUN
iajs-2127	27	31	in	in	ADP
iajs-2127	27	32	serum	serum	NOUN
iajs-2127	27	33	bili	bili	PROPN
iajs-2127	27	34	level	level	NOUN
iajs-2127	28	1	[	[	X
iajs-2127	28	2	11	11	NUM
iajs-2127	28	3	]	]	PUNCT
iajs-2127	28	4	.	.	PUNCT
iajs-2127	29	1	since	since	SCONJ
iajs-2127	29	2	hbv	hbv	NOUN
iajs-2127	29	3	may	may	AUX
iajs-2127	29	4	be	be	AUX
iajs-2127	29	5	detected	detect	VERB
iajs-2127	29	6	in	in	ADP
iajs-2127	29	7	the	the	DET
iajs-2127	29	8	pancreas	pancrea	NOUN
iajs-2127	29	9	,	,	PUNCT
iajs-2127	29	10	it	it	PRON
iajs-2127	29	11	may	may	AUX
iajs-2127	29	12	impair	impair	VERB
iajs-2127	29	13	the	the	DET
iajs-2127	29	14	clearance	clearance	NOUN
iajs-2127	29	15	of	of	ADP
iajs-2127	29	16	pancreatic	pancreatic	ADJ
iajs-2127	29	17	enzymes	enzyme	NOUN
iajs-2127	29	18	(	(	PUNCT
iajs-2127	29	19	such	such	ADJ
iajs-2127	29	20	as	as	ADP
iajs-2127	29	21	amylase	amylase	NOUN
iajs-2127	29	22	)	)	PUNCT
iajs-2127	29	23	by	by	ADP
iajs-2127	29	24	the	the	DET
iajs-2127	29	25	liver	liver	NOUN
iajs-2127	29	26	reticulo	reticulo	NOUN
iajs-2127	29	27	-	-	PUNCT
iajs-2127	29	28	endothelial	endothelial	NOUN
iajs-2127	29	29	system	system	NOUN
iajs-2127	29	30	in	in	ADP
iajs-2127	29	31	proceeded	proceed	VERB
iajs-2127	29	32	liver	liver	NOUN
iajs-2127	29	33	diseases	disease	NOUN
iajs-2127	29	34	[	[	X
iajs-2127	29	35	12	12	NUM
iajs-2127	29	36	]	]	PUNCT
iajs-2127	29	37	.	.	PUNCT
iajs-2127	30	1	alb	alb	PROPN
iajs-2127	30	2	and	and	CCONJ
iajs-2127	30	3	crp	crp	PROPN
iajs-2127	30	4	are	be	AUX
iajs-2127	30	5	synthesized	synthesize	VERB
iajs-2127	30	6	in	in	ADP
iajs-2127	30	7	liver	liver	NOUN
iajs-2127	30	8	and	and	CCONJ
iajs-2127	30	9	secreted	secrete	VERB
iajs-2127	30	10	in	in	ADP
iajs-2127	30	11	extracellular	extracellular	ADJ
iajs-2127	30	12	fluids	fluid	NOUN
iajs-2127	30	13	[	[	X
iajs-2127	30	14	13	13	NUM
iajs-2127	30	15	]	]	PUNCT
iajs-2127	30	16	.	.	PUNCT
iajs-2127	31	1	alb	alb	PROPN
iajs-2127	31	2	has	have	AUX
iajs-2127	31	3	been	be	AUX
iajs-2127	31	4	shown	show	VERB
iajs-2127	31	5	to	to	PART
iajs-2127	31	6	be	be	AUX
iajs-2127	31	7	a	a	DET
iajs-2127	31	8	multifunctional	multifunctional	ADJ
iajs-2127	31	9	protein	protein	NOUN
iajs-2127	31	10	with	with	ADP
iajs-2127	31	11	transports	transport	NOUN
iajs-2127	31	12	bili	bili	NOUN
iajs-2127	31	13	besides	besides	SCONJ
iajs-2127	31	14	antioxidant	antioxidant	NOUN
iajs-2127	31	15	,	,	PUNCT
iajs-2127	31	16	immune	immune	ADJ
iajs-2127	31	17	modulatory	modulatory	NOUN
iajs-2127	31	18	and	and	CCONJ
iajs-2127	31	19	oncotic	oncotic	ADJ
iajs-2127	31	20	functions	function	NOUN
iajs-2127	31	21	,	,	PUNCT
iajs-2127	31	22	therefore	therefore	ADV
iajs-2127	31	23	hypoalbuminemia	hypoalbuminemia	ADV
iajs-2127	31	24	is	be	AUX
iajs-2127	31	25	one	one	NUM
iajs-2127	31	26	of	of	ADP
iajs-2127	31	27	the	the	DET
iajs-2127	31	28	characteristic	characteristic	ADJ
iajs-2127	31	29	features	feature	NOUN
iajs-2127	31	30	of	of	ADP
iajs-2127	31	31	certain	certain	ADJ
iajs-2127	31	32	forms	form	NOUN
iajs-2127	31	33	of	of	ADP
iajs-2127	31	34	liver	liver	NOUN
iajs-2127	31	35	disease	disease	NOUN
iajs-2127	31	36	such	such	ADJ
iajs-2127	31	37	as	as	ADP
iajs-2127	31	38	hbv	hbv	NOUN
iajs-2127	31	39	[	[	X
iajs-2127	31	40	14	14	NUM
iajs-2127	31	41	-	-	SYM
iajs-2127	31	42	15	15	NUM
iajs-2127	31	43	]	]	PUNCT
iajs-2127	31	44	.	.	PUNCT
iajs-2127	32	1	the	the	DET
iajs-2127	32	2	marked	mark	VERB
iajs-2127	32	3	increase	increase	NOUN
iajs-2127	32	4	of	of	ADP
iajs-2127	32	5	acutephase	acutephase	ADJ
iajs-2127	32	6	crp	crp	PROPN
iajs-2127	32	7	occurs	occur	VERB
iajs-2127	32	8	with	with	ADP
iajs-2127	32	9	inflammations	inflammation	NOUN
iajs-2127	32	10	,	,	PUNCT
iajs-2127	32	11	viral	viral	ADJ
iajs-2127	32	12	infections	infection	NOUN
iajs-2127	32	13	and	and	CCONJ
iajs-2127	32	14	tissue	tissue	NOUN
iajs-2127	32	15	necrosis	necrosis	NOUN
iajs-2127	32	16	[	[	X
iajs-2127	32	17	16	16	NUM
iajs-2127	32	18	]	]	PUNCT
iajs-2127	32	19	.	.	PUNCT
iajs-2127	33	1	nemours	nemours	PROPN
iajs-2127	33	2	studies	study	NOUN
iajs-2127	33	3	have	have	AUX
iajs-2127	33	4	performed	perform	VERB
iajs-2127	33	5	on	on	ADP
iajs-2127	33	6	the	the	DET
iajs-2127	33	7	relationship	relationship	NOUN
iajs-2127	33	8	of	of	ADP
iajs-2127	33	9	crp	crp	PROPN
iajs-2127	33	10	with	with	ADP
iajs-2127	33	11	the	the	DET
iajs-2127	33	12	severity	severity	NOUN
iajs-2127	33	13	of	of	ADP
iajs-2127	33	14	inflammation	inflammation	NOUN
iajs-2127	33	15	in	in	ADP
iajs-2127	33	16	liver	liver	NOUN
iajs-2127	33	17	diseases	disease	NOUN
iajs-2127	33	18	,	,	PUNCT
iajs-2127	33	19	such	such	ADJ
iajs-2127	33	20	hbv	hbv	NOUN
iajs-2127	34	1	[	[	X
iajs-2127	34	2	13	13	NUM
iajs-2127	34	3	]	]	PUNCT
iajs-2127	34	4	,	,	PUNCT
iajs-2127	34	5	[	[	X
iajs-2127	34	6	16	16	NUM
iajs-2127	34	7	-	-	SYM
iajs-2127	34	8	18	18	NUM
iajs-2127	34	9	]	]	PUNCT
iajs-2127	34	10	.	.	PUNCT
iajs-2127	35	1	an	an	DET
iajs-2127	35	2	increase	increase	NOUN
iajs-2127	35	3	of	of	ADP
iajs-2127	35	4	pancreatic	pancreatic	ADJ
iajs-2127	35	5	enzymes	enzyme	NOUN
iajs-2127	35	6	is	be	AUX
iajs-2127	35	7	generally	generally	ADV
iajs-2127	35	8	an	an	DET
iajs-2127	35	9	expression	expression	NOUN
iajs-2127	35	10	of	of	ADP
iajs-2127	35	11	inflammatory	inflammatory	ADJ
iajs-2127	35	12	disease	disease	NOUN
iajs-2127	35	13	or	or	CCONJ
iajs-2127	35	14	pancreatic	pancreatic	ADJ
iajs-2127	35	15	cancer	cancer	NOUN
iajs-2127	35	16	.	.	PUNCT
iajs-2127	36	1	hyperamylasemia	hyperamylasemia	NOUN
iajs-2127	36	2	was	be	AUX
iajs-2127	36	3	also	also	ADV
iajs-2127	36	4	indicated	indicate	VERB
iajs-2127	36	5	in	in	ADP
iajs-2127	36	6	patients	patient	NOUN
iajs-2127	36	7	diagnosed	diagnose	VERB
iajs-2127	36	8	with	with	ADP
iajs-2127	36	9	acute	acute	ADJ
iajs-2127	36	10	viral	viral	ADJ
iajs-2127	36	11	hepatitis	hepatitis	NOUN
iajs-2127	36	12	infection	infection	NOUN
iajs-2127	36	13	without	without	ADP
iajs-2127	36	14	any	any	DET
iajs-2127	36	15	pancreatic	pancreatic	ADJ
iajs-2127	36	16	disease	disease	NOUN
iajs-2127	36	17	[	[	X
iajs-2127	36	18	19	19	NUM
iajs-2127	36	19	]	]	PUNCT
iajs-2127	36	20	.	.	PUNCT
iajs-2127	37	1	during	during	ADP
iajs-2127	37	2	hbv	hbv	NOUN
iajs-2127	37	3	infection	infection	NOUN
iajs-2127	37	4	,	,	PUNCT
iajs-2127	37	5	serum	serum	PROPN
iajs-2127	37	6	crea	crea	PROPN
iajs-2127	37	7	and	and	CCONJ
iajs-2127	37	8	some	some	DET
iajs-2127	37	9	electrolytes	electrolyte	NOUN
iajs-2127	37	10	are	be	AUX
iajs-2127	37	11	usually	usually	ADV
iajs-2127	37	12	elevated	elevate	VERB
iajs-2127	37	13	,	,	PUNCT
iajs-2127	37	14	these	these	DET
iajs-2127	37	15	effectsare	effectsare	NOUN
iajs-2127	37	16	signals	signal	NOUN
iajs-2127	37	17	of	of	ADP
iajs-2127	37	18	on	on	ADP
iajs-2127	37	19	-	-	PUNCT
iajs-2127	37	20	going	go	VERB
iajs-2127	37	21	kidney	kidney	NOUN
iajs-2127	37	22	disease	disease	NOUN
iajs-2127	37	23	particularly	particularly	ADV
iajs-2127	37	24	glomerulonephritis	glomerulonephritis	NOUN
iajs-2127	37	25	[	[	X
iajs-2127	37	26	20	20	NUM
iajs-2127	37	27	]	]	PUNCT
iajs-2127	37	28	.	.	PUNCT
iajs-2127	38	1	this	this	DET
iajs-2127	38	2	study	study	NOUN
iajs-2127	38	3	was	be	AUX
iajs-2127	38	4	performed	perform	VERB
iajs-2127	38	5	for	for	ADP
iajs-2127	38	6	the	the	DET
iajs-2127	38	7	determination	determination	NOUN
iajs-2127	38	8	of	of	ADP
iajs-2127	38	9	the	the	DET
iajs-2127	38	10	relationship	relationship	NOUN
iajs-2127	38	11	between	between	ADP
iajs-2127	38	12	biochemical	biochemical	ADJ
iajs-2127	38	13	and	and	CCONJ
iajs-2127	38	14	haematological	haematological	ADJ
iajs-2127	38	15	alternations	alternation	NOUN
iajs-2127	38	16	,	,	PUNCT
iajs-2127	38	17	and	and	CCONJ
iajs-2127	38	18	whether	whether	SCONJ
iajs-2127	38	19	this	this	PRON
iajs-2127	38	20	could	could	AUX
iajs-2127	38	21	provide	provide	VERB
iajs-2127	38	22	a	a	DET
iajs-2127	38	23	reliable	reliable	ADJ
iajs-2127	38	24	method	method	NOUN
iajs-2127	38	25	for	for	ADP
iajs-2127	38	26	a	a	DET
iajs-2127	38	27	better	well	ADJ
iajs-2127	38	28	assessment	assessment	NOUN
iajs-2127	38	29	of	of	ADP
iajs-2127	38	30	liver	liver	ADJ
iajs-2127	38	31	destruction	destruction	NOUN
iajs-2127	38	32	in	in	ADP
iajs-2127	38	33	patients	patient	NOUN
iajs-2127	38	34	with	with	ADP
iajs-2127	38	35	hbv	hbv	NOUN
iajs-2127	38	36	.	.	PUNCT
iajs-2127	39	1	2	2	X
iajs-2127	39	2	.	.	X
iajs-2127	39	3	materials	material	NOUN
iajs-2127	39	4	and	and	CCONJ
iajs-2127	39	5	methods	method	NOUN
iajs-2127	39	6	the	the	DET
iajs-2127	39	7	study	study	NOUN
iajs-2127	39	8	was	be	AUX
iajs-2127	39	9	executed	execute	VERB
iajs-2127	39	10	on	on	ADP
iajs-2127	39	11	76	76	NUM
iajs-2127	39	12	men	man	NOUN
iajs-2127	39	13	,	,	PUNCT
iajs-2127	39	14	50	50	NUM
iajs-2127	39	15	of	of	ADP
iajs-2127	39	16	them	they	PRON
iajs-2127	39	17	were	be	AUX
iajs-2127	39	18	infected	infect	VERB
iajs-2127	39	19	with	with	ADP
iajs-2127	39	20	hbv	hbv	NOUN
iajs-2127	39	21	and	and	CCONJ
iajs-2127	39	22	26	26	NUM
iajs-2127	39	23	healthy	healthy	ADJ
iajs-2127	39	24	individuals	individual	NOUN
iajs-2127	39	25	as	as	ADP
iajs-2127	39	26	a	a	DET
iajs-2127	39	27	control	control	NOUN
iajs-2127	39	28	(	(	PUNCT
iajs-2127	39	29	with	with	ADP
iajs-2127	39	30	no	no	INTJ
iajs-2127	39	31	,	,	PUNCT
iajs-2127	39	32	clinical	clinical	ADJ
iajs-2127	39	33	or	or	CCONJ
iajs-2127	39	34	laboratory	laboratory	NOUN
iajs-2127	39	35	,	,	PUNCT
iajs-2127	39	36	evidence	evidence	NOUN
iajs-2127	39	37	of	of	ADP
iajs-2127	39	38	liver	liver	NOUN
iajs-2127	39	39	diseases	disease	NOUN
iajs-2127	39	40	)	)	PUNCT
iajs-2127	39	41	mean	mean	VERB
iajs-2127	39	42	age	age	NOUN
iajs-2127	39	43	was53±5.7years	was53±5.7year	NOUN
iajs-2127	39	44	.	.	PUNCT
iajs-2127	40	1	none	none	NOUN
iajs-2127	40	2	of	of	ADP
iajs-2127	40	3	the	the	DET
iajs-2127	40	4	76	76	NUM
iajs-2127	40	5	subjects	subject	NOUN
iajs-2127	40	6	had	have	AUX
iajs-2127	40	7	received	receive	VERB
iajs-2127	40	8	medications	medication	NOUN
iajs-2127	40	9	.	.	PUNCT
iajs-2127	41	1	the	the	DET
iajs-2127	41	2	duration	duration	NOUN
iajs-2127	41	3	of	of	ADP
iajs-2127	41	4	this	this	DET
iajs-2127	41	5	study	study	NOUN
iajs-2127	41	6	,	,	PUNCT
iajs-2127	41	7	was	be	AUX
iajs-2127	41	8	from	from	ADP
iajs-2127	41	9	october	october	PROPN
iajs-2127	41	10	2017	2017	NUM
iajs-2127	41	11	to	to	ADP
iajs-2127	41	12	april	april	PROPN
iajs-2127	41	13	2018	2018	NUM
iajs-2127	41	14	.	.	PUNCT
iajs-2127	42	1	the	the	DET
iajs-2127	42	2	study	study	NOUN
iajs-2127	42	3	was	be	AUX
iajs-2127	42	4	achieved	achieve	VERB
iajs-2127	42	5	in	in	ADP
iajs-2127	42	6	the	the	DET
iajs-2127	42	7	tikrit	tikrit	NOUN
iajs-2127	42	8	teaching	teach	VERB
iajs-2127	42	9	hospital	hospital	NOUN
iajs-2127	42	10	.	.	PUNCT
iajs-2127	43	1	specimens	specimen	NOUN
iajs-2127	43	2	were	be	AUX
iajs-2127	43	3	collected	collect	VERB
iajs-2127	43	4	by	by	ADP
iajs-2127	43	5	withdraw	withdraw	VERB
iajs-2127	43	6	almost	almost	ADV
iajs-2127	43	7	10	10	NUM
iajs-2127	43	8	ml	ml	NOUN
iajs-2127	43	9	of	of	ADP
iajs-2127	43	10	,	,	PUNCT
iajs-2127	43	11	venous	venous	ADJ
iajs-2127	43	12	blood	blood	NOUN
iajs-2127	43	13	,	,	PUNCT
iajs-2127	43	14	3	3	NUM
iajs-2127	43	15	ml	ml	NOUN
iajs-2127	43	16	was	be	AUX
iajs-2127	43	17	used	use	VERB
iajs-2127	43	18	for	for	ADP
iajs-2127	43	19	haematological	haematological	ADJ
iajs-2127	43	20	tests	test	NOUN
iajs-2127	43	21	that	that	PRON
iajs-2127	43	22	performed	perform	VERB
iajs-2127	43	23	by	by	ADP
iajs-2127	43	24	auto	auto	NOUN
iajs-2127	43	25	haematology	haematology	NOUN
iajs-2127	43	26	analyzer	analyzer	NOUN
iajs-2127	43	27	(	(	PUNCT
iajs-2127	43	28	bc-3000	bc-3000	PROPN
iajs-2127	43	29	plus	plus	CCONJ
iajs-2127	43	30	)	)	PUNCT
iajs-2127	43	31	.	.	PUNCT
iajs-2127	44	1	the	the	DET
iajs-2127	44	2	remaining	remain	VERB
iajs-2127	44	3	amount	amount	NOUN
iajs-2127	44	4	of	of	ADP
iajs-2127	44	5	blood	blood	NOUN
iajs-2127	44	6	samples	sample	NOUN
iajs-2127	44	7	,	,	PUNCT
iajs-2127	44	8	were	be	AUX
iajs-2127	44	9	left	leave	VERB
iajs-2127	44	10	for	for	ADP
iajs-2127	44	11	half	half	DET
iajs-2127	44	12	an	an	DET
iajs-2127	44	13	hour	hour	NOUN
iajs-2127	44	14	at	at	ADP
iajs-2127	44	15	room	room	NOUN
iajs-2127	44	16	,	,	PUNCT
iajs-2127	44	17	temperature	temperature	NOUN
iajs-2127	44	18	.	.	PUNCT
iajs-2127	45	1	the	the	DET
iajs-2127	45	2	serum	serum	NOUN
iajs-2127	45	3	was	be	AUX
iajs-2127	45	4	separated	separate	VERB
iajs-2127	45	5	then	then	ADV
iajs-2127	45	6	frozen	freeze	VERB
iajs-2127	45	7	at	at	ADP
iajs-2127	45	8	about	about	ADP
iajs-2127	45	9	-20c	-20c	NOUN
iajs-2127	45	10	°	°	NOUN
iajs-2127	45	11	until	until	ADP
iajs-2127	45	12	analysis	analysis	NOUN
iajs-2127	45	13	.	.	PUNCT
iajs-2127	46	1	both	both	DET
iajs-2127	46	2	patients	patient	NOUN
iajs-2127	46	3	and	and	CCONJ
iajs-2127	46	4	healthy	healthy	ADJ
iajs-2127	46	5	groups	group	NOUN
iajs-2127	46	6	were	be	AUX
iajs-2127	46	7	screened	screen	VERB
iajs-2127	46	8	,	,	PUNCT
iajs-2127	46	9	for	for	ADP
iajs-2127	46	10	hbsag	hbsag	NOUN
iajs-2127	46	11	using	use	VERB
iajs-2127	46	12	(	(	PUNCT
iajs-2127	46	13	hbsag	hbsag	ADJ
iajs-2127	46	14	elisa	elisa	PROPN
iajs-2127	46	15	test	test	NOUN
iajs-2127	46	16	kit	kit	NOUN
iajs-2127	46	17	(	(	PUNCT
iajs-2127	46	18	plasmatecal	plasmatecal	ADJ
iajs-2127	46	19	http://pubmedcentralcanada.ca/pmcc/articles/pmc4812173/#b22-mco-0-0-742	http://pubmedcentralcanada.ca/pmcc/articles/pmc4812173/#b22-mco-0-0-742	PROPN
iajs-2127	46	20	12	12	NUM
iajs-2127	46	21	ibn	ibn	PROPN
iajs-2127	46	22	al	al	PROPN
iajs-2127	46	23	-	-	PUNCT
iajs-2127	46	24	haitham	haitham	PROPN
iajs-2127	46	25	jour	jour	X
iajs-2127	46	26	.	.	PROPN
iajs-2127	47	1	for	for	ADP
iajs-2127	47	2	pure	pure	ADJ
iajs-2127	47	3	&	&	CCONJ
iajs-2127	47	4	appl	appl	PROPN
iajs-2127	47	5	.	.	PUNCT
iajs-2127	48	1	sci	sci	PROPN
iajs-2127	48	2	.	.	PROPN
iajs-2127	48	3	32	32	NUM
iajs-2127	48	4	(	(	PUNCT
iajs-2127	48	5	2	2	NUM
iajs-2127	48	6	)	)	PUNCT
iajs-2127	48	7	2019	2019	NUM
iajs-2127	48	8	laboratory	laboratory	NOUN
iajs-2127	48	9	products	product	NOUN
iajs-2127	48	10	)	)	PUNCT
iajs-2127	48	11	.	.	PUNCT
iajs-2127	49	1	all	all	DET
iajs-2127	49	2	cases	case	NOUN
iajs-2127	49	3	were	be	AUX
iajs-2127	49	4	tested	test	VERB
iajs-2127	49	5	for	for	ADP
iajs-2127	49	6	amy	amy	NOUN
iajs-2127	49	7	using	use	VERB
iajs-2127	49	8	biolabo	biolabo	NOUN
iajs-2127	49	9	kits	kit	NOUN
iajs-2127	49	10	,	,	PUNCT
iajs-2127	49	11	serum	serum	NOUN
iajs-2127	49	12	levels	level	NOUN
iajs-2127	49	13	of	of	ADP
iajs-2127	49	14	bil	bil	NUM
iajs-2127	49	15	,	,	PUNCT
iajs-2127	49	16	alt	alt	ADJ
iajs-2127	49	17	,	,	PUNCT
iajs-2127	49	18	ast	ast	PROPN
iajs-2127	49	19	,	,	PUNCT
iajs-2127	49	20	ggt	ggt	NOUN
iajs-2127	49	21	and	and	CCONJ
iajs-2127	49	22	tsb	tsb	VERB
iajs-2127	49	23	by	by	ADP
iajs-2127	49	24	randox	randox	NOUN
iajs-2127	49	25	kit	kit	PROPN
iajs-2127	49	26	,	,	PUNCT
iajs-2127	49	27	alp	alp	PROPN
iajs-2127	49	28	by	by	ADP
iajs-2127	49	29	biomerieuxr	biomerieuxr	PROPN
iajs-2127	49	30	kit	kit	PROPN
iajs-2127	49	31	,	,	PUNCT
iajs-2127	49	32	alb	alb	INTJ
iajs-2127	49	33	by	by	ADP
iajs-2127	49	34	spinrct	spinrct	PROPN
iajs-2127	49	35	kit	kit	PROPN
iajs-2127	49	36	.	.	PUNCT
iajs-2127	50	1	crp	crp	PROPN
iajs-2127	50	2	,	,	PUNCT
iajs-2127	50	3	na	na	X
iajs-2127	50	4	and	and	CCONJ
iajs-2127	50	5	k	k	AUX
iajs-2127	50	6	by	by	ADP
iajs-2127	50	7	vitro	vitro	X
iajs-2127	50	8	scient	scient	PROPN
iajs-2127	50	9	company	company	NOUN
iajs-2127	50	10	.	.	PUNCT
iajs-2127	51	1	3	3	X
iajs-2127	51	2	.	.	X
iajs-2127	51	3	statistical	statistical	ADJ
iajs-2127	51	4	analysis	analysis	NOUN
iajs-2127	51	5	statistical	statistical	ADJ
iajs-2127	51	6	analysis	analysis	NOUN
iajs-2127	51	7	of	of	ADP
iajs-2127	51	8	quantitative	quantitative	ADJ
iajs-2127	51	9	variables	variable	NOUN
iajs-2127	51	10	was	be	AUX
iajs-2127	51	11	obtained	obtain	VERB
iajs-2127	51	12	by	by	ADP
iajs-2127	51	13	calculation	calculation	NOUN
iajs-2127	51	14	of	of	ADP
iajs-2127	51	15	mean	mean	ADJ
iajs-2127	51	16	and	and	CCONJ
iajs-2127	51	17	standard	standard	ADJ
iajs-2127	51	18	deviation	deviation	NOUN
iajs-2127	51	19	(	(	PUNCT
iajs-2127	51	20	mean±	mean±	NOUN
iajs-2127	51	21	sd	sd	PROPN
iajs-2127	51	22	)	)	PUNCT
iajs-2127	51	23	.	.	PUNCT
iajs-2127	52	1	sample	sample	PROPN
iajs-2127	52	2	t	t	PROPN
iajs-2127	52	3	test	test	NOUN
iajs-2127	52	4	was	be	AUX
iajs-2127	52	5	performed	perform	VERB
iajs-2127	52	6	for	for	ADP
iajs-2127	52	7	the	the	DET
iajs-2127	52	8	comparisons	comparison	NOUN
iajs-2127	52	9	of	of	ADP
iajs-2127	52	10	alt	alt	NOUN
iajs-2127	52	11	with	with	ADP
iajs-2127	52	12	some	some	DET
iajs-2127	52	13	biochemical	biochemical	ADJ
iajs-2127	52	14	and	and	CCONJ
iajs-2127	52	15	haematological	haematological	ADJ
iajs-2127	52	16	parameters	parameter	NOUN
iajs-2127	52	17	.	.	PUNCT
iajs-2127	53	1	statistical	statistical	ADJ
iajs-2127	53	2	software	software	NOUN
iajs-2127	53	3	was	be	AUX
iajs-2127	53	4	spss	spss	ADJ
iajs-2127	53	5	version	version	NOUN
iajs-2127	53	6	11	11	NUM
iajs-2127	53	7	.	.	PUNCT
iajs-2127	54	1	significance	significance	NOUN
iajs-2127	54	2	grade	grade	NOUN
iajs-2127	54	3	was	be	AUX
iajs-2127	54	4	conceder	conceder	NOUN
iajs-2127	54	5	when	when	SCONJ
iajs-2127	54	6	p	p	PRON
iajs-2127	54	7	≤	≤	NOUN
iajs-2127	54	8	0.05	0.05	NUM
iajs-2127	54	9	.	.	PUNCT
iajs-2127	55	1	4	4	NUM
iajs-2127	55	2	.	.	NOUN
iajs-2127	55	3	results	result	VERB
iajs-2127	55	4	the	the	DET
iajs-2127	55	5	study	study	NOUN
iajs-2127	55	6	included	include	VERB
iajs-2127	55	7	76	76	NUM
iajs-2127	55	8	men	man	NOUN
iajs-2127	55	9	,	,	PUNCT
iajs-2127	55	10	50	50	NUM
iajs-2127	55	11	of	of	ADP
iajs-2127	55	12	them	they	PRON
iajs-2127	55	13	with	with	ADP
iajs-2127	55	14	hbv	hbv	NOUN
iajs-2127	55	15	and	and	CCONJ
iajs-2127	55	16	26	26	NUM
iajs-2127	55	17	healthy	healthy	ADJ
iajs-2127	55	18	individuals	individual	NOUN
iajs-2127	55	19	with	with	ADP
iajs-2127	55	20	mean	mean	ADJ
iajs-2127	55	21	age	age	NOUN
iajs-2127	55	22	53±5.7	53±5.7	NUM
iajs-2127	55	23	years	year	NOUN
iajs-2127	55	24	.	.	PUNCT
iajs-2127	56	1	there	there	PRON
iajs-2127	56	2	were	be	VERB
iajs-2127	56	3	significant	significant	ADJ
iajs-2127	56	4	(	(	PUNCT
iajs-2127	56	5	p<0.05	p<0.05	NOUN
iajs-2127	56	6	)	)	PUNCT
iajs-2127	56	7	increase	increase	NOUN
iajs-2127	56	8	in	in	ADP
iajs-2127	56	9	hb	hb	PROPN
iajs-2127	56	10	,	,	PUNCT
iajs-2127	56	11	neut	neut	NOUN
iajs-2127	56	12	,	,	PUNCT
iajs-2127	56	13	lymp	lymp	PROPN
iajs-2127	56	14	,	,	PUNCT
iajs-2127	56	15	baso	baso	PROPN
iajs-2127	56	16	,	,	PUNCT
iajs-2127	56	17	abs.neut	abs.neut	PROPN
iajs-2127	56	18	,	,	PUNCT
iajs-2127	56	19	ast	ast	NOUN
iajs-2127	56	20	,	,	PUNCT
iajs-2127	56	21	amy	amy	PROPN
iajs-2127	56	22	,	,	PUNCT
iajs-2127	56	23	alb	alb	NOUN
iajs-2127	56	24	,	,	PUNCT
iajs-2127	56	25	t.bil	t.bil	VERB
iajs-2127	56	26	and	and	CCONJ
iajs-2127	56	27	crp	crp	NOUN
iajs-2127	56	28	,	,	PUNCT
iajs-2127	56	29	highly	highly	ADV
iajs-2127	56	30	significant	significant	ADJ
iajs-2127	56	31	increase	increase	NOUN
iajs-2127	56	32	in	in	ADP
iajs-2127	56	33	abs.plt	abs.plt	NOUN
iajs-2127	56	34	,	,	PUNCT
iajs-2127	56	35	alt	alt	VERB
iajs-2127	56	36	and	and	CCONJ
iajs-2127	56	37	alp	alp	NOUN
iajs-2127	56	38	while	while	SCONJ
iajs-2127	56	39	no	no	DET
iajs-2127	56	40	significant	significant	ADJ
iajs-2127	56	41	(	(	PUNCT
iajs-2127	56	42	p>0.05	p>0.05	NOUN
iajs-2127	56	43	)	)	PUNCT
iajs-2127	56	44	difference	difference	NOUN
iajs-2127	56	45	in	in	ADP
iajs-2127	56	46	abs	ab	NOUN
iajs-2127	56	47	.	.	PUNCT
iajs-2127	57	1	leuk	leuk	PROPN
iajs-2127	57	2	,	,	PUNCT
iajs-2127	57	3	abs	ab	NOUN
iajs-2127	57	4	.	.	PUNCT
iajs-2127	58	1	eryt	eryt	PROPN
iajs-2127	58	2	,	,	PUNCT
iajs-2127	58	3	pcv	pcv	NOUN
iajs-2127	58	4	,	,	PUNCT
iajs-2127	58	5	mcv	mcv	PROPN
iajs-2127	58	6	,	,	PUNCT
iajs-2127	58	7	mch	mch	PROPN
iajs-2127	58	8	,	,	PUNCT
iajs-2127	58	9	mchc	mchc	NOUN
iajs-2127	58	10	,	,	PUNCT
iajs-2127	58	11	mono	mono	NOUN
iajs-2127	58	12	,	,	PUNCT
iajs-2127	58	13	eosin	eosin	NOUN
iajs-2127	58	14	,	,	PUNCT
iajs-2127	58	15	abs	ab	NOUN
iajs-2127	58	16	lym	lym	NOUN
iajs-2127	58	17	,	,	PUNCT
iajs-2127	58	18	abs	ab	NOUN
iajs-2127	58	19	.	.	PUNCT
iajs-2127	59	1	mono	mono	PROPN
iajs-2127	59	2	,	,	PUNCT
iajs-2127	59	3	abs	ab	NOUN
iajs-2127	59	4	.	.	PUNCT
iajs-2127	59	5	esino	esino	PROPN
iajs-2127	59	6	,	,	PUNCT
iajs-2127	59	7	abs	ab	NOUN
iajs-2127	59	8	.	.	PUNCT
iajs-2127	60	1	baso	baso	PROPN
iajs-2127	60	2	,	,	PUNCT
iajs-2127	60	3	crea	crea	VERB
iajs-2127	60	4	,	,	PUNCT
iajs-2127	60	5	na	na	ADP
iajs-2127	60	6	and	and	CCONJ
iajs-2127	60	7	k	k	PROPN
iajs-2127	60	8	compared	compare	VERB
iajs-2127	60	9	with	with	ADP
iajs-2127	60	10	controls	control	NOUN
iajs-2127	60	11	as	as	SCONJ
iajs-2127	60	12	seen	see	VERB
iajs-2127	60	13	in	in	ADP
iajs-2127	60	14	table	table	NOUN
iajs-2127	60	15	1	1	NUM
iajs-2127	60	16	.	.	PUNCT
iajs-2127	60	17	table	table	NOUN
iajs-2127	60	18	1	1	NUM
iajs-2127	60	19	.	.	PUNCT
iajs-2127	61	1	mean±sd	mean±sd	ADP
iajs-2127	61	2	of	of	ADP
iajs-2127	61	3	patients	patient	NOUN
iajs-2127	61	4	with	with	ADP
iajs-2127	61	5	hbv	hbv	NOUN
iajs-2127	61	6	compared	compare	VERB
iajs-2127	61	7	with	with	ADP
iajs-2127	61	8	control	control	NOUN
iajs-2127	61	9	.	.	PUNCT
iajs-2127	62	1	variables	variable	NOUN
iajs-2127	62	2	controls	control	VERB
iajs-2127	62	3	hbv	hbv	NOUN
iajs-2127	62	4	abs.eryt	abs.eryt	X
iajs-2127	63	1	(	(	PUNCT
iajs-2127	63	2	x10	x10	NOUN
iajs-2127	63	3	9	9	NUM
iajs-2127	63	4	/l	/l	SYM
iajs-2127	63	5	)	)	PUNCT
iajs-2127	63	6	4.09±	4.09±	NOUN
iajs-2127	63	7	0.887	0.887	NUM
iajs-2127	63	8	5.0616±0.1327	5.0616±0.1327	NOUN
iajs-2127	63	9	hb	hb	X
iajs-2127	63	10	(	(	PUNCT
iajs-2127	63	11	g	g	PROPN
iajs-2127	63	12	/	/	SYM
iajs-2127	63	13	l	l	NOUN
iajs-2127	63	14	)	)	PUNCT
iajs-2127	63	15	141.76±2.95	141.76±2.95	NUM
iajs-2127	63	16	156.03±3.68	156.03±3.68	PROPN
iajs-2127	63	17	*	*	PUNCT
iajs-2127	63	18	pcv	pcv	NOUN
iajs-2127	63	19	(	(	PUNCT
iajs-2127	63	20	%	%	INTJ
iajs-2127	63	21	)	)	PUNCT
iajs-2127	63	22	43.112±3.051	43.112±3.051	NUM
iajs-2127	63	23	45.919±1.120	45.919±1.120	NUM
iajs-2127	63	24	mcv(fl	mcv(fl	NOUN
iajs-2127	63	25	)	)	PUNCT
iajs-2127	64	1	85.32±7.1	85.32±7.1	NUM
iajs-2127	64	2	89.59±9.08	89.59±9.08	NUM
iajs-2127	64	3	rdw	rdw	ADJ
iajs-2127	64	4	(	(	PUNCT
iajs-2127	64	5	%	%	NOUN
iajs-2127	64	6	)	)	PUNCT
iajs-2127	64	7	13.2±1.67	13.2±1.67	NUM
iajs-2127	64	8	13.110±0.488	13.110±0.488	NUM
iajs-2127	64	9	mch	mch	NOUN
iajs-2127	64	10	(	(	PUNCT
iajs-2127	64	11	pg	pg	NOUN
iajs-2127	64	12	)	)	PUNCT
iajs-2127	64	13	29.638±1.43	29.638±1.43	NUM
iajs-2127	64	14	30.897±0.641	30.897±0.641	NUM
iajs-2127	64	15	mchc	mchc	NOUN
iajs-2127	64	16	(	(	PUNCT
iajs-2127	64	17	g	g	NOUN
iajs-2127	64	18	/	/	SYM
iajs-2127	64	19	l	l	NOUN
iajs-2127	64	20	)	)	PUNCT
iajs-2127	64	21	340±17.3	340±17.3	NUM
iajs-2127	64	22	340.90±5.15	340.90±5.15	NUM
iajs-2127	64	23	abs.leuk	abs.leuk	NOUN
iajs-2127	64	24	(	(	PUNCT
iajs-2127	64	25	x10	x10	NOUN
iajs-2127	64	26	9	9	NUM
iajs-2127	64	27	/l	/l	SYM
iajs-2127	64	28	)	)	PUNCT
iajs-2127	65	1	6.41±1.029	6.41±1.029	NUM
iajs-2127	65	2	5.76	5.76	NUM
iajs-2127	65	3	±	±	NUM
iajs-2127	65	4	0.8360	0.8360	NUM
iajs-2127	65	5	abs.neut	abs.neut	NOUN
iajs-2127	65	6	(	(	PUNCT
iajs-2127	65	7	x10	x10	NOUN
iajs-2127	65	8	9	9	NUM
iajs-2127	65	9	/l	/l	SYM
iajs-2127	65	10	)	)	PUNCT
iajs-2127	65	11	3.0459±1.2496	3.0459±1.2496	NOUN
iajs-2127	65	12	2.3840±0.5846	2.3840±0.5846	NOUN
iajs-2127	65	13	*	*	NOUN
iajs-2127	65	14	abs.lymp	abs.lymp	X
iajs-2127	66	1	(	(	PUNCT
iajs-2127	66	2	x10	x10	NOUN
iajs-2127	66	3	9	9	NUM
iajs-2127	66	4	/l	/l	SYM
iajs-2127	66	5	)	)	PUNCT
iajs-2127	66	6	2.1468±0.752	2.1468±0.752	PRON
iajs-2127	66	7	2.299±0.499	2.299±0.499	NUM
iajs-2127	66	8	abs.mono	abs.mono	X
iajs-2127	66	9	(	(	PUNCT
iajs-2127	66	10	x10	x10	NOUN
iajs-2127	66	11	9	9	NUM
iajs-2127	66	12	/l	/l	SYM
iajs-2127	66	13	)	)	PUNCT
iajs-2127	66	14	0.432±0.2041	0.432±0.2041	PROPN
iajs-2127	66	15	0.5327±0.1313	0.5327±0.1313	NOUN
iajs-2127	66	16	abs.esin	abs.esin	PROPN
iajs-2127	67	1	(	(	PUNCT
iajs-2127	67	2	x10	x10	PROPN
iajs-2127	67	3	9	9	NUM
iajs-2127	67	4	/l	/l	SYM
iajs-2127	67	5	)	)	PUNCT
iajs-2127	67	6	0.15249±0.091	0.15249±0.091	NUM
iajs-2127	67	7	0.2586±0.0887	0.2586±0.0887	ADJ
iajs-2127	67	8	abs.baso	abs.baso	NOUN
iajs-2127	67	9	(	(	PUNCT
iajs-2127	67	10	x10	x10	PROPN
iajs-2127	67	11	9	9	NUM
iajs-2127	67	12	/l	/l	SYM
iajs-2127	67	13	)	)	PUNCT
iajs-2127	67	14	0.0331±0.00773	0.0331±0.00773	NOUN
iajs-2127	68	1	0.02429±0.00811	0.02429±0.00811	INTJ
iajs-2127	68	2	neut	neut	PROPN
iajs-2127	68	3	(	(	PUNCT
iajs-2127	68	4	%	%	INTJ
iajs-2127	68	5	)	)	PUNCT
iajs-2127	68	6	56.3±7.9	56.3±7.9	NUM
iajs-2127	68	7	47.17±6.55	47.17±6.55	NUM
iajs-2127	68	8	*	*	NOUN
iajs-2127	68	9	lymp	lymp	PROPN
iajs-2127	68	10	(	(	PUNCT
iajs-2127	68	11	%	%	INTJ
iajs-2127	68	12	)	)	PUNCT
iajs-2127	68	13	53.92±8.2	53.92±8.2	NUM
iajs-2127	68	14	37.76±5.55	37.76±5.55	NUM
iajs-2127	68	15	*	*	SYM
iajs-2127	68	16	mono	mono	PROPN
iajs-2127	68	17	(	(	PUNCT
iajs-2127	68	18	%	%	NOUN
iajs-2127	68	19	)	)	PUNCT
iajs-2127	68	20	7.1±0.96	7.1±0.96	NUM
iajs-2127	68	21	8.952±1.627	8.952±1.627	NUM
iajs-2127	68	22	eosin	eosin	NOUN
iajs-2127	68	23	(	(	PUNCT
iajs-2127	68	24	%	%	NOUN
iajs-2127	68	25	)	)	PUNCT
iajs-2127	68	26	4.6±2.88	4.6±2.88	NUM
iajs-2127	69	1	4.429±4.429	4.429±4.429	NUM
iajs-2127	69	2	baso	baso	NOUN
iajs-2127	69	3	(	(	PUNCT
iajs-2127	69	4	%	%	INTJ
iajs-2127	69	5	)	)	PUNCT
iajs-2127	69	6	0.71±0.21	0.71±0.21	NOUN
iajs-2127	69	7	0.444±0.511	0.444±0.511	NUM
iajs-2127	69	8	*	*	PUNCT
iajs-2127	69	9	abs.plt	abs.plt	NOUN
iajs-2127	69	10	(	(	PUNCT
iajs-2127	69	11	x10	x10	NOUN
iajs-2127	69	12	9	9	NUM
iajs-2127	69	13	/l	/l	SYM
iajs-2127	69	14	)	)	PUNCT
iajs-2127	69	15	216.8±76.38	216.8±76.38	NUM
iajs-2127	69	16	72.04±19.62	72.04±19.62	NOUN
iajs-2127	69	17	*	*	NOUN
iajs-2127	69	18	*	*	PUNCT
iajs-2127	69	19	alt	alt	ADJ
iajs-2127	69	20	(	(	PUNCT
iajs-2127	69	21	u	u	NOUN
iajs-2127	69	22	/	/	SYM
iajs-2127	69	23	l	l	NOUN
iajs-2127	69	24	)	)	PUNCT
iajs-2127	69	25	22.85±8.78	22.85±8.78	PROPN
iajs-2127	69	26	106.49±55.41	106.49±55.41	NUM
iajs-2127	69	27	*	*	PROPN
iajs-2127	69	28	*	*	PUNCT
iajs-2127	69	29	ast	ast	PROPN
iajs-2127	69	30	(	(	PUNCT
iajs-2127	69	31	u	u	NOUN
iajs-2127	69	32	/	/	SYM
iajs-2127	69	33	l	l	NOUN
iajs-2127	69	34	)	)	PUNCT
iajs-2127	69	35	27.43±11.09	27.43±11.09	NUM
iajs-2127	69	36	59.39±8.97	59.39±8.97	NUM
iajs-2127	69	37	*	*	SYM
iajs-2127	69	38	*	*	PUNCT
iajs-2127	69	39	alp	alp	PROPN
iajs-2127	69	40	(	(	PUNCT
iajs-2127	69	41	u	u	NOUN
iajs-2127	69	42	/	/	SYM
iajs-2127	69	43	l	l	NOUN
iajs-2127	69	44	)	)	PUNCT
iajs-2127	69	45	62.75±14.433	62.75±14.433	NUM
iajs-2127	69	46	139.94±26.28	139.94±26.28	NOUN
iajs-2127	69	47	*	*	PUNCT
iajs-2127	69	48	*	*	PUNCT
iajs-2127	69	49	ggt	ggt	NOUN
iajs-2127	69	50	(	(	PUNCT
iajs-2127	69	51	u	u	NOUN
iajs-2127	69	52	/	/	SYM
iajs-2127	69	53	l	l	NOUN
iajs-2127	69	54	)	)	PUNCT
iajs-2127	69	55	78.45±2.7	78.45±2.7	PROPN
iajs-2127	69	56	327.4±49.7	327.4±49.7	NOUN
iajs-2127	69	57	*	*	SYM
iajs-2127	69	58	*	*	PUNCT
iajs-2127	69	59	t.	t.	PROPN
iajs-2127	69	60	bil	bil	PROPN
iajs-2127	69	61	(	(	PUNCT
iajs-2127	69	62	µmol	µmol	PROPN
iajs-2127	69	63	/	/	SYM
iajs-2127	69	64	l	l	NOUN
iajs-2127	69	65	)	)	PUNCT
iajs-2127	69	66	7.2±2.02	7.2±2.02	NOUN
iajs-2127	69	67	14.438±2.816	14.438±2.816	NUM
iajs-2127	69	68	*	*	PUNCT
iajs-2127	69	69	*	*	PUNCT
iajs-2127	69	70	alb	alb	PROPN
iajs-2127	69	71	(	(	PUNCT
iajs-2127	69	72	g	g	PROPN
iajs-2127	69	73	/	/	SYM
iajs-2127	69	74	l	l	NOUN
iajs-2127	69	75	)	)	PUNCT
iajs-2127	69	76	42.35±7.93	42.35±7.93	NUM
iajs-2127	69	77	34.580±2.010	34.580±2.010	NUM
iajs-2127	69	78	*	*	SYM
iajs-2127	69	79	crp	crp	PROPN
iajs-2127	69	80	(	(	PUNCT
iajs-2127	69	81	mg	mg	PROPN
iajs-2127	69	82	/	/	SYM
iajs-2127	69	83	l	l	NOUN
iajs-2127	69	84	)	)	PUNCT
iajs-2127	69	85	5.1±0.84	5.1±0.84	PROPN
iajs-2127	69	86	6.47	6.47	NUM
iajs-2127	69	87	±5.51	±5.51	PROPN
iajs-2127	69	88	*	*	SYM
iajs-2127	69	89	amy	amy	PROPN
iajs-2127	69	90	(	(	PUNCT
iajs-2127	69	91	u	u	NOUN
iajs-2127	69	92	/	/	SYM
iajs-2127	69	93	l	l	NOUN
iajs-2127	69	94	)	)	PUNCT
iajs-2127	69	95	31.82±5.63	31.82±5.63	NUM
iajs-2127	70	1	42.444±2.455	42.444±2.455	NUM
iajs-2127	70	2	*	*	PUNCT
iajs-2127	70	3	crea	crea	PROPN
iajs-2127	70	4	(	(	PUNCT
iajs-2127	70	5	µmol	µmol	PROPN
iajs-2127	70	6	/	/	SYM
iajs-2127	70	7	l	l	NOUN
iajs-2127	70	8	)	)	PUNCT
iajs-2127	70	9	85.7±14.33	85.7±14.33	NUM
iajs-2127	71	1	96.238±6.805	96.238±6.805	NUM
iajs-2127	71	2	na	na	NOUN
iajs-2127	71	3	(	(	PUNCT
iajs-2127	71	4	mmol	mmol	NOUN
iajs-2127	71	5	/	/	SYM
iajs-2127	71	6	l	l	NOUN
iajs-2127	71	7	)	)	PUNCT
iajs-2127	71	8	139.21±2.77	139.21±2.77	NUM
iajs-2127	71	9	141.58±2.55	141.58±2.55	NUM
iajs-2127	71	10	k	k	NOUN
iajs-2127	71	11	(	(	PUNCT
iajs-2127	71	12	mmol	mmol	NOUN
iajs-2127	71	13	/	/	SYM
iajs-2127	71	14	l	l	NOUN
iajs-2127	71	15	)	)	PUNCT
iajs-2127	71	16	3.514±0.127	3.514±0.127	NUM
iajs-2127	71	17	3.9962±0.2163	3.9962±0.2163	NUM
iajs-2127	71	18	13	13	NUM
iajs-2127	71	19	ibn	ibn	PROPN
iajs-2127	71	20	al	al	PROPN
iajs-2127	71	21	-	-	PUNCT
iajs-2127	71	22	haitham	haitham	PROPN
iajs-2127	71	23	jour	jour	X
iajs-2127	71	24	.	.	PROPN
iajs-2127	72	1	for	for	ADP
iajs-2127	72	2	pure	pure	ADJ
iajs-2127	72	3	&	&	CCONJ
iajs-2127	72	4	appl	appl	PROPN
iajs-2127	72	5	.	.	PUNCT
iajs-2127	73	1	sci	sci	PROPN
iajs-2127	73	2	.	.	PROPN
iajs-2127	73	3	32	32	NUM
iajs-2127	73	4	(	(	PUNCT
iajs-2127	73	5	2	2	NUM
iajs-2127	73	6	)	)	PUNCT
iajs-2127	73	7	2019	2019	NUM
iajs-2127	73	8	25020015010050	25020015010050	NUM
iajs-2127	73	9	8	8	NUM
iajs-2127	73	10	7	7	NUM
iajs-2127	73	11	6	6	NUM
iajs-2127	73	12	5	5	NUM
iajs-2127	73	13	4	4	NUM
iajs-2127	73	14	s	s	PART
iajs-2127	73	15	0.889398	0.889398	NUM
iajs-2127	73	16	r	r	X
iajs-2127	73	17	-	-	PUNCT
iajs-2127	73	18	sq	sq	ADJ
iajs-2127	73	19	0.0	0.0	NUM
iajs-2127	73	20	%	%	NOUN
iajs-2127	73	21	r	r	NOUN
iajs-2127	73	22	-	-	PUNCT
iajs-2127	73	23	sq(adj	sq(adj	NOUN
iajs-2127	73	24	)	)	PUNCT
iajs-2127	73	25	0.0	0.0	NUM
iajs-2127	73	26	%	%	NOUN
iajs-2127	73	27	alt	alt	NOUN
iajs-2127	73	28	l	l	NOUN
iajs-2127	73	29	e	e	NOUN
iajs-2127	73	30	u	u	X
iajs-2127	73	31	k	k	PROPN
iajs-2127	73	32	fitted	fit	VERB
iajs-2127	73	33	line	line	NOUN
iajs-2127	73	34	plot	plot	NOUN
iajs-2127	73	35	leuk	leuk	NOUN
iajs-2127	73	36	=	=	PUNCT
iajs-2127	73	37	5.833	5.833	NUM
iajs-2127	73	38	+	+	CCONJ
iajs-2127	73	39	0.000219	0.000219	NUM
iajs-2127	73	40	alt	alt	ADJ
iajs-2127	73	41	25020015010050	25020015010050	NUM
iajs-2127	73	42	120	120	NUM
iajs-2127	73	43	110	110	NUM
iajs-2127	73	44	100	100	NUM
iajs-2127	73	45	90	90	NUM
iajs-2127	73	46	80	80	NUM
iajs-2127	73	47	70	70	NUM
iajs-2127	73	48	60	60	NUM
iajs-2127	73	49	50	50	NUM
iajs-2127	73	50	40	40	NUM
iajs-2127	73	51	30	30	NUM
iajs-2127	73	52	s	s	NOUN
iajs-2127	73	53	20.2435	20.2435	NUM
iajs-2127	73	54	r	r	NOUN
iajs-2127	73	55	-	-	PUNCT
iajs-2127	73	56	sq	sq	INTJ
iajs-2127	73	57	4.2	4.2	NUM
iajs-2127	73	58	%	%	NOUN
iajs-2127	73	59	r	r	NOUN
iajs-2127	73	60	-	-	PUNCT
iajs-2127	73	61	sq(adj	sq(adj	NOUN
iajs-2127	73	62	)	)	PUNCT
iajs-2127	73	63	2.3	2.3	NUM
iajs-2127	73	64	%	%	NOUN
iajs-2127	73	65	alt	alt	NOUN
iajs-2127	73	66	p	p	NOUN
iajs-2127	73	67	lt	lt	PRON
iajs-2127	73	68	fitted	fit	VERB
iajs-2127	73	69	line	line	NOUN
iajs-2127	73	70	plot	plot	NOUN
iajs-2127	73	71	plt	plt	NOUN
iajs-2127	73	72	=	=	PUNCT
iajs-2127	73	73	67.22	67.22	NUM
iajs-2127	73	74	+	+	CCONJ
iajs-2127	73	75	0.07570	0.07570	NUM
iajs-2127	73	76	alt	alt	NOUN
iajs-2127	73	77	abs	ab	NOUN
iajs-2127	73	78	.	.	PUNCT
iajs-2127	74	1	:	:	PUNCT
iajs-2127	74	2	absolute	absolute	ADJ
iajs-2127	74	3	,	,	PUNCT
iajs-2127	74	4	eryt	eryt	ADJ
iajs-2127	74	5	:	:	PUNCT
iajs-2127	74	6	erythrocyte	erythrocyte	NOUN
iajs-2127	74	7	,	,	PUNCT
iajs-2127	74	8	leuk	leuk	NOUN
iajs-2127	74	9	:	:	PUNCT
iajs-2127	74	10	leukocyte	leukocyte	ADJ
iajs-2127	74	11	hb	hb	PROPN
iajs-2127	74	12	:	:	PUNCT
iajs-2127	74	13	haemoglobin	haemoglobin	PROPN
iajs-2127	74	14	,	,	PUNCT
iajs-2127	74	15	pcv	pcv	NOUN
iajs-2127	74	16	:	:	PUNCT
iajs-2127	74	17	packed	pack	VERB
iajs-2127	74	18	cell	cell	NOUN
iajs-2127	74	19	volume	volume	NOUN
iajs-2127	74	20	,	,	PUNCT
iajs-2127	74	21	mcv	mcv	PROPN
iajs-2127	74	22	:	:	PUNCT
iajs-2127	74	23	mean	mean	ADJ
iajs-2127	74	24	corpuscular	corpuscular	NOUN
iajs-2127	74	25	volume	volume	NOUN
iajs-2127	74	26	,	,	PUNCT
iajs-2127	74	27	rdw	rdw	PROPN
iajs-2127	74	28	:	:	PUNCT
iajs-2127	74	29	read	read	VERB
iajs-2127	74	30	cell	cell	NOUN
iajs-2127	74	31	distribution	distribution	NOUN
iajs-2127	74	32	width	width	NOUN
iajs-2127	74	33	,	,	PUNCT
iajs-2127	74	34	mch	mch	PROPN
iajs-2127	74	35	:	:	PUNCT
iajs-2127	74	36	mean	mean	VERB
iajs-2127	74	37	corpuscular	corpuscular	PROPN
iajs-2127	74	38	haemoglobin	haemoglobin	NOUN
iajs-2127	74	39	,	,	PUNCT
iajs-2127	74	40	mchc	mchc	NOUN
iajs-2127	74	41	:	:	PUNCT
iajs-2127	74	42	mch	mch	PROPN
iajs-2127	74	43	concentration	concentration	NOUN
iajs-2127	74	44	,	,	PUNCT
iajs-2127	74	45	neut	neut	NOUN
iajs-2127	74	46	:	:	PUNCT
iajs-2127	74	47	neutrophiles	neutrophile	NOUN
iajs-2127	74	48	,	,	PUNCT
iajs-2127	74	49	lymp	lymp	NOUN
iajs-2127	74	50	:	:	PUNCT
iajs-2127	74	51	lymphocyte	lymphocyte	ADJ
iajs-2127	74	52	,	,	PUNCT
iajs-2127	74	53	mono	mono	INTJ
iajs-2127	74	54	:	:	PUNCT
iajs-2127	74	55	monocyte	monocyte	NOUN
iajs-2127	74	56	,	,	PUNCT
iajs-2127	74	57	eosin	eosin	NOUN
iajs-2127	74	58	:	:	PUNCT
iajs-2127	74	59	eosinophile	eosinophile	NOUN
iajs-2127	74	60	,	,	PUNCT
iajs-2127	74	61	baso	baso	PROPN
iajs-2127	74	62	:	:	PUNCT
iajs-2127	75	1	basophile	basophile	NOUN
iajs-2127	75	2	,	,	PUNCT
iajs-2127	75	3	plt	plt	NOUN
iajs-2127	75	4	:	:	PUNCT
iajs-2127	75	5	platelet	platelet	NOUN
iajs-2127	75	6	,	,	PUNCT
iajs-2127	75	7	rbd	rbd	NOUN
iajs-2127	75	8	:	:	PUNCT
iajs-2127	75	9	read	read	ADJ
iajs-2127	75	10	blooddistribution	blooddistribution	NOUN
iajs-2127	75	11	,	,	PUNCT
iajs-2127	75	12	alt	alt	ADJ
iajs-2127	75	13	:	:	PUNCT
iajs-2127	75	14	alanine	alanine	NOUN
iajs-2127	75	15	aminotransferase	aminotransferase	PROPN
iajs-2127	75	16	,	,	PUNCT
iajs-2127	75	17	ast	ast	NOUN
iajs-2127	75	18	:	:	PUNCT
iajs-2127	75	19	aspartate	aspartate	NOUN
iajs-2127	75	20	aminotransferase	aminotransferase	NOUN
iajs-2127	75	21	,	,	PUNCT
iajs-2127	75	22	ggt	ggt	NOUN
iajs-2127	75	23	:	:	PUNCT
iajs-2127	75	24	gamma	gamma	PROPN
iajs-2127	75	25	glutamyl	glutamyl	PROPN
iajs-2127	75	26	transpeptidase	transpeptidase	NOUN
iajs-2127	75	27	,	,	PUNCT
iajs-2127	75	28	alp	alp	PROPN
iajs-2127	75	29	:	:	PUNCT
iajs-2127	75	30	alkaline	alkaline	NOUN
iajs-2127	75	31	phosphatase	phosphatase	NOUN
iajs-2127	75	32	,	,	PUNCT
iajs-2127	75	33	amy	amy	ADJ
iajs-2127	75	34	:	:	PUNCT
iajs-2127	75	35	amylase	amylase	NOUN
iajs-2127	75	36	,	,	PUNCT
iajs-2127	75	37	alb	alb	NOUN
iajs-2127	75	38	:	:	PUNCT
iajs-2127	75	39	albomine	albomine	ADJ
iajs-2127	75	40	,	,	PUNCT
iajs-2127	75	41	crea	crea	VERB
iajs-2127	75	42	:	:	PUNCT
iajs-2127	75	43	creatinine	creatinine	NOUN
iajs-2127	75	44	,	,	PUNCT
iajs-2127	75	45	t.bil	t.bil	VERB
iajs-2127	75	46	:	:	PUNCT
iajs-2127	75	47	total	total	ADJ
iajs-2127	75	48	bilirubin	bilirubin	NOUN
iajs-2127	75	49	,	,	PUNCT
iajs-2127	75	50	na	na	NOUN
iajs-2127	75	51	:	:	PUNCT
iajs-2127	75	52	sodium	sodium	NOUN
iajs-2127	75	53	,	,	PUNCT
iajs-2127	75	54	k	k	NOUN
iajs-2127	75	55	:	:	PUNCT
iajs-2127	75	56	potassium	potassium	NOUN
iajs-2127	75	57	,	,	PUNCT
iajs-2127	75	58	crp	crp	NOUN
iajs-2127	75	59	:	:	PUNCT
iajs-2127	75	60	creactive	creactive	ADJ
iajs-2127	75	61	protein	protein	NOUN
iajs-2127	75	62	.	.	PUNCT
iajs-2127	76	1	(	(	PUNCT
iajs-2127	76	2	*	*	NOUN
iajs-2127	76	3	:	:	PUNCT
iajs-2127	76	4	significant	significant	ADJ
iajs-2127	76	5	difference	difference	NOUN
iajs-2127	76	6	,	,	PUNCT
iajs-2127	76	7	*	*	PUNCT
iajs-2127	76	8	*	*	PUNCT
iajs-2127	76	9	:	:	PUNCT
iajs-2127	76	10	highly	highly	ADV
iajs-2127	76	11	significant	significant	ADJ
iajs-2127	76	12	difference	difference	NOUN
iajs-2127	76	13	)	)	PUNCT
iajs-2127	76	14	.	.	PUNCT
iajs-2127	77	1	alt	alt	PROPN
iajs-2127	77	2	was	be	AUX
iajs-2127	77	3	strongly	strongly	ADV
iajs-2127	77	4	positive	positive	ADJ
iajs-2127	77	5	correlated	correlate	VERB
iajs-2127	77	6	with	with	ADP
iajs-2127	77	7	leuk	leuk	NOUN
iajs-2127	77	8	(	(	PUNCT
iajs-2127	77	9	r	r	NOUN
iajs-2127	77	10	0.420	0.420	NUM
iajs-2127	77	11	)	)	PUNCT
iajs-2127	77	12	and	and	CCONJ
iajs-2127	77	13	with	with	ADP
iajs-2127	77	14	plt	plt	NOUN
iajs-2127	77	15	(	(	PUNCT
iajs-2127	77	16	r	r	NOUN
iajs-2127	77	17	0.592	0.592	NUM
iajs-2127	77	18	)	)	PUNCT
iajs-2127	77	19	,	,	PUNCT
iajs-2127	77	20	weak	weak	ADJ
iajs-2127	77	21	positive	positive	ADJ
iajs-2127	77	22	correlation	correlation	NOUN
iajs-2127	77	23	was	be	AUX
iajs-2127	77	24	observed	observe	VERB
iajs-2127	77	25	with	with	ADP
iajs-2127	77	26	hb	hb	PROPN
iajs-2127	77	27	(	(	PUNCT
iajs-2127	77	28	r	r	NOUN
iajs-2127	77	29	0.282	0.282	NUM
iajs-2127	77	30	)	)	PUNCT
iajs-2127	77	31	,	,	PUNCT
iajs-2127	77	32	ast	ast	INTJ
iajs-2127	77	33	(	(	PUNCT
iajs-2127	77	34	r	r	NOUN
iajs-2127	77	35	0.336	0.336	NUM
iajs-2127	77	36	)	)	PUNCT
iajs-2127	77	37	,	,	PUNCT
iajs-2127	78	1	alp	alp	PROPN
iajs-2127	78	2	(	(	PUNCT
iajs-2127	78	3	r	r	NOUN
iajs-2127	78	4	0.288	0.288	NUM
iajs-2127	78	5	)	)	PUNCT
iajs-2127	78	6	,	,	PUNCT
iajs-2127	78	7	ggt	ggt	NOUN
iajs-2127	78	8	(	(	PUNCT
iajs-2127	78	9	r	r	NOUN
iajs-2127	78	10	0.169	0.169	NUM
iajs-2127	78	11	)	)	PUNCT
iajs-2127	78	12	,	,	PUNCT
iajs-2127	78	13	alb	alb	PROPN
iajs-2127	78	14	(	(	PUNCT
iajs-2127	78	15	r	r	NOUN
iajs-2127	78	16	0.278	0.278	NUM
iajs-2127	78	17	)	)	PUNCT
iajs-2127	78	18	,	,	PUNCT
iajs-2127	78	19	bil	bil	NUM
iajs-2127	78	20	(	(	PUNCT
iajs-2127	78	21	r	r	NOUN
iajs-2127	78	22	0.240	0.240	NUM
iajs-2127	78	23	)	)	PUNCT
iajs-2127	78	24	and	and	CCONJ
iajs-2127	78	25	crea	crea	X
iajs-2127	78	26	(	(	PUNCT
iajs-2127	78	27	r	r	NOUN
iajs-2127	78	28	0.026	0.026	NUM
iajs-2127	78	29	)	)	PUNCT
iajs-2127	78	30	while	while	SCONJ
iajs-2127	78	31	week	week	NOUN
iajs-2127	78	32	negative	negative	ADJ
iajs-2127	78	33	correlation	correlation	NOUN
iajs-2127	78	34	was	be	AUX
iajs-2127	78	35	observed	observe	VERB
iajs-2127	78	36	with	with	ADP
iajs-2127	78	37	crp	crp	PROPN
iajs-2127	78	38	(	(	PUNCT
iajs-2127	78	39	r	r	NOUN
iajs-2127	78	40	-0.277	-0.277	NOUN
iajs-2127	78	41	)	)	PUNCT
iajs-2127	78	42	as	as	SCONJ
iajs-2127	78	43	shown	show	VERB
iajs-2127	78	44	in	in	ADP
iajs-2127	78	45	table	table	NOUN
iajs-2127	78	46	2	2	NUM
iajs-2127	78	47	,	,	PUNCT
iajs-2127	78	48	and	and	CCONJ
iajs-2127	78	49	figures	figure	VERB
iajs-2127	78	50	1	1	NUM
iajs-2127	78	51	-	-	SYM
iajs-2127	78	52	10	10	NUM
iajs-2127	78	53	.	.	PUNCT
iajs-2127	78	54	table	table	NOUN
iajs-2127	78	55	2	2	NUM
iajs-2127	78	56	.	.	PUNCT
iajs-2127	78	57	correlation	correlation	NOUN
iajs-2127	78	58	analysis	analysis	NOUN
iajs-2127	78	59	between	between	ADP
iajs-2127	78	60	alt	alt	NOUN
iajs-2127	78	61	and	and	CCONJ
iajs-2127	78	62	some	some	DET
iajs-2127	78	63	studied	studied	ADJ
iajs-2127	78	64	variables	variable	NOUN
iajs-2127	78	65	.	.	PUNCT
iajs-2127	79	1	alt	alt	VERB
iajs-2127	79	2	variables	variable	NOUN
iajs-2127	79	3	r	r	NOUN
iajs-2127	79	4	-	-	PUNCT
iajs-2127	79	5	value	value	NOUN
iajs-2127	79	6	p	p	NOUN
iajs-2127	79	7	-	-	PUNCT
iajs-2127	79	8	value	value	NOUN
iajs-2127	79	9	abs	ab	NOUN
iajs-2127	79	10	.	.	PUNCT
iajs-2127	80	1	leuk	leuk	VERB
iajs-2127	80	2	0.420	0.420	NUM
iajs-2127	80	3	0.065	0.065	NUM
iajs-2127	80	4	abs.plt	abs.plt	NOUN
iajs-2127	80	5	0.592	0.592	NUM
iajs-2127	80	6	0.006	0.006	NUM
iajs-2127	80	7	hb	hb	ADP
iajs-2127	80	8	0.282	0.282	NUM
iajs-2127	80	9	0.228	0.228	NUM
iajs-2127	80	10	ast	ast	NOUN
iajs-2127	80	11	0.336	0.336	NUM
iajs-2127	80	12	0.148	0.148	NUM
iajs-2127	80	13	alp	alp	NOUN
iajs-2127	80	14	0.288	0.288	NUM
iajs-2127	80	15	0.219	0.219	NUM
iajs-2127	80	16	ggt	ggt	NOUN
iajs-2127	80	17	0.169	0.169	NUM
iajs-2127	81	1	0.476	0.476	NUM
iajs-2127	81	2	alb	alb	PROPN
iajs-2127	81	3	0.278	0.278	NUM
iajs-2127	81	4	0.235	0.235	NUM
iajs-2127	81	5	t.bil	t.bil	VERB
iajs-2127	81	6	0.240	0.240	NUM
iajs-2127	81	7	0.308	0.308	NUM
iajs-2127	81	8	crea	crea	NOUN
iajs-2127	81	9	0.026	0.026	NUM
iajs-2127	81	10	0.912	0.912	NUM
iajs-2127	81	11	crp	crp	NOUN
iajs-2127	81	12	-0.277	-0.277	NOUN
iajs-2127	81	13	0.238	0.238	NUM
iajs-2127	81	14	figure	figure	NOUN
iajs-2127	81	15	1	1	NUM
iajs-2127	81	16	.	.	PUNCT
iajs-2127	81	17	correlation	correlation	NOUN
iajs-2127	81	18	between	between	ADP
iajs-2127	81	19	alt	alt	NOUN
iajs-2127	81	20	and	and	CCONJ
iajs-2127	81	21	leuk	leuk	NOUN
iajs-2127	81	22	in	in	ADP
iajs-2127	81	23	hbv	hbv	NOUN
iajs-2127	81	24	patients	patient	NOUN
iajs-2127	81	25	.	.	PUNCT
iajs-2127	82	1	figure	figure	VERB
iajs-2127	82	2	2	2	NUM
iajs-2127	82	3	.	.	PUNCT
iajs-2127	82	4	correlation	correlation	NOUN
iajs-2127	82	5	between	between	ADP
iajs-2127	82	6	alt	alt	NOUN
iajs-2127	82	7	and	and	CCONJ
iajs-2127	82	8	abs.plt	abs.plt	NOUN
iajs-2127	82	9	in	in	ADP
iajs-2127	82	10	hbv	hbv	NOUN
iajs-2127	82	11	patients	patient	NOUN
iajs-2127	82	12	.	.	PUNCT
iajs-2127	83	1	14	14	NUM
iajs-2127	83	2	ibn	ibn	PROPN
iajs-2127	83	3	al	al	PROPN
iajs-2127	83	4	-	-	PUNCT
iajs-2127	83	5	haitham	haitham	PROPN
iajs-2127	83	6	jour	jour	X
iajs-2127	83	7	.	.	PROPN
iajs-2127	83	8	for	for	ADP
iajs-2127	83	9	pure	pure	ADJ
iajs-2127	83	10	&	&	CCONJ
iajs-2127	83	11	appl	appl	PROPN
iajs-2127	83	12	.	.	PUNCT
iajs-2127	84	1	sci	sci	PROPN
iajs-2127	84	2	.	.	PROPN
iajs-2127	84	3	32	32	NUM
iajs-2127	84	4	(	(	PUNCT
iajs-2127	84	5	2	2	NUM
iajs-2127	84	6	)	)	PUNCT
iajs-2127	84	7	2019	2019	NUM
iajs-2127	84	8	25020015010050	25020015010050	NUM
iajs-2127	84	9	162.5	162.5	NUM
iajs-2127	84	10	160.0	160.0	NUM
iajs-2127	84	11	157.5	157.5	NUM
iajs-2127	84	12	155.0	155.0	NUM
iajs-2127	84	13	152.5	152.5	NUM
iajs-2127	84	14	150.0	150.0	NUM
iajs-2127	84	15	147.5	147.5	NUM
iajs-2127	84	16	145.0	145.0	NUM
iajs-2127	84	17	s	s	NOUN
iajs-2127	84	18	3.66442	3.66442	NUM
iajs-2127	84	19	r	r	NOUN
iajs-2127	84	20	-	-	PUNCT
iajs-2127	84	21	sq	sq	ADJ
iajs-2127	84	22	0.1	0.1	NUM
iajs-2127	84	23	%	%	NOUN
iajs-2127	84	24	r	r	NOUN
iajs-2127	84	25	-	-	PUNCT
iajs-2127	84	26	sq(adj	sq(adj	NOUN
iajs-2127	84	27	)	)	PUNCT
iajs-2127	84	28	0.0	0.0	NUM
iajs-2127	84	29	%	%	NOUN
iajs-2127	84	30	alt	alt	PROPN
iajs-2127	84	31	h	h	PROPN
iajs-2127	84	32	b	b	NUM
iajs-2127	84	33	fitted	fit	VERB
iajs-2127	84	34	line	line	NOUN
iajs-2127	84	35	plot	plot	NOUN
iajs-2127	84	36	hb	hb	X
iajs-2127	85	1	=	=	PUNCT
iajs-2127	85	2	155.9	155.9	NUM
iajs-2127	86	1	+	+	NOUN
iajs-2127	86	2	0.001760	0.001760	NUM
iajs-2127	86	3	alt	alt	NOUN
iajs-2127	86	4	25020015010050	25020015010050	NUM
iajs-2127	86	5	70	70	NUM
iajs-2127	86	6	65	65	NUM
iajs-2127	86	7	60	60	NUM
iajs-2127	86	8	55	55	NUM
iajs-2127	86	9	50	50	NUM
iajs-2127	86	10	45	45	NUM
iajs-2127	86	11	40	40	NUM
iajs-2127	86	12	s	s	PART
iajs-2127	86	13	8.84103	8.84103	NUM
iajs-2127	86	14	r	r	NOUN
iajs-2127	86	15	-	-	PUNCT
iajs-2127	86	16	sq	sq	ADJ
iajs-2127	86	17	7.3	7.3	NUM
iajs-2127	86	18	%	%	NOUN
iajs-2127	86	19	r	r	NOUN
iajs-2127	86	20	-	-	PUNCT
iajs-2127	86	21	sq(adj	sq(adj	NOUN
iajs-2127	86	22	)	)	PUNCT
iajs-2127	86	23	2.9	2.9	NUM
iajs-2127	86	24	%	%	NOUN
iajs-2127	86	25	alt	alt	VERB
iajs-2127	86	26	a	a	DET
iajs-2127	86	27	s	s	X
iajs-2127	86	28	t	t	NOUN
iajs-2127	86	29	fitted	fit	VERB
iajs-2127	86	30	line	line	NOUN
iajs-2127	86	31	plot	plot	NOUN
iajs-2127	86	32	ast	ast	NOUN
iajs-2127	86	33	=	=	PUNCT
iajs-2127	87	1	55.29	55.29	NUM
iajs-2127	87	2	+	+	SYM
iajs-2127	87	3	0.04556	0.04556	NUM
iajs-2127	87	4	alt	alt	ADJ
iajs-2127	87	5	25020015010050	25020015010050	NUM
iajs-2127	87	6	40	40	NUM
iajs-2127	87	7	39	39	NUM
iajs-2127	87	8	38	38	NUM
iajs-2127	87	9	37	37	NUM
iajs-2127	87	10	36	36	NUM
iajs-2127	87	11	35	35	NUM
iajs-2127	87	12	34	34	NUM
iajs-2127	87	13	33	33	NUM
iajs-2127	87	14	32	32	NUM
iajs-2127	87	15	s	s	PROPN
iajs-2127	87	16	1.98403	1.98403	NUM
iajs-2127	87	17	r	r	NOUN
iajs-2127	87	18	-	-	PUNCT
iajs-2127	87	19	sq	sq	ADJ
iajs-2127	87	20	7.7	7.7	NUM
iajs-2127	87	21	%	%	NOUN
iajs-2127	87	22	r	r	NOUN
iajs-2127	87	23	-	-	PUNCT
iajs-2127	87	24	sq(adj	sq(adj	NOUN
iajs-2127	87	25	)	)	PUNCT
iajs-2127	87	26	2.6	2.6	NUM
iajs-2127	87	27	%	%	NOUN
iajs-2127	87	28	alt	alt	VERB
iajs-2127	87	29	a	a	DET
iajs-2127	87	30	lb	lb	ADP
iajs-2127	87	31	fitted	fit	VERB
iajs-2127	87	32	line	line	NOUN
iajs-2127	87	33	plot	plot	NOUN
iajs-2127	87	34	alb	alb	PROPN
iajs-2127	87	35	=	=	SYM
iajs-2127	87	36	33.61	33.61	NUM
iajs-2127	87	37	+	+	NUM
iajs-2127	87	38	0.01017	0.01017	NUM
iajs-2127	87	39	alt	alt	VERB
iajs-2127	87	40	25020015010050	25020015010050	NUM
iajs-2127	87	41	22.5	22.5	NUM
iajs-2127	87	42	20.0	20.0	NUM
iajs-2127	87	43	17.5	17.5	NUM
iajs-2127	87	44	15.0	15.0	NUM
iajs-2127	87	45	12.5	12.5	NUM
iajs-2127	87	46	10.0	10.0	NUM
iajs-2127	87	47	7.5	7.5	NUM
iajs-2127	87	48	5.0	5.0	NUM
iajs-2127	87	49	s	s	NOUN
iajs-2127	87	50	4.69176	4.69176	NUM
iajs-2127	87	51	r	r	NOUN
iajs-2127	87	52	-	-	PUNCT
iajs-2127	87	53	sq	sq	ADJ
iajs-2127	87	54	4.4	4.4	NUM
iajs-2127	87	55	%	%	NOUN
iajs-2127	87	56	r	r	NOUN
iajs-2127	87	57	-	-	PUNCT
iajs-2127	87	58	sq(adj	sq(adj	NOUN
iajs-2127	87	59	)	)	PUNCT
iajs-2127	87	60	0.0	0.0	NUM
iajs-2127	87	61	%	%	NOUN
iajs-2127	87	62	alt	alt	PROPN
iajs-2127	87	63	b	b	PROPN
iajs-2127	87	64	il	il	PROPN
iajs-2127	87	65	fitted	fit	VERB
iajs-2127	87	66	line	line	NOUN
iajs-2127	87	67	plot	plot	NOUN
iajs-2127	87	68	bil	bil	NUM
iajs-2127	87	69	=	=	SYM
iajs-2127	87	70	11.18	11.18	NUM
iajs-2127	87	71	+	+	NUM
iajs-2127	87	72	0.01833	0.01833	NUM
iajs-2127	87	73	alt	alt	VERB
iajs-2127	87	74	25020015010050	25020015010050	NUM
iajs-2127	87	75	120	120	NUM
iajs-2127	87	76	110	110	NUM
iajs-2127	87	77	100	100	NUM
iajs-2127	87	78	90	90	NUM
iajs-2127	87	79	80	80	NUM
iajs-2127	87	80	s	s	NOUN
iajs-2127	87	81	7.30404	7.30404	NUM
iajs-2127	87	82	r	r	NOUN
iajs-2127	87	83	-	-	PUNCT
iajs-2127	87	84	sq	sq	ADJ
iajs-2127	87	85	0.0	0.0	NUM
iajs-2127	87	86	%	%	NOUN
iajs-2127	87	87	r	r	NOUN
iajs-2127	87	88	-	-	PUNCT
iajs-2127	87	89	sq(adj	sq(adj	NOUN
iajs-2127	87	90	)	)	PUNCT
iajs-2127	87	91	0.0	0.0	NUM
iajs-2127	87	92	%	%	NOUN
iajs-2127	87	93	alt	alt	NOUN
iajs-2127	87	94	c	c	NOUN
iajs-2127	87	95	re	re	ADP
iajs-2127	87	96	a	a	DET
iajs-2127	87	97	fitted	fit	VERB
iajs-2127	87	98	line	line	NOUN
iajs-2127	87	99	plot	plot	NOUN
iajs-2127	87	100	crea	crea	X
iajs-2127	88	1	=	=	SYM
iajs-2127	88	2	97.02	97.02	NUM
iajs-2127	88	3	0.00252	0.00252	NUM
iajs-2127	88	4	alt	alt	ADJ
iajs-2127	88	5	25020015010050	25020015010050	NUM
iajs-2127	88	6	25	25	NUM
iajs-2127	88	7	20	20	NUM
iajs-2127	88	8	15	15	NUM
iajs-2127	88	9	10	10	NUM
iajs-2127	88	10	5	5	NUM
iajs-2127	88	11	0	0	NUM
iajs-2127	88	12	s	s	PART
iajs-2127	88	13	5.36018	5.36018	NUM
iajs-2127	88	14	r	r	X
iajs-2127	88	15	-	-	PUNCT
iajs-2127	88	16	sq	sq	NUM
iajs-2127	88	17	8.7	8.7	NUM
iajs-2127	88	18	%	%	NOUN
iajs-2127	88	19	r	r	NOUN
iajs-2127	88	20	-	-	PUNCT
iajs-2127	88	21	sq(adj	sq(adj	NOUN
iajs-2127	88	22	)	)	PUNCT
iajs-2127	88	23	5.5	5.5	NUM
iajs-2127	88	24	%	%	NOUN
iajs-2127	88	25	alt	alt	NOUN
iajs-2127	88	26	c	c	NOUN
iajs-2127	88	27	r	r	NOUN
iajs-2127	88	28	p	p	NOUN
iajs-2127	88	29	fitted	fit	VERB
iajs-2127	88	30	line	line	NOUN
iajs-2127	88	31	plot	plot	NOUN
iajs-2127	88	32	crp	crp	NOUN
iajs-2127	88	33	=	=	NOUN
iajs-2127	88	34	9.320	9.320	NUM
iajs-2127	88	35	0.02711	0.02711	NUM
iajs-2127	88	36	alt	alt	ADJ
iajs-2127	88	37	figure	figure	NOUN
iajs-2127	88	38	3	3	NUM
iajs-2127	88	39	.	.	X
iajs-2127	88	40	correlation	correlation	NOUN
iajs-2127	88	41	between	between	ADP
iajs-2127	88	42	alt	alt	PROPN
iajs-2127	88	43	and	and	CCONJ
iajs-2127	88	44	hb	hb	PROPN
iajs-2127	88	45	in	in	ADP
iajs-2127	88	46	hbv	hbv	NOUN
iajs-2127	88	47	patients	patient	NOUN
iajs-2127	88	48	.	.	PUNCT
iajs-2127	89	1	figure	figure	VERB
iajs-2127	89	2	4	4	NUM
iajs-2127	89	3	.	.	PUNCT
iajs-2127	89	4	correlation	correlation	NOUN
iajs-2127	89	5	between	between	ADP
iajs-2127	89	6	alt	alt	NOUN
iajs-2127	89	7	and	and	CCONJ
iajs-2127	89	8	ast	ast	VERB
iajs-2127	89	9	in	in	ADP
iajs-2127	89	10	hbv	hbv	NOUN
iajs-2127	89	11	patients	patient	NOUN
iajs-2127	89	12	.	.	PUNCT
iajs-2127	90	1	25020015010050	25020015010050	NUM
iajs-2127	90	2	190	190	NUM
iajs-2127	90	3	180	180	NUM
iajs-2127	90	4	170	170	NUM
iajs-2127	90	5	160	160	NUM
iajs-2127	90	6	150	150	NUM
iajs-2127	90	7	140	140	NUM
iajs-2127	90	8	130	130	NUM
iajs-2127	90	9	120	120	NUM
iajs-2127	90	10	110	110	NUM
iajs-2127	90	11	100	100	NUM
iajs-2127	90	12	s	s	NOUN
iajs-2127	90	13	24.2690	24.2690	NUM
iajs-2127	90	14	r	r	NOUN
iajs-2127	90	15	-	-	PUNCT
iajs-2127	90	16	sq	sq	ADJ
iajs-2127	90	17	17.5	17.5	NUM
iajs-2127	90	18	%	%	NOUN
iajs-2127	90	19	r	r	NOUN
iajs-2127	90	20	-	-	PUNCT
iajs-2127	90	21	sq(adj	sq(adj	NOUN
iajs-2127	90	22	)	)	PUNCT
iajs-2127	90	23	14.7	14.7	NUM
iajs-2127	90	24	%	%	NOUN
iajs-2127	90	25	alt	alt	VERB
iajs-2127	90	26	a	a	DET
iajs-2127	90	27	l	l	NOUN
iajs-2127	90	28	p	p	NOUN
iajs-2127	90	29	fitted	fit	VERB
iajs-2127	90	30	line	line	NOUN
iajs-2127	90	31	plot	plot	NOUN
iajs-2127	90	32	alp	alp	NOUN
iajs-2127	91	1	=	=	PUNCT
iajs-2127	92	1	120.2	120.2	NUM
iajs-2127	92	2	+	+	CCONJ
iajs-2127	92	3	0.1844	0.1844	NUM
iajs-2127	92	4	alt	alt	ADJ
iajs-2127	92	5	25020015010050	25020015010050	NUM
iajs-2127	92	6	400	400	NUM
iajs-2127	92	7	375	375	NUM
iajs-2127	92	8	350	350	NUM
iajs-2127	92	9	325	325	NUM
iajs-2127	92	10	300	300	NUM
iajs-2127	92	11	275	275	NUM
iajs-2127	92	12	250	250	NUM
iajs-2127	92	13	s	s	PART
iajs-2127	92	14	50.2922	50.2922	NUM
iajs-2127	92	15	r	r	NOUN
iajs-2127	92	16	-	-	PUNCT
iajs-2127	92	17	sq	sq	ADJ
iajs-2127	92	18	2.9	2.9	NUM
iajs-2127	92	19	%	%	NOUN
iajs-2127	92	20	r	r	NOUN
iajs-2127	92	21	-	-	PUNCT
iajs-2127	92	22	sq(adj	sq(adj	NOUN
iajs-2127	92	23	)	)	PUNCT
iajs-2127	92	24	0.0	0.0	NUM
iajs-2127	92	25	%	%	NOUN
iajs-2127	92	26	alt	alt	NOUN
iajs-2127	92	27	g	g	PROPN
iajs-2127	92	28	g	g	PROPN
iajs-2127	92	29	t	t	PROPN
iajs-2127	92	30	fitted	fit	VERB
iajs-2127	92	31	line	line	NOUN
iajs-2127	92	32	plot	plot	NOUN
iajs-2127	92	33	ggt	ggt	NOUN
iajs-2127	92	34	=	=	PUNCT
iajs-2127	93	1	312.7	312.7	NUM
iajs-2127	93	2	+	+	NUM
iajs-2127	93	3	0.1529	0.1529	NUM
iajs-2127	93	4	alt	alt	VERB
iajs-2127	93	5	figure	figure	NOUN
iajs-2127	93	6	5	5	NUM
iajs-2127	93	7	.	.	PUNCT
iajs-2127	94	1	correlation	correlation	NOUN
iajs-2127	94	2	between	between	ADP
iajs-2127	94	3	alt	alt	PROPN
iajs-2127	94	4	and	and	CCONJ
iajs-2127	94	5	alp	alp	NOUN
iajs-2127	94	6	in	in	ADP
iajs-2127	94	7	hbv	hbv	NOUN
iajs-2127	94	8	patients	patient	NOUN
iajs-2127	94	9	.	.	PUNCT
iajs-2127	95	1	figure	figure	VERB
iajs-2127	95	2	6	6	NUM
iajs-2127	95	3	.	.	PUNCT
iajs-2127	95	4	correlation	correlation	NOUN
iajs-2127	95	5	between	between	ADP
iajs-2127	95	6	alt	alt	PROPN
iajs-2127	95	7	and	and	CCONJ
iajs-2127	95	8	ggt	ggt	NOUN
iajs-2127	95	9	in	in	ADP
iajs-2127	95	10	hbv	hbv	NOUN
iajs-2127	95	11	patients	patient	NOUN
iajs-2127	95	12	.	.	PUNCT
iajs-2127	96	1	figure	figure	VERB
iajs-2127	96	2	7	7	NUM
iajs-2127	96	3	.	.	PUNCT
iajs-2127	96	4	correlation	correlation	NOUN
iajs-2127	96	5	between	between	ADP
iajs-2127	96	6	alt	alt	VERB
iajs-2127	96	7	and	and	CCONJ
iajs-2127	96	8	alb	alb	VERB
iajs-2127	96	9	in	in	ADP
iajs-2127	96	10	hbv	hbv	NOUN
iajs-2127	96	11	patients	patient	NOUN
iajs-2127	96	12	.	.	PUNCT
iajs-2127	97	1	figure	figure	VERB
iajs-2127	97	2	9	9	NUM
iajs-2127	97	3	.	.	PUNCT
iajs-2127	97	4	correlation	correlation	NOUN
iajs-2127	97	5	between	between	ADP
iajs-2127	97	6	alt	alt	PROPN
iajs-2127	97	7	and	and	CCONJ
iajs-2127	97	8	crea	crea	VERB
iajs-2127	97	9	in	in	ADP
iajs-2127	97	10	hbv	hbv	NOUN
iajs-2127	97	11	patients	patient	NOUN
iajs-2127	97	12	.	.	PUNCT
iajs-2127	98	1	figure	figure	VERB
iajs-2127	98	2	8	8	NUM
iajs-2127	98	3	.	.	PUNCT
iajs-2127	99	1	correlation	correlation	NOUN
iajs-2127	99	2	between	between	ADP
iajs-2127	99	3	alt	alt	VERB
iajs-2127	99	4	and	and	CCONJ
iajs-2127	99	5	t.bil	t.bil	VERB
iajs-2127	99	6	in	in	ADP
iajs-2127	99	7	hbv	hbv	NOUN
iajs-2127	99	8	patients	patient	NOUN
iajs-2127	99	9	.	.	PUNCT
iajs-2127	100	1	figure	figure	VERB
iajs-2127	100	2	10	10	NUM
iajs-2127	100	3	.	.	PUNCT
iajs-2127	101	1	correlation	correlation	NOUN
iajs-2127	101	2	between	between	ADP
iajs-2127	101	3	alt	alt	PROPN
iajs-2127	101	4	and	and	CCONJ
iajs-2127	101	5	crp	crp	PROPN
iajs-2127	101	6	in	in	ADP
iajs-2127	101	7	hbv	hbv	NOUN
iajs-2127	101	8	patients	patient	NOUN
iajs-2127	101	9	.	.	PUNCT
iajs-2127	102	1	15	15	NUM
iajs-2127	102	2	ibn	ibn	PROPN
iajs-2127	102	3	al	al	PROPN
iajs-2127	102	4	-	-	PUNCT
iajs-2127	102	5	haitham	haitham	PROPN
iajs-2127	102	6	jour	jour	X
iajs-2127	102	7	.	.	PROPN
iajs-2127	102	8	for	for	ADP
iajs-2127	102	9	pure	pure	ADJ
iajs-2127	102	10	&	&	CCONJ
iajs-2127	102	11	appl	appl	PROPN
iajs-2127	102	12	.	.	PUNCT
iajs-2127	103	1	sci	sci	PROPN
iajs-2127	103	2	.	.	PROPN
iajs-2127	103	3	32	32	NUM
iajs-2127	103	4	(	(	PUNCT
iajs-2127	103	5	2	2	NUM
iajs-2127	103	6	)	)	PUNCT
iajs-2127	103	7	2019	2019	NUM
iajs-2127	103	8	5	5	NUM
iajs-2127	103	9	.	.	PUNCT
iajs-2127	104	1	discussion	discussion	NOUN
iajs-2127	104	2	it	it	PRON
iajs-2127	104	3	has	have	AUX
iajs-2127	104	4	been	be	AUX
iajs-2127	104	5	well	well	ADV
iajs-2127	104	6	established	establish	VERB
iajs-2127	104	7	that	that	SCONJ
iajs-2127	104	8	many	many	ADJ
iajs-2127	104	9	haematological	haematological	ADJ
iajs-2127	104	10	and	and	CCONJ
iajs-2127	104	11	biochemical	biochemical	ADJ
iajs-2127	104	12	abnormalities	abnormality	NOUN
iajs-2127	104	13	occur	occur	VERB
iajs-2127	104	14	in	in	ADP
iajs-2127	104	15	hbv	hbv	NOUN
iajs-2127	104	16	infection	infection	NOUN
iajs-2127	105	1	[	[	X
iajs-2127	105	2	21	21	NUM
iajs-2127	105	3	]	]	PUNCT
iajs-2127	105	4	.	.	PUNCT
iajs-2127	106	1	in	in	ADP
iajs-2127	106	2	the	the	DET
iajs-2127	106	3	present	present	ADJ
iajs-2127	106	4	study	study	NOUN
iajs-2127	106	5	,	,	PUNCT
iajs-2127	106	6	out	out	ADP
iajs-2127	106	7	of	of	ADP
iajs-2127	106	8	50	50	NUM
iajs-2127	106	9	hbsag	hbsag	ADV
iajs-2127	106	10	positive	positive	ADJ
iajs-2127	106	11	and	and	CCONJ
iajs-2127	106	12	26	26	NUM
iajs-2127	106	13	hbsag	hbsag	ADJ
iajs-2127	106	14	negative	negative	ADJ
iajs-2127	106	15	males	male	NOUN
iajs-2127	106	16	with	with	ADP
iajs-2127	106	17	age	age	NOUN
iajs-2127	106	18	(	(	PUNCT
iajs-2127	106	19	53±5.7	53±5.7	NUM
iajs-2127	106	20	)	)	PUNCT
iajs-2127	106	21	years	year	NOUN
iajs-2127	106	22	were	be	AUX
iajs-2127	106	23	included	include	VERB
iajs-2127	106	24	.	.	PUNCT
iajs-2127	107	1	table	table	NOUN
iajs-2127	107	2	1	1	NUM
iajs-2127	107	3	,	,	PUNCT
iajs-2127	107	4	shows	show	VERB
iajs-2127	107	5	the	the	DET
iajs-2127	107	6	statistical	statistical	ADJ
iajs-2127	107	7	difference	difference	NOUN
iajs-2127	107	8	in	in	ADP
iajs-2127	107	9	haemoglobin	haemoglobin	PROPN
iajs-2127	107	10	concentration	concentration	NOUN
iajs-2127	107	11	of	of	ADP
iajs-2127	107	12	hbv	hbv	NOUN
iajs-2127	107	13	positive	positive	ADJ
iajs-2127	107	14	subjects	subject	NOUN
iajs-2127	107	15	was	be	AUX
iajs-2127	107	16	significantly	significantly	ADV
iajs-2127	107	17	higher	high	ADJ
iajs-2127	107	18	(	(	PUNCT
iajs-2127	107	19	p≤0.05	p≤0.05	NOUN
iajs-2127	107	20	)	)	PUNCT
iajs-2127	107	21	when	when	SCONJ
iajs-2127	107	22	compared	compare	VERB
iajs-2127	107	23	with	with	ADP
iajs-2127	107	24	hbv	hbv	NOUN
iajs-2127	107	25	negative	negative	ADJ
iajs-2127	107	26	subjects	subject	NOUN
iajs-2127	107	27	,	,	PUNCT
iajs-2127	107	28	this	this	DET
iajs-2127	107	29	result	result	NOUN
iajs-2127	107	30	in	in	ADP
iajs-2127	107	31	line	line	NOUN
iajs-2127	107	32	with	with	ADP
iajs-2127	107	33	work	work	NOUN
iajs-2127	107	34	done	do	VERB
iajs-2127	107	35	by	by	ADP
iajs-2127	107	36	xue	xue	PROPN
iajs-2127	107	37	-	-	PUNCT
iajs-2127	107	38	hua	hua	PROPN
iajs-2127	107	39	,	,	PUNCT
iajs-2127	107	40	et	et	PROPN
iajs-2127	107	41	al	al	PROPN
iajs-2127	107	42	.	.	PUNCT
iajs-2127	108	1	[	[	X
iajs-2127	108	2	22	22	NUM
iajs-2127	108	3	]	]	PUNCT
iajs-2127	108	4	.	.	PUNCT
iajs-2127	109	1	the	the	DET
iajs-2127	109	2	possible	possible	ADJ
iajs-2127	109	3	explanation	explanation	NOUN
iajs-2127	109	4	is	be	AUX
iajs-2127	109	5	that	that	SCONJ
iajs-2127	109	6	hbv	hbv	NOUN
iajs-2127	109	7	associated	associate	VERB
iajs-2127	109	8	with	with	ADP
iajs-2127	109	9	alternation	alternation	NOUN
iajs-2127	109	10	in	in	ADP
iajs-2127	109	11	iron	iron	NOUN
iajs-2127	109	12	metabolism	metabolism	NOUN
iajs-2127	109	13	[	[	X
iajs-2127	109	14	23	23	NUM
iajs-2127	109	15	]	]	PUNCT
iajs-2127	109	16	.	.	PUNCT
iajs-2127	110	1	interestingly	interestingly	ADV
iajs-2127	110	2	,	,	PUNCT
iajs-2127	110	3	no	no	DET
iajs-2127	110	4	differences	difference	NOUN
iajs-2127	110	5	in	in	ADP
iajs-2127	110	6	abs	ab	NOUN
iajs-2127	110	7	.	.	PUNCT
iajs-2127	111	1	eryt	eryt	PROPN
iajs-2127	111	2	.	.	PROPN
iajs-2127	111	3	,	,	PUNCT
iajs-2127	112	1	pcv	pcv	PROPN
iajs-2127	112	2	,	,	PUNCT
iajs-2127	112	3	mcv	mcv	PROPN
iajs-2127	112	4	,	,	PUNCT
iajs-2127	112	5	rdw	rdw	PROPN
iajs-2127	112	6	,	,	PUNCT
iajs-2127	112	7	mch	mch	PROPN
iajs-2127	112	8	and	and	CCONJ
iajs-2127	112	9	mchc	mchc	NOUN
iajs-2127	112	10	were	be	AUX
iajs-2127	112	11	observed	observe	VERB
iajs-2127	112	12	.	.	PUNCT
iajs-2127	113	1	in	in	ADP
iajs-2127	113	2	conclusion	conclusion	NOUN
iajs-2127	113	3	,	,	PUNCT
iajs-2127	113	4	inflammation	inflammation	NOUN
iajs-2127	113	5	caused	cause	VERB
iajs-2127	113	6	by	by	ADP
iajs-2127	113	7	hbv	hbv	NOUN
iajs-2127	113	8	infection	infection	NOUN
iajs-2127	113	9	has	have	VERB
iajs-2127	113	10	effects	effect	NOUN
iajs-2127	113	11	on	on	ADP
iajs-2127	113	12	the	the	DET
iajs-2127	113	13	production	production	NOUN
iajs-2127	113	14	of	of	ADP
iajs-2127	113	15	haematological	haematological	ADJ
iajs-2127	113	16	precursor	precursor	NOUN
iajs-2127	113	17	cells	cell	NOUN
iajs-2127	113	18	and	and	CCONJ
iajs-2127	113	19	on	on	ADP
iajs-2127	113	20	red	red	ADJ
iajs-2127	113	21	blood	blood	NOUN
iajs-2127	113	22	cell	cell	NOUN
iajs-2127	113	23	morphology	morphology	NOUN
iajs-2127	113	24	,	,	PUNCT
iajs-2127	113	25	these	these	DET
iajs-2127	113	26	findings	finding	NOUN
iajs-2127	113	27	are	be	AUX
iajs-2127	113	28	in	in	ADP
iajs-2127	113	29	tune	tune	NOUN
iajs-2127	113	30	with	with	ADP
iajs-2127	113	31	the	the	DET
iajs-2127	113	32	study	study	NOUN
iajs-2127	113	33	by	by	ADP
iajs-2127	113	34	das	das	PROPN
iajs-2127	113	35	s	s	PROPN
iajs-2127	113	36	k	k	PROPN
iajs-2127	113	37	,	,	PUNCT
iajs-2127	113	38	et	et	PROPN
iajs-2127	113	39	al	al	PROPN
iajs-2127	114	1	[	[	X
iajs-2127	114	2	24	24	NUM
iajs-2127	114	3	]	]	PUNCT
iajs-2127	114	4	.	.	PUNCT
iajs-2127	115	1	in	in	ADP
iajs-2127	115	2	the	the	DET
iajs-2127	115	3	liver	liver	NOUN
iajs-2127	115	4	,	,	PUNCT
iajs-2127	115	5	the	the	DET
iajs-2127	115	6	innate	innate	ADJ
iajs-2127	115	7	,	,	PUNCT
iajs-2127	115	8	immune	immune	ADJ
iajs-2127	115	9	system	system	NOUN
iajs-2127	115	10	is	be	AUX
iajs-2127	115	11	driven	drive	VERB
iajs-2127	115	12	by	by	ADP
iajs-2127	115	13	a	a	DET
iajs-2127	115	14	complex	complex	ADJ
iajs-2127	115	15	series	series	NOUN
iajs-2127	115	16	of	of	ADP
iajs-2127	115	17	leukocytes	leukocyte	NOUN
iajs-2127	115	18	(	(	PUNCT
iajs-2127	115	19	granulocytes	granulocyte	NOUN
iajs-2127	115	20	such	such	ADJ
iajs-2127	115	21	as	as	ADP
iajs-2127	115	22	neut	neut	NOUN
iajs-2127	115	23	,	,	PUNCT
iajs-2127	115	24	eosin	eosin	NOUN
iajs-2127	115	25	and	and	CCONJ
iajs-2127	115	26	baso	baso	PROPN
iajs-2127	115	27	and	and	CCONJ
iajs-2127	115	28	nongranulocytes	nongranulocyte	NOUN
iajs-2127	115	29	such	such	ADJ
iajs-2127	115	30	as	as	ADP
iajs-2127	115	31	lymp	lymp	NOUN
iajs-2127	115	32	and	and	CCONJ
iajs-2127	115	33	mono	mono	PROPN
iajs-2127	115	34	)	)	PUNCT
iajs-2127	116	1	[	[	X
iajs-2127	116	2	24	24	NUM
iajs-2127	116	3	-	-	SYM
iajs-2127	116	4	25	25	NUM
iajs-2127	116	5	]	]	PUNCT
iajs-2127	116	6	.	.	PUNCT
iajs-2127	117	1	of	of	ADP
iajs-2127	117	2	these	these	DET
iajs-2127	117	3	cell	cell	NOUN
iajs-2127	117	4	subsets	subset	NOUN
iajs-2127	117	5	,	,	PUNCT
iajs-2127	117	6	neut	neut	NOUN
iajs-2127	117	7	which	which	PRON
iajs-2127	117	8	accumulate	accumulate	VERB
iajs-2127	117	9	in	in	ADP
iajs-2127	117	10	the	the	DET
iajs-2127	117	11	liver	liver	NOUN
iajs-2127	117	12	have	have	VERB
iajs-2127	117	13	special	special	ADJ
iajs-2127	117	14	role	role	NOUN
iajs-2127	117	15	in	in	ADP
iajs-2127	117	16	the	the	DET
iajs-2127	117	17	defence	defence	NOUN
iajs-2127	117	18	against	against	ADP
iajs-2127	117	19	viral	viral	ADJ
iajs-2127	117	20	infections	infection	NOUN
iajs-2127	117	21	[	[	X
iajs-2127	117	22	26	26	NUM
iajs-2127	117	23	]	]	PUNCT
iajs-2127	117	24	.	.	PUNCT
iajs-2127	118	1	significant	significant	ADJ
iajs-2127	118	2	difference	difference	NOUN
iajs-2127	118	3	existed	exist	VERB
iajs-2127	118	4	(	(	PUNCT
iajs-2127	118	5	p≤0.05	p≤0.05	NOUN
iajs-2127	118	6	)	)	PUNCT
iajs-2127	118	7	in	in	ADP
iajs-2127	118	8	abs	ab	NOUN
iajs-2127	118	9	neut	neut	VERB
iajs-2127	118	10	hbv	hbv	NOUN
iajs-2127	118	11	in	in	ADP
iajs-2127	118	12	positive	positive	ADJ
iajs-2127	118	13	male	male	ADJ
iajs-2127	118	14	subjects	subject	NOUN
iajs-2127	118	15	when	when	SCONJ
iajs-2127	118	16	compared	compare	VERB
iajs-2127	118	17	with	with	ADP
iajs-2127	118	18	negative	negative	ADJ
iajs-2127	118	19	control	control	NOUN
iajs-2127	118	20	group	group	NOUN
iajs-2127	118	21	,	,	PUNCT
iajs-2127	118	22	while	while	SCONJ
iajs-2127	118	23	no	no	DET
iajs-2127	118	24	differences	difference	NOUN
iajs-2127	118	25	were	be	AUX
iajs-2127	118	26	observed	observe	VERB
iajs-2127	118	27	in	in	ADP
iajs-2127	118	28	luk	luk	PROPN
iajs-2127	118	29	,	,	PUNCT
iajs-2127	118	30	lym	lym	PROPN
iajs-2127	118	31	,	,	PUNCT
iajs-2127	118	32	mono	mono	NOUN
iajs-2127	118	33	,	,	PUNCT
iajs-2127	118	34	eosin	eosin	NOUN
iajs-2127	118	35	and	and	CCONJ
iajs-2127	118	36	baso	baso	PROPN
iajs-2127	118	37	.	.	PUNCT
iajs-2127	119	1	recently	recently	ADV
iajs-2127	119	2	,	,	PUNCT
iajs-2127	119	3	there	there	PRON
iajs-2127	119	4	has	have	AUX
iajs-2127	119	5	been	be	AUX
iajs-2127	119	6	evidence	evidence	NOUN
iajs-2127	119	7	that	that	SCONJ
iajs-2127	119	8	the	the	DET
iajs-2127	119	9	,	,	PUNCT
iajs-2127	119	10	functional	functional	ADJ
iajs-2127	119	11	defect	defect	NOUN
iajs-2127	119	12	in	in	ADP
iajs-2127	119	13	neut	neut	NOUN
iajs-2127	119	14	take	take	VERB
iajs-2127	119	15	place	place	NOUN
iajs-2127	119	16	in	in	ADP
iajs-2127	119	17	liver	liver	NOUN
iajs-2127	119	18	cirrhosis	cirrhosis	NOUN
iajs-2127	119	19	[	[	X
iajs-2127	119	20	25	25	NUM
iajs-2127	119	21	]	]	PUNCT
iajs-2127	119	22	.	.	PUNCT
iajs-2127	120	1	another	another	DET
iajs-2127	120	2	study	study	NOUN
iajs-2127	120	3	showed	show	VERB
iajs-2127	120	4	that	that	SCONJ
iajs-2127	120	5	the	the	DET
iajs-2127	120	6	lym	lym	PROPN
iajs-2127	120	7	will	will	AUX
iajs-2127	120	8	increase	increase	VERB
iajs-2127	120	9	while	while	SCONJ
iajs-2127	120	10	the	the	DET
iajs-2127	120	11	neut	neut	NOUN
iajs-2127	120	12	will	will	AUX
iajs-2127	120	13	decrease	decrease	VERB
iajs-2127	120	14	but	but	CCONJ
iajs-2127	120	15	no	no	DET
iajs-2127	120	16	changes	change	NOUN
iajs-2127	120	17	in	in	ADP
iajs-2127	120	18	total	total	ADJ
iajs-2127	120	19	leuk	leuk	NOUN
iajs-2127	120	20	count	count	NOUN
iajs-2127	120	21	was	be	AUX
iajs-2127	120	22	observed	observe	VERB
iajs-2127	120	23	[	[	X
iajs-2127	120	24	27	27	NUM
iajs-2127	120	25	]	]	PUNCT
iajs-2127	120	26	.	.	PUNCT
iajs-2127	121	1	the	the	DET
iajs-2127	121	2	positive	positive	ADJ
iajs-2127	121	3	decreases	decrease	NOUN
iajs-2127	121	4	in	in	ADP
iajs-2127	121	5	neut	neut	NOUN
iajs-2127	121	6	(	(	PUNCT
iajs-2127	121	7	%	%	INTJ
iajs-2127	121	8	)	)	PUNCT
iajs-2127	121	9	,	,	PUNCT
iajs-2127	121	10	lymp	lymp	PROPN
iajs-2127	121	11	(	(	PUNCT
iajs-2127	121	12	%	%	INTJ
iajs-2127	121	13	)	)	PUNCT
iajs-2127	121	14	and	and	CCONJ
iajs-2127	121	15	baso	baso	PROPN
iajs-2127	121	16	(	(	PUNCT
iajs-2127	121	17	%	%	NOUN
iajs-2127	121	18	)	)	PUNCT
iajs-2127	121	19	,	,	PUNCT
iajs-2127	121	20	may	may	AUX
iajs-2127	121	21	,	,	PUNCT
iajs-2127	121	22	reflect	reflect	VERB
iajs-2127	121	23	the	the	DET
iajs-2127	121	24	severity	severity	NOUN
iajs-2127	121	25	and	and	CCONJ
iajs-2127	121	26	progression	progression	NOUN
iajs-2127	121	27	of	of	ADP
iajs-2127	121	28	,	,	PUNCT
iajs-2127	121	29	liver	liver	NOUN
iajs-2127	121	30	,	,	PUNCT
iajs-2127	121	31	injury	injury	NOUN
iajs-2127	121	32	[	[	X
iajs-2127	121	33	28	28	NUM
iajs-2127	121	34	]	]	PUNCT
iajs-2127	121	35	.	.	PUNCT
iajs-2127	122	1	our	our	PRON
iajs-2127	122	2	results	result	NOUN
iajs-2127	122	3	are	be	AUX
iajs-2127	122	4	in	in	ADP
iajs-2127	122	5	agree	agree	NOUN
iajs-2127	122	6	with	with	ADP
iajs-2127	122	7	francisca	francisca	PROPN
iajs-2127	122	8	,	,	PUNCT
iajs-2127	122	9	et	et	PROPN
iajs-2127	122	10	al	al	PROPN
iajs-2127	122	11	.	.	PROPN
iajs-2127	122	12	,	,	PUNCT
iajs-2127	123	1	[	[	X
iajs-2127	123	2	29	29	NUM
iajs-2127	123	3	]	]	PUNCT
iajs-2127	123	4	.	.	PUNCT
iajs-2127	124	1	abs	ab	NOUN
iajs-2127	124	2	plt	plt	NOUN
iajs-2127	124	3	was	be	AUX
iajs-2127	124	4	highly	highly	ADV
iajs-2127	124	5	significant	significant	ADJ
iajs-2127	124	6	related	relate	VERB
iajs-2127	124	7	to	to	ADP
iajs-2127	124	8	liver	liver	NOUN
iajs-2127	124	9	infection	infection	NOUN
iajs-2127	124	10	in	in	ADP
iajs-2127	124	11	the	the	DET
iajs-2127	124	12	present	present	ADJ
iajs-2127	124	13	study	study	NOUN
iajs-2127	124	14	compared	compare	VERB
iajs-2127	124	15	with	with	ADP
iajs-2127	124	16	non	non	ADJ
iajs-2127	124	17	-	-	ADJ
iajs-2127	124	18	infected	infected	ADJ
iajs-2127	124	19	liver	liver	NOUN
iajs-2127	124	20	,	,	PUNCT
iajs-2127	124	21	this	this	DET
iajs-2127	124	22	result	result	NOUN
iajs-2127	124	23	is	be	AUX
iajs-2127	124	24	in	in	ADP
iajs-2127	124	25	agreement	agreement	NOUN
iajs-2127	124	26	with	with	ADP
iajs-2127	124	27	the	the	DET
iajs-2127	124	28	fact	fact	NOUN
iajs-2127	124	29	stated	state	VERB
iajs-2127	124	30	by	by	ADP
iajs-2127	124	31	others	other	NOUN
iajs-2127	124	32	that	that	SCONJ
iajs-2127	124	33	plt	plt	NOUN
iajs-2127	124	34	is	be	AUX
iajs-2127	124	35	a	a	DET
iajs-2127	124	36	good	good	ADJ
iajs-2127	124	37	indicator	indicator	NOUN
iajs-2127	124	38	for	for	ADP
iajs-2127	124	39	liver	liver	NOUN
iajs-2127	124	40	inflammation	inflammation	NOUN
iajs-2127	124	41	and	and	CCONJ
iajs-2127	124	42	advanced	advanced	ADJ
iajs-2127	124	43	liver	liver	NOUN
iajs-2127	124	44	fibrosis	fibrosis	NOUN
iajs-2127	124	45	and	and	CCONJ
iajs-2127	124	46	strongly	strongly	ADV
iajs-2127	124	47	related	relate	VERB
iajs-2127	124	48	with	with	ADP
iajs-2127	124	49	the	the	DET
iajs-2127	124	50	hbv	hbv	NOUN
iajs-2127	124	51	status	status	NOUN
iajs-2127	124	52	[	[	X
iajs-2127	124	53	30	30	NUM
iajs-2127	124	54	-	-	SYM
iajs-2127	124	55	31	31	NUM
iajs-2127	124	56	]	]	PUNCT
iajs-2127	124	57	.	.	PUNCT
iajs-2127	125	1	biomarkers	biomarker	NOUN
iajs-2127	125	2	are	be	AUX
iajs-2127	125	3	equally	equally	ADV
iajs-2127	125	4	valuable	valuable	ADJ
iajs-2127	125	5	for	for	SCONJ
iajs-2127	125	6	the	the	DET
iajs-2127	125	7	estimation	estimation	NOUN
iajs-2127	125	8	and	and	CCONJ
iajs-2127	125	9	assessment	assessment	NOUN
iajs-2127	125	10	of	of	ADP
iajs-2127	125	11	hepatic	hepatic	ADJ
iajs-2127	125	12	disease	disease	NOUN
iajs-2127	125	13	severity	severity	NOUN
iajs-2127	125	14	due	due	ADP
iajs-2127	125	15	to	to	ADP
iajs-2127	125	16	hbv	hbv	NOUN
iajs-2127	125	17	infection	infection	NOUN
iajs-2127	125	18	may	may	AUX
iajs-2127	125	19	alter	alter	VERB
iajs-2127	125	20	the	the	DET
iajs-2127	125	21	levels	level	NOUN
iajs-2127	125	22	of	of	ADP
iajs-2127	125	23	certain	certain	ADJ
iajs-2127	125	24	liver	liver	NOUN
iajs-2127	125	25	enzymes	enzyme	NOUN
iajs-2127	125	26	as	as	ADP
iajs-2127	125	27	a	a	DET
iajs-2127	125	28	result	result	NOUN
iajs-2127	125	29	of	of	ADP
iajs-2127	125	30	hepatocellular	hepatocellular	ADJ
iajs-2127	125	31	damage	damage	NOUN
iajs-2127	125	32	[	[	X
iajs-2127	125	33	32	32	NUM
iajs-2127	125	34	]	]	PUNCT
iajs-2127	125	35	.	.	PUNCT
iajs-2127	126	1	high	high	ADJ
iajs-2127	126	2	significant	significant	ADJ
iajs-2127	126	3	increases	increase	NOUN
iajs-2127	126	4	were	be	AUX
iajs-2127	126	5	observed	observe	VERB
iajs-2127	126	6	in	in	ADP
iajs-2127	126	7	alt	alt	ADJ
iajs-2127	126	8	,	,	PUNCT
iajs-2127	126	9	ast	ast	PROPN
iajs-2127	126	10	,	,	PUNCT
iajs-2127	126	11	alp	alp	PROPN
iajs-2127	126	12	and	and	CCONJ
iajs-2127	126	13	ggt	ggt	PROPN
iajs-2127	126	14	at	at	ADP
iajs-2127	126	15	(	(	PUNCT
iajs-2127	126	16	p≤0.05	p≤0.05	NOUN
iajs-2127	126	17	)	)	PUNCT
iajs-2127	126	18	in	in	ADP
iajs-2127	126	19	hbv	hbv	NOUN
iajs-2127	126	20	compared	compare	VERB
iajs-2127	126	21	with	with	ADP
iajs-2127	126	22	control	control	NOUN
iajs-2127	126	23	,	,	PUNCT
iajs-2127	126	24	these	these	DET
iajs-2127	126	25	results	result	NOUN
iajs-2127	126	26	are	be	AUX
iajs-2127	126	27	in	in	ADP
iajs-2127	126	28	agreement	agreement	NOUN
iajs-2127	126	29	with	with	ADP
iajs-2127	126	30	others	other	NOUN
iajs-2127	127	1	[	[	X
iajs-2127	127	2	22	22	NUM
iajs-2127	127	3	]	]	PUNCT
iajs-2127	127	4	,	,	PUNCT
iajs-2127	128	1	[	[	X
iajs-2127	128	2	33	33	NUM
iajs-2127	128	3	-	-	SYM
iajs-2127	128	4	34	34	NUM
iajs-2127	128	5	]	]	PUNCT
iajs-2127	128	6	.	.	PUNCT
iajs-2127	129	1	alt	alt	VERB
iajs-2127	129	2	and	and	CCONJ
iajs-2127	129	3	ggt	ggt	PROPN
iajs-2127	129	4	showed	show	VERB
iajs-2127	129	5	the	the	DET
iajs-2127	129	6	highest	high	ADJ
iajs-2127	129	7	increments	increment	NOUN
iajs-2127	129	8	in	in	ADP
iajs-2127	129	9	hbv	hbv	NOUN
iajs-2127	129	10	infection	infection	NOUN
iajs-2127	129	11	,	,	PUNCT
iajs-2127	129	12	it	it	PRON
iajs-2127	129	13	has	have	AUX
iajs-2127	129	14	been	be	AUX
iajs-2127	129	15	stated	state	VERB
iajs-2127	129	16	that	that	SCONJ
iajs-2127	129	17	moderate	moderate	ADJ
iajs-2127	129	18	elevation	elevation	NOUN
iajs-2127	129	19	(	(	PUNCT
iajs-2127	129	20	3	3	NUM
iajs-2127	129	21	-	-	SYM
iajs-2127	129	22	20	20	NUM
iajs-2127	129	23	times	time	NOUN
iajs-2127	129	24	)	)	PUNCT
iajs-2127	129	25	of	of	ADP
iajs-2127	129	26	alt	alt	ADJ
iajs-2127	129	27	level	level	NOUN
iajs-2127	129	28	usually	usually	ADV
iajs-2127	129	29	observed	observe	VERB
iajs-2127	129	30	in	in	ADP
iajs-2127	129	31	acute	acute	ADJ
iajs-2127	129	32	hepatitis	hepatitis	NOUN
iajs-2127	129	33	,	,	PUNCT
iajs-2127	129	34	neonatal	neonatal	ADJ
iajs-2127	129	35	hepatitis	hepatitis	NOUN
iajs-2127	129	36	,	,	PUNCT
iajs-2127	129	37	chronic	chronic	ADJ
iajs-2127	129	38	hepatitis	hepatitis	NOUN
iajs-2127	129	39	,	,	PUNCT
iajs-2127	129	40	autoimmune	autoimmune	ADJ
iajs-2127	129	41	hepatitis	hepatitis	NOUN
iajs-2127	129	42	,	,	PUNCT
iajs-2127	129	43	drug	drug	NOUN
iajs-2127	129	44	induced	induce	VERB
iajs-2127	129	45	hepatitis	hepatitis	NOUN
iajs-2127	129	46	,	,	PUNCT
iajs-2127	129	47	alcoholic	alcoholic	ADJ
iajs-2127	129	48	hepatitis	hepatitis	NOUN
iajs-2127	130	1	[	[	X
iajs-2127	130	2	30	30	NUM
iajs-2127	130	3	]	]	PUNCT
iajs-2127	130	4	,	,	PUNCT
iajs-2127	131	1	[	[	X
iajs-2127	131	2	33	33	NUM
iajs-2127	131	3	]	]	PUNCT
iajs-2127	131	4	.	.	PUNCT
iajs-2127	132	1	other	other	ADJ
iajs-2127	132	2	study	study	NOUN
iajs-2127	132	3	deduced	deduce	VERB
iajs-2127	132	4	that	that	SCONJ
iajs-2127	132	5	the	the	DET
iajs-2127	132	6	ggt	ggt	NOUN
iajs-2127	132	7	increment	increment	NOUN
iajs-2127	132	8	that	that	PRON
iajs-2127	132	9	reflects	reflect	VERB
iajs-2127	132	10	inflammation	inflammation	NOUN
iajs-2127	132	11	in	in	ADP
iajs-2127	132	12	,	,	PUNCT
iajs-2127	132	13	the	the	DET
iajs-2127	132	14	liver	liver	NOUN
iajs-2127	132	15	is	be	AUX
iajs-2127	132	16	superior	superior	ADJ
iajs-2127	132	17	than	than	ADP
iajs-2127	132	18	alt	alt	ADJ
iajs-2127	132	19	,	,	PUNCT
iajs-2127	132	20	and	and	CCONJ
iajs-2127	132	21	that	that	SCONJ
iajs-2127	132	22	ggt	ggt	NOUN
iajs-2127	132	23	may	may	AUX
iajs-2127	132	24	have	have	VERB
iajs-2127	132	25	a	a	DET
iajs-2127	132	26	significant	significant	ADJ
iajs-2127	132	27	role	role	NOUN
iajs-2127	132	28	in	in	ADP
iajs-2127	132	29	the	the	DET
iajs-2127	132	30	clinical	clinical	ADJ
iajs-2127	132	31	,	,	PUNCT
iajs-2127	132	32	evaluation	evaluation	NOUN
iajs-2127	132	33	of	of	ADP
iajs-2127	132	34	hbv	hbv	NOUN
iajs-2127	133	1	[	[	X
iajs-2127	133	2	34	34	NUM
iajs-2127	133	3	]	]	PUNCT
iajs-2127	133	4	.	.	PUNCT
iajs-2127	134	1	t.bil	t.bil	PROPN
iajs-2127	134	2	was	be	AUX
iajs-2127	134	3	significantly	significantly	ADV
iajs-2127	134	4	elevated	elevate	VERB
iajs-2127	134	5	in	in	ADP
iajs-2127	134	6	hbv	hbv	NOUN
iajs-2127	134	7	patients	patient	NOUN
iajs-2127	134	8	compared	compare	VERB
iajs-2127	134	9	with	with	ADP
iajs-2127	134	10	controls	control	NOUN
iajs-2127	134	11	as	as	SCONJ
iajs-2127	134	12	indicated	indicate	VERB
iajs-2127	134	13	in	in	ADP
iajs-2127	134	14	table	table	NOUN
iajs-2127	134	15	1	1	NUM
iajs-2127	134	16	.	.	PUNCT
iajs-2127	135	1	the	the	DET
iajs-2127	135	2	agreement	agreement	NOUN
iajs-2127	135	3	of	of	ADP
iajs-2127	135	4	this	this	DET
iajs-2127	135	5	result	result	NOUN
iajs-2127	135	6	with	with	ADP
iajs-2127	135	7	other	other	ADJ
iajs-2127	135	8	studies	study	NOUN
iajs-2127	135	9	[	[	X
iajs-2127	135	10	21	21	NUM
iajs-2127	135	11	-	-	SYM
iajs-2127	135	12	22	22	NUM
iajs-2127	135	13	]	]	PUNCT
iajs-2127	135	14	.	.	PUNCT
iajs-2127	136	1	reflect	reflect	VERB
iajs-2127	136	2	the	the	DET
iajs-2127	136	3	use	use	NOUN
iajs-2127	136	4	of	of	ADP
iajs-2127	136	5	t.bil	t.bil	VERB
iajs-2127	136	6	as	as	ADP
iajs-2127	136	7	one	one	NUM
iajs-2127	136	8	of	of	ADP
iajs-2127	136	9	the	the	DET
iajs-2127	136	10	markers	marker	NOUN
iajs-2127	136	11	of	of	ADP
iajs-2127	136	12	liver	liver	NOUN
iajs-2127	136	13	injury	injury	NOUN
iajs-2127	136	14	[	[	X
iajs-2127	136	15	35	35	NUM
iajs-2127	136	16	]	]	SYM
iajs-2127	136	17	.	.	PUNCT
iajs-2127	137	1	also	also	ADV
iajs-2127	137	2	very	very	ADV
iajs-2127	137	3	high	high	ADJ
iajs-2127	137	4	increment	increment	NOUN
iajs-2127	137	5	in	in	ADP
iajs-2127	137	6	both	both	CCONJ
iajs-2127	137	7	alt	alt	VERB
iajs-2127	137	8	and/or	and/or	CCONJ
iajs-2127	137	9	ggt	ggt	PROPN
iajs-2127	137	10	obtained	obtain	VERB
iajs-2127	137	11	in	in	ADP
iajs-2127	137	12	this	this	DET
iajs-2127	137	13	study	study	NOUN
iajs-2127	137	14	can	can	AUX
iajs-2127	137	15	provide	provide	VERB
iajs-2127	137	16	a	a	DET
iajs-2127	137	17	valuable	valuable	ADJ
iajs-2127	137	18	information	information	NOUN
iajs-2127	137	19	through	through	ADP
iajs-2127	137	20	the	the	DET
iajs-2127	137	21	assessment	assessment	NOUN
iajs-2127	137	22	of	of	ADP
iajs-2127	137	23	hepatic	hepatic	ADJ
iajs-2127	137	24	inflammation	inflammation	NOUN
iajs-2127	137	25	and	and	CCONJ
iajs-2127	137	26	fibrosis	fibrosis	NOUN
iajs-2127	137	27	and	and	CCONJ
iajs-2127	137	28	beside	beside	ADP
iajs-2127	137	29	plt	plt	NOUN
iajs-2127	137	30	no	no	DET
iajs-2127	137	31	other	other	ADJ
iajs-2127	137	32	biochemical	biochemical	ADJ
iajs-2127	137	33	tests	test	NOUN
iajs-2127	137	34	have	have	AUX
iajs-2127	137	35	been	be	AUX
iajs-2127	137	36	shown	show	VERB
iajs-2127	137	37	to	to	PART
iajs-2127	137	38	be	be	AUX
iajs-2127	137	39	a	a	DET
iajs-2127	137	40	better	well	ADJ
iajs-2127	137	41	indicators	indicator	NOUN
iajs-2127	137	42	of	of	ADP
iajs-2127	137	43	liver	liver	NOUN
iajs-2127	137	44	injury	injury	NOUN
iajs-2127	137	45	.	.	PUNCT
iajs-2127	138	1	another	another	DET
iajs-2127	138	2	important	important	ADJ
iajs-2127	138	3	mediator	mediator	NOUN
iajs-2127	138	4	of	of	ADP
iajs-2127	138	5	host	host	NOUN
iajs-2127	138	6	immune	immune	ADJ
iajs-2127	138	7	defence	defence	NOUN
iajs-2127	138	8	crp	crp	PROPN
iajs-2127	138	9	and	and	CCONJ
iajs-2127	138	10	alb	alb	PROPN
iajs-2127	138	11	showed	show	VERB
iajs-2127	138	12	level	level	NOUN
iajs-2127	138	13	increment	increment	NOUN
iajs-2127	138	14	in	in	ADP
iajs-2127	138	15	sera	sera	NOUN
iajs-2127	138	16	of	of	ADP
iajs-2127	138	17	hbv	hbv	NOUN
iajs-2127	138	18	individuals	individual	NOUN
iajs-2127	138	19	compared	compare	VERB
iajs-2127	138	20	with	with	ADP
iajs-2127	138	21	controls	control	NOUN
iajs-2127	138	22	at	at	ADP
iajs-2127	138	23	(	(	PUNCT
iajs-2127	138	24	p≤0.05	p≤0.05	NOUN
iajs-2127	138	25	)	)	PUNCT
iajs-2127	138	26	,	,	PUNCT
iajs-2127	138	27	our	our	PRON
iajs-2127	138	28	finding	finding	NOUN
iajs-2127	138	29	is	be	AUX
iajs-2127	138	30	in	in	ADP
iajs-2127	138	31	agreement	agreement	NOUN
iajs-2127	138	32	with	with	ADP
iajs-2127	138	33	other	other	ADJ
iajs-2127	138	34	studies	study	NOUN
iajs-2127	138	35	[	[	X
iajs-2127	138	36	16	16	NUM
iajs-2127	138	37	,	,	PUNCT
iajs-2127	138	38	30	30	NUM
iajs-2127	138	39	]	]	PUNCT
iajs-2127	138	40	,	,	PUNCT
iajs-2127	138	41	these	these	DET
iajs-2127	138	42	findings	finding	NOUN
iajs-2127	138	43	sound	sound	VERB
iajs-2127	138	44	not	not	PART
iajs-2127	138	45	unusual	unusual	ADJ
iajs-2127	138	46	since	since	SCONJ
iajs-2127	138	47	liver	liver	NOUN
iajs-2127	138	48	is	be	AUX
iajs-2127	138	49	the	the	DET
iajs-2127	138	50	target	target	NOUN
iajs-2127	138	51	,	,	PUNCT
iajs-2127	138	52	organ	organ	VERB
iajs-2127	138	53	for	for	ADP
iajs-2127	138	54	the	the	DET
iajs-2127	138	55	replication	replication	NOUN
iajs-2127	138	56	of	of	ADP
iajs-2127	138	57	hbv	hbv	NOUN
iajs-2127	138	58	,	,	PUNCT
iajs-2127	138	59	leading	lead	VERB
iajs-2127	138	60	to	to	ADP
iajs-2127	138	61	the	the	DET
iajs-2127	138	62	demolition	demolition	NOUN
iajs-2127	138	63	of	of	ADP
iajs-2127	138	64	hepatocytes	hepatocyte	NOUN
iajs-2127	138	65	and	and	CCONJ
iajs-2127	138	66	,	,	PUNCT
iajs-2127	138	67	consequently	consequently	ADV
iajs-2127	138	68	increase	increase	VERB
iajs-2127	138	69	the	the	DET
iajs-2127	138	70	releasing	releasing	NOUN
iajs-2127	138	71	of	of	ADP
iajs-2127	138	72	these	these	DET
iajs-2127	138	73	molecules	molecule	NOUN
iajs-2127	138	74	[	[	X
iajs-2127	138	75	18	18	NUM
iajs-2127	138	76	]	]	PUNCT
iajs-2127	138	77	.	.	PUNCT
iajs-2127	139	1	the	the	DET
iajs-2127	139	2	effect	effect	NOUN
iajs-2127	139	3	of	of	ADP
iajs-2127	139	4	hbv	hbv	NOUN
iajs-2127	139	5	infection	infection	NOUN
iajs-2127	139	6	on	on	ADP
iajs-2127	139	7	liver	liver	NOUN
iajs-2127	139	8	's	's	PART
iajs-2127	139	9	clearance	clearance	NOUN
iajs-2127	139	10	of	of	ADP
iajs-2127	139	11	pancreatic	pancreatic	ADJ
iajs-2127	139	12	enzymes	enzyme	NOUN
iajs-2127	139	13	was	be	AUX
iajs-2127	139	14	followed	follow	VERB
iajs-2127	139	15	by	by	ADP
iajs-2127	139	16	evaluation	evaluation	NOUN
iajs-2127	139	17	of	of	ADP
iajs-2127	139	18	amy	amy	PROPN
iajs-2127	139	19	activity	activity	NOUN
iajs-2127	139	20	,	,	PUNCT
iajs-2127	139	21	table	table	NOUN
iajs-2127	139	22	1	1	NUM
iajs-2127	139	23	,	,	PUNCT
iajs-2127	139	24	revealed	reveal	VERB
iajs-2127	139	25	significant	significant	ADJ
iajs-2127	139	26	increase(p≤0.05	increase(p≤0.05	NOUN
iajs-2127	139	27	)	)	PUNCT
iajs-2127	139	28	in	in	ADP
iajs-2127	139	29	amy	amy	NOUN
iajs-2127	139	30	activity	activity	NOUN
iajs-2127	139	31	in	in	ADP
iajs-2127	139	32	hbv	hbv	NOUN
iajs-2127	139	33	patients	patient	NOUN
iajs-2127	139	34	compared	compare	VERB
iajs-2127	139	35	with	with	ADP
iajs-2127	139	36	control	control	NOUN
iajs-2127	139	37	group	group	NOUN
iajs-2127	139	38	,	,	PUNCT
iajs-2127	139	39	our	our	PRON
iajs-2127	139	40	results	result	NOUN
iajs-2127	139	41	are	be	AUX
iajs-2127	139	42	in	in	ADP
iajs-2127	139	43	agreement	agreement	NOUN
iajs-2127	139	44	with	with	ADP
iajs-2127	139	45	katakura	katakura	NOUN
iajs-2127	139	46	yet	yet	ADV
iajs-2127	139	47	al	al	PROPN
iajs-2127	140	1	[	[	X
iajs-2127	140	2	36	36	NUM
iajs-2127	140	3	]	]	PUNCT
iajs-2127	140	4	,	,	PUNCT
iajs-2127	140	5	and	and	CCONJ
iajs-2127	140	6	kaur	kaur	PROPN
iajs-2127	140	7	n	n	INTJ
iajs-2127	140	8	et	et	NOUN
iajs-2127	140	9	al	al	PROPN
iajs-2127	141	1	[	[	X
iajs-2127	141	2	19	19	NUM
iajs-2127	141	3	]	]	PUNCT
iajs-2127	141	4	.	.	PUNCT
iajs-2127	142	1	for	for	ADP
iajs-2127	142	2	investigating	investigate	VERB
iajs-2127	142	3	renal	renal	ADJ
iajs-2127	142	4	abnormalities	abnormality	NOUN
iajs-2127	142	5	associated	associate	VERB
iajs-2127	142	6	with	with	ADP
iajs-2127	142	7	hbv	hbv	NOUN
iajs-2127	142	8	infection	infection	NOUN
iajs-2127	142	9	,	,	PUNCT
iajs-2127	142	10	serum	serum	PROPN
iajs-2127	142	11	crea	crea	PROPN
iajs-2127	142	12	and	and	CCONJ
iajs-2127	142	13	some	some	DET
iajs-2127	142	14	electrolytes	electrolyte	NOUN
iajs-2127	142	15	have	have	AUX
iajs-2127	142	16	been	be	AUX
iajs-2127	142	17	estimated	estimate	VERB
iajs-2127	142	18	,	,	PUNCT
iajs-2127	142	19	as	as	SCONJ
iajs-2127	142	20	showed	show	VERB
iajs-2127	142	21	in	in	ADP
iajs-2127	142	22	table	table	NOUN
iajs-2127	142	23	1	1	NUM
iajs-2127	142	24	,	,	PUNCT
iajs-2127	142	25	non	non	ADJ
iajs-2127	142	26	significant	significant	ADJ
iajs-2127	142	27	increase	increase	NOUN
iajs-2127	142	28	in	in	ADP
iajs-2127	142	29	crea	crea	PROPN
iajs-2127	142	30	.	.	PROPN
iajs-2127	142	31	,	,	PUNCT
iajs-2127	142	32	na	na	NOUN
iajs-2127	142	33	and	and	CCONJ
iajs-2127	142	34	k	k	PROPN
iajs-2127	142	35	levels	level	NOUN
iajs-2127	142	36	in	in	ADP
iajs-2127	142	37	hbv	hbv	NOUN
iajs-2127	142	38	group	group	NOUN
iajs-2127	142	39	compared	compare	VERB
iajs-2127	142	40	with	with	ADP
iajs-2127	142	41	controls	control	NOUN
iajs-2127	142	42	at	at	ADP
iajs-2127	142	43	(	(	PUNCT
iajs-2127	142	44	p≤	p≤	NOUN
iajs-2127	142	45	0.01	0.01	NUM
iajs-2127	142	46	)	)	PUNCT
iajs-2127	142	47	,	,	PUNCT
iajs-2127	142	48	ayelagbe	ayelagbe	NOUN
iajs-2127	142	49	and	and	CCONJ
iajs-2127	142	50	oladipo	oladipo	NOUN
iajs-2127	142	51	found	find	VERB
iajs-2127	142	52	no	no	DET
iajs-2127	142	53	significant	significant	ADJ
iajs-2127	142	54	differences	difference	NOUN
iajs-2127	142	55	in	in	ADP
iajs-2127	142	56	serum	serum	NOUN
iajs-2127	142	57	concentrations	concentration	NOUN
iajs-2127	142	58	of	of	ADP
iajs-2127	142	59	crea	crea	NOUN
iajs-2127	142	60	,	,	PUNCT
iajs-2127	142	61	and	and	CCONJ
iajs-2127	142	62	na	na	AUX
iajs-2127	142	63	while	while	SCONJ
iajs-2127	142	64	k	k	PROPN
iajs-2127	142	65	was	be	AUX
iajs-2127	142	66	significantly	significantly	ADV
iajs-2127	142	67	,	,	PUNCT
iajs-2127	142	68	increased	increase	VERB
iajs-2127	142	69	in	in	ADP
iajs-2127	142	70	hbv	hbv	NOUN
iajs-2127	142	71	compared	compare	VERB
iajs-2127	142	72	with	with	ADP
iajs-2127	142	73	the	the	DET
iajs-2127	142	74	control	control	NOUN
iajs-2127	142	75	subjects	subject	NOUN
iajs-2127	142	76	[	[	X
iajs-2127	142	77	37	37	NUM
iajs-2127	142	78	]	]	PUNCT
iajs-2127	142	79	.	.	PUNCT
iajs-2127	143	1	however	however	ADV
iajs-2127	143	2	,	,	PUNCT
iajs-2127	143	3	in	in	ADP
iajs-2127	143	4	a	a	DET
iajs-2127	143	5	preliminary	preliminary	ADJ
iajs-2127	143	6	study	study	NOUN
iajs-2127	143	7	conducted	conduct	VERB
iajs-2127	143	8	by	by	ADP
iajs-2127	143	9	shahid	shahid	PROPN
iajs-2127	143	10	et	et	PROPN
iajs-2127	143	11	al	al	PROPN
iajs-2127	143	12	hypokalaemia	hypokalaemia	PROPN
iajs-2127	143	13	was	be	AUX
iajs-2127	143	14	found	find	VERB
iajs-2127	143	15	in	in	ADP
iajs-2127	143	16	37	37	NUM
iajs-2127	143	17	%	%	NOUN
iajs-2127	143	18	16	16	NUM
iajs-2127	143	19	ibn	ibn	PROPN
iajs-2127	143	20	al	al	PROPN
iajs-2127	143	21	-	-	PUNCT
iajs-2127	143	22	haitham	haitham	PROPN
iajs-2127	143	23	jour	jour	X
iajs-2127	143	24	.	.	PROPN
iajs-2127	144	1	for	for	ADP
iajs-2127	144	2	pure	pure	ADJ
iajs-2127	144	3	&	&	CCONJ
iajs-2127	144	4	appl	appl	PROPN
iajs-2127	144	5	.	.	PUNCT
iajs-2127	145	1	sci	sci	PROPN
iajs-2127	145	2	.	.	PROPN
iajs-2127	145	3	32	32	NUM
iajs-2127	145	4	(	(	PUNCT
iajs-2127	145	5	2	2	NUM
iajs-2127	145	6	)	)	PUNCT
iajs-2127	145	7	2019	2019	NUM
iajs-2127	145	8	cirrhotics	cirrhotic	NOUN
iajs-2127	145	9	liver	liver	NOUN
iajs-2127	145	10	[	[	X
iajs-2127	145	11	38	38	NUM
iajs-2127	145	12	]	]	PUNCT
iajs-2127	145	13	.	.	PUNCT
iajs-2127	146	1	it	it	PRON
iajs-2127	146	2	could	could	AUX
iajs-2127	146	3	be	be	AUX
iajs-2127	146	4	concluded	conclude	VERB
iajs-2127	146	5	from	from	ADP
iajs-2127	146	6	the	the	DET
iajs-2127	146	7	current	current	ADJ
iajs-2127	146	8	study	study	NOUN
iajs-2127	146	9	that	that	SCONJ
iajs-2127	146	10	there	there	PRON
iajs-2127	146	11	is	be	VERB
iajs-2127	146	12	no	no	DET
iajs-2127	146	13	renal	renal	ADJ
iajs-2127	146	14	complications	complication	NOUN
iajs-2127	146	15	of	of	ADP
iajs-2127	146	16	viral	viral	ADJ
iajs-2127	146	17	hepatitis	hepatitis	NOUN
iajs-2127	146	18	b	b	NOUN
iajs-2127	146	19	infection	infection	NOUN
iajs-2127	146	20	.	.	PUNCT
iajs-2127	147	1	in	in	ADP
iajs-2127	147	2	hepatitis	hepatitis	PROPN
iajs-2127	147	3	,	,	PUNCT
iajs-2127	147	4	alt	alt	AUX
iajs-2127	147	5	become	become	VERB
iajs-2127	147	6	elevated	elevated	ADJ
iajs-2127	148	1	may	may	AUX
iajs-2127	148	2	be	be	AUX
iajs-2127	148	3	100	100	NUM
iajs-2127	148	4	times	time	NOUN
iajs-2127	148	5	normal	normal	ADJ
iajs-2127	148	6	with	with	ADP
iajs-2127	148	7	the	the	DET
iajs-2127	148	8	progression	progression	NOUN
iajs-2127	148	9	of	of	ADP
iajs-2127	148	10	liver	liver	NOUN
iajs-2127	148	11	disease	disease	NOUN
iajs-2127	148	12	,	,	PUNCT
iajs-2127	148	13	likely	likely	ADV
iajs-2127	148	14	as	as	ADP
iajs-2127	148	15	a	a	DET
iajs-2127	148	16	result	result	NOUN
iajs-2127	148	17	of	of	ADP
iajs-2127	148	18	direct	direct	ADJ
iajs-2127	148	19	hepatocellular	hepatocellular	ADJ
iajs-2127	148	20	damage	damage	NOUN
iajs-2127	148	21	and	and	CCONJ
iajs-2127	148	22	membrane	membrane	NOUN
iajs-2127	148	23	leakage	leakage	NOUN
iajs-2127	148	24	,	,	PUNCT
iajs-2127	148	25	and	and	CCONJ
iajs-2127	148	26	no	no	DET
iajs-2127	148	27	other	other	ADJ
iajs-2127	148	28	biochemical	biochemical	ADJ
iajs-2127	148	29	test	test	NOUN
iajs-2127	148	30	has	have	AUX
iajs-2127	148	31	been	be	AUX
iajs-2127	148	32	shown	show	VERB
iajs-2127	148	33	to	to	PART
iajs-2127	148	34	be	be	AUX
iajs-2127	148	35	a	a	DET
iajs-2127	148	36	better	well	ADJ
iajs-2127	148	37	indicator	indicator	NOUN
iajs-2127	149	1	[	[	X
iajs-2127	149	2	3940	3940	NUM
iajs-2127	149	3	]	]	PUNCT
iajs-2127	149	4	.	.	PUNCT
iajs-2127	150	1	for	for	ADP
iajs-2127	150	2	this	this	PRON
iajs-2127	150	3	,	,	PUNCT
iajs-2127	150	4	we	we	PRON
iajs-2127	150	5	attempted	attempt	VERB
iajs-2127	150	6	to	to	PART
iajs-2127	150	7	find	find	VERB
iajs-2127	150	8	the	the	DET
iajs-2127	150	9	correlation	correlation	NOUN
iajs-2127	150	10	between	between	ADP
iajs-2127	150	11	alt	alt	PROPN
iajs-2127	150	12	and	and	CCONJ
iajs-2127	150	13	parameters	parameter	NOUN
iajs-2127	150	14	in	in	ADP
iajs-2127	150	15	table	table	NOUN
iajs-2127	150	16	1	1	NUM
iajs-2127	150	17	,	,	PUNCT
iajs-2127	150	18	that	that	PRON
iajs-2127	150	19	showed	show	VERB
iajs-2127	150	20	highest	high	ADJ
iajs-2127	150	21	increments	increment	NOUN
iajs-2127	150	22	in	in	ADP
iajs-2127	150	23	hbv	hbv	NOUN
iajs-2127	150	24	compared	compare	VERB
iajs-2127	150	25	with	with	ADP
iajs-2127	150	26	controls	control	NOUN
iajs-2127	150	27	pearson	pearson	NOUN
iajs-2127	150	28	correlation	correlation	NOUN
iajs-2127	150	29	analysis	analysis	NOUN
iajs-2127	150	30	in	in	ADP
iajs-2127	150	31	table	table	NOUN
iajs-2127	150	32	2	2	NUM
iajs-2127	150	33	,	,	PUNCT
iajs-2127	150	34	showed	show	VERB
iajs-2127	150	35	that	that	SCONJ
iajs-2127	150	36	alt	alt	NOUN
iajs-2127	150	37	was	be	AUX
iajs-2127	150	38	strongly	strongly	ADV
iajs-2127	150	39	positive	positive	ADJ
iajs-2127	150	40	correlate	correlate	NOUN
iajs-2127	150	41	with	with	ADP
iajs-2127	150	42	abs	ab	NOUN
iajs-2127	150	43	leuk	leuk	NOUN
iajs-2127	150	44	and	and	CCONJ
iajs-2127	150	45	abs	ab	NOUN
iajs-2127	150	46	plt	plt	NOUN
iajs-2127	150	47	(	(	PUNCT
iajs-2127	150	48	r	r	NOUN
iajs-2127	150	49	=	=	SYM
iajs-2127	150	50	0.420	0.420	NUM
iajs-2127	150	51	and	and	CCONJ
iajs-2127	150	52	0.592	0.592	NUM
iajs-2127	150	53	resp	resp	NOUN
iajs-2127	150	54	.	.	PUNCT
iajs-2127	150	55	)	)	PUNCT
iajs-2127	150	56	,	,	PUNCT
iajs-2127	150	57	moderately	moderately	ADV
iajs-2127	150	58	positive	positive	ADJ
iajs-2127	150	59	correlate	correlate	NOUN
iajs-2127	150	60	with	with	ADP
iajs-2127	150	61	ast	ast	NOUN
iajs-2127	150	62	(	(	PUNCT
iajs-2127	150	63	r	r	NOUN
iajs-2127	150	64	=	=	NOUN
iajs-2127	150	65	0.336	0.336	NUM
iajs-2127	150	66	)	)	PUNCT
iajs-2127	150	67	,	,	PUNCT
iajs-2127	150	68	weakly	weakly	ADV
iajs-2127	150	69	positive	positive	ADJ
iajs-2127	150	70	correlate	correlate	NOUN
iajs-2127	150	71	with	with	ADP
iajs-2127	150	72	hb	hb	PROPN
iajs-2127	150	73	,	,	PUNCT
iajs-2127	150	74	alp	alp	PROPN
iajs-2127	150	75	,	,	PUNCT
iajs-2127	150	76	alb	alb	PROPN
iajs-2127	150	77	and	and	CCONJ
iajs-2127	150	78	t.	t.	PROPN
iajs-2127	150	79	bil	bil	PROPN
iajs-2127	150	80	(	(	PUNCT
iajs-2127	150	81	r	r	NOUN
iajs-2127	150	82	=	=	SYM
iajs-2127	150	83	0.282	0.282	NUM
iajs-2127	150	84	,	,	PUNCT
iajs-2127	150	85	0.288,0.278	0.288,0.278	PROPN
iajs-2127	150	86	and	and	CCONJ
iajs-2127	150	87	0.240	0.240	NUM
iajs-2127	150	88	resp	resp	NOUN
iajs-2127	150	89	.	.	PUNCT
iajs-2127	150	90	)	)	PUNCT
iajs-2127	151	1	both	both	CCONJ
iajs-2127	151	2	ggt	ggt	PROPN
iajs-2127	151	3	and	and	CCONJ
iajs-2127	151	4	crea	crea	PROPN
iajs-2127	151	5	showed	show	VERB
iajs-2127	151	6	no	no	DET
iajs-2127	151	7	correlation	correlation	NOUN
iajs-2127	151	8	(	(	PUNCT
iajs-2127	151	9	r	r	NOUN
iajs-2127	151	10	=	=	SYM
iajs-2127	151	11	0.169	0.169	NUM
iajs-2127	151	12	and	and	CCONJ
iajs-2127	151	13	0.026	0.026	NUM
iajs-2127	151	14	resp	resp	NOUN
iajs-2127	151	15	.	.	PUNCT
iajs-2127	151	16	)	)	PUNCT
iajs-2127	152	1	while	while	SCONJ
iajs-2127	152	2	weak	weak	ADJ
iajs-2127	152	3	negative	negative	ADJ
iajs-2127	152	4	correlation	correlation	NOUN
iajs-2127	152	5	was	be	AUX
iajs-2127	152	6	observed	observe	VERB
iajs-2127	152	7	between	between	ADP
iajs-2127	152	8	alt	alt	PROPN
iajs-2127	152	9	and	and	CCONJ
iajs-2127	152	10	crp	crp	PROPN
iajs-2127	152	11	(	(	PUNCT
iajs-2127	152	12	r	r	NOUN
iajs-2127	152	13	=	=	SYM
iajs-2127	152	14	-0.277	-0.277	NOUN
iajs-2127	152	15	)	)	PUNCT
iajs-2127	152	16	.	.	PUNCT
iajs-2127	153	1	6.cconclusion	6.cconclusion	NUM
iajs-2127	153	2	,	,	PUNCT
iajs-2127	153	3	liver	liver	NOUN
iajs-2127	153	4	enzymes	enzyme	NOUN
iajs-2127	153	5	alt	alt	ADJ
iajs-2127	153	6	,	,	PUNCT
iajs-2127	153	7	ast	ast	PROPN
iajs-2127	153	8	,	,	PUNCT
iajs-2127	153	9	alp	alp	PROPN
iajs-2127	153	10	,	,	PUNCT
iajs-2127	153	11	ggt	ggt	NOUN
iajs-2127	153	12	,	,	PUNCT
iajs-2127	153	13	t.bil	t.bil	VERB
iajs-2127	153	14	and	and	CCONJ
iajs-2127	153	15	abs	ab	NOUN
iajs-2127	153	16	pltcan	pltcan	ADJ
iajs-2127	153	17	be	be	AUX
iajs-2127	153	18	used	use	VERB
iajs-2127	153	19	as	as	ADP
iajs-2127	153	20	monitoring	monitor	VERB
iajs-2127	153	21	markers	marker	NOUN
iajs-2127	153	22	with	with	ADP
iajs-2127	153	23	the	the	DET
iajs-2127	153	24	strong	strong	ADJ
iajs-2127	153	25	correlation	correlation	NOUN
iajs-2127	153	26	between	between	ADP
iajs-2127	153	27	altand	altand	CCONJ
iajs-2127	153	28	abs	ab	NOUN
iajs-2127	153	29	plt	plt	NOUN
iajs-2127	153	30	as	as	ADP
iajs-2127	153	31	an	an	DET
iajs-2127	153	32	assessment	assessment	NOUN
iajs-2127	153	33	tools	tool	NOUN
iajs-2127	153	34	for	for	ADP
iajs-2127	153	35	hbv	hbv	NOUN
iajs-2127	153	36	infection	infection	NOUN
iajs-2127	153	37	references	reference	NOUN
iajs-2127	153	38	1	1	NUM
iajs-2127	153	39	.	.	PUNCT
iajs-2127	153	40	della	della	PROPN
iajs-2127	153	41	,	,	PUNCT
iajs-2127	153	42	c.c	c.c	PROPN
iajs-2127	153	43	.	.	PROPN
iajs-2127	153	44	;	;	PUNCT
iajs-2127	153	45	nobili	nobili	PROPN
iajs-2127	153	46	,	,	PUNCT
iajs-2127	153	47	v.	v.	PROPN
iajs-2127	153	48	;	;	PUNCT
iajs-2127	153	49	comparcola	comparcola	PROPN
iajs-2127	153	50	,	,	PUNCT
iajs-2127	153	51	cainelli	cainelli	PROPN
iajs-2127	153	52	,	,	PUNCT
iajs-2127	153	53	d.f	d.f	PROPN
iajs-2127	153	54	.	.	PROPN
iajs-2127	153	55	;	;	PUNCT
iajs-2127	153	56	vento	vento	PROPN
iajs-2127	153	57	,	,	PUNCT
iajs-2127	153	58	s.	s.	PROPN
iajs-2127	153	59	management	management	PROPN
iajs-2127	153	60	of	of	ADP
iajs-2127	153	61	chronic	chronic	NOUN
iajs-2127	153	62	,	,	PUNCT
iajs-2127	153	63	hepatitis	hepatitis	NOUN
iajs-2127	153	64	,	,	PUNCT
iajs-2127	153	65	b	b	NOUN
iajs-2127	153	66	in	in	ADP
iajs-2127	153	67	children	child	NOUN
iajs-2127	153	68	:	:	PUNCT
iajs-2127	153	69	an	an	DET
iajs-2127	153	70	unresolved	unresolved	ADJ
iajs-2127	153	71	,	,	PUNCT
iajs-2127	153	72	issue	issue	NOUN
iajs-2127	153	73	.	.	PUNCT
iajs-2127	154	1	j	j	PROPN
iajs-2127	154	2	gastroenterol	gastroenterol	NOUN
iajs-2127	154	3	hepatol	hepatol	ADJ
iajs-2127	154	4	.	.	PUNCT
iajs-2127	155	1	2014	2014	NUM
iajs-2127	155	2	,	,	PUNCT
iajs-2127	155	3	29	29	NUM
iajs-2127	155	4	,	,	PUNCT
iajs-2127	155	5	912	912	NUM
iajs-2127	155	6	-	-	SYM
iajs-2127	155	7	919	919	NUM
iajs-2127	155	8	.	.	PUNCT
iajs-2127	156	1	2	2	NUM
iajs-2127	156	2	.	.	X
iajs-2127	156	3	yuen	yuen	PROPN
iajs-2127	156	4	,	,	PUNCT
iajs-2127	156	5	m.f	m.f	PROPN
iajs-2127	156	6	.	.	PROPN
iajs-2127	156	7	;	;	PUNCT
iajs-2127	156	8	hui	hui	PROPN
iajs-2127	156	9	,	,	PUNCT
iajs-2127	156	10	c.k	c.k	PROPN
iajs-2127	156	11	.	.	PROPN
iajs-2127	156	12	;	;	PUNCT
iajs-2127	156	13	cheng	cheng	PROPN
iajs-2127	156	14	,	,	PUNCT
iajs-2127	156	15	c.c	c.c	PROPN
iajs-2127	156	16	.	.	PROPN
iajs-2127	156	17	longterm	longterm	PROPN
iajs-2127	156	18	follow	follow	NOUN
iajs-2127	156	19	-	-	PUNCT
iajs-2127	156	20	up	up	NOUN
iajs-2127	156	21	of	of	ADP
iajs-2127	156	22	interferon	interferon	NOUN
iajs-2127	156	23	,	,	PUNCT
iajs-2127	156	24	alfa	alfa	NOUN
iajs-2127	156	25	treatment	treatment	NOUN
iajs-2127	156	26	in	in	ADP
iajs-2127	156	27	,	,	PUNCT
iajs-2127	156	28	chinese	chinese	ADJ
iajs-2127	156	29	patients	patient	NOUN
iajs-2127	156	30	,	,	PUNCT
iajs-2127	156	31	with	with	ADP
iajs-2127	156	32	chronic	chronic	ADJ
iajs-2127	156	33	hepatitis	hepatitis	NOUN
iajs-2127	156	34	,	,	PUNCT
iajs-2127	156	35	b	b	NOUN
iajs-2127	156	36	,	,	PUNCT
iajs-2127	156	37	infection	infection	NOUN
iajs-2127	156	38	:	:	PUNCT
iajs-2127	156	39	the	the	DET
iajs-2127	156	40	effect	effect	NOUN
iajs-2127	156	41	,	,	PUNCT
iajs-2127	156	42	on	on	ADP
iajs-2127	156	43	hepatitis	hepatitis	PROPN
iajs-2127	156	44	,	,	PUNCT
iajs-2127	156	45	b	b	NOUN
iajs-2127	156	46	antigen	antigen	ADJ
iajs-2127	156	47	,	,	PUNCT
iajs-2127	156	48	seroconversion	seroconversion	NOUN
iajs-2127	156	49	and	and	CCONJ
iajs-2127	156	50	the	the	DET
iajs-2127	156	51	development	development	NOUN
iajs-2127	156	52	of	of	ADP
iajs-2127	156	53	cirrhosisrelated	cirrhosisrelated	ADJ
iajs-2127	156	54	complications	complication	NOUN
iajs-2127	156	55	.	.	PUNCT
iajs-2127	157	1	hepatology	hepatology	NOUN
iajs-2127	157	2	.	.	PUNCT
iajs-2127	158	1	2001	2001	NUM
iajs-2127	158	2	,	,	PUNCT
iajs-2127	158	3	34	34	NUM
iajs-2127	158	4	,	,	PUNCT
iajs-2127	158	5	139–145	139–145	NUM
iajs-2127	158	6	3	3	NUM
iajs-2127	158	7	.	.	PUNCT
iajs-2127	159	1	pan	pan	PROPN
iajs-2127	159	2	,	,	PUNCT
iajs-2127	159	3	y.	y.	PROPN
iajs-2127	159	4	;	;	PUNCT
iajs-2127	159	5	muheremu	muheremu	NOUN
iajs-2127	159	6	,	,	PUNCT
iajs-2127	159	7	a.	a.	NOUN
iajs-2127	159	8	;	;	PUNCT
iajs-2127	159	9	wu	wu	PROPN
iajs-2127	159	10	,	,	PUNCT
iajs-2127	159	11	x.	x.	PROPN
iajs-2127	159	12	;	;	PUNCT
iajs-2127	159	13	liu	liu	PROPN
iajs-2127	159	14	,	,	PUNCT
iajs-2127	159	15	j.	j.	PROPN
iajs-2127	159	16	relationship	relationship	NOUN
iajs-2127	159	17	between	between	ADP
iajs-2127	159	18	platelet	platelet	NOUN
iajs-2127	159	19	,	,	PUNCT
iajs-2127	159	20	parameters	parameter	NOUN
iajs-2127	159	21	and	and	CCONJ
iajs-2127	159	22	hepatic	hepatic	ADJ
iajs-2127	159	23	pathology	pathology	NOUN
iajs-2127	159	24	,	,	PUNCT
iajs-2127	159	25	in	in	ADP
iajs-2127	159	26	patients	patient	NOUN
iajs-2127	159	27	with	with	ADP
iajs-2127	159	28	chronic	chronic	ADJ
iajs-2127	159	29	hepatitis	hepatitis	NOUN
iajs-2127	159	30	,	,	PUNCT
iajs-2127	159	31	b	b	X
iajs-2127	159	32	infection	infection	NOUN
iajs-2127	159	33	–	–	PUNCT
iajs-2127	159	34	a	a	DET
iajs-2127	159	35	retrospective	retrospective	ADJ
iajs-2127	159	36	cohort	cohort	NOUN
iajs-2127	159	37	study	study	NOUN
iajs-2127	159	38	,	,	PUNCT
iajs-2127	159	39	of	of	ADP
iajs-2127	159	40	677	677	NUM
iajs-2127	159	41	patients	patient	NOUN
iajs-2127	159	42	.	.	PUNCT
iajs-2127	160	1	j	j	NOUN
iajs-2127	160	2	,	,	PUNCT
iajs-2127	160	3	int	int	NOUN
iajs-2127	160	4	med	med	ADJ
iajs-2127	160	5	res	re	NOUN
iajs-2127	160	6	.	.	PROPN
iajs-2127	160	7	2016	2016	NUM
iajs-2127	160	8	,	,	PUNCT
iajs-2127	160	9	44	44	NUM
iajs-2127	160	10	,	,	PUNCT
iajs-2127	160	11	4	4	NUM
iajs-2127	160	12	,	,	PUNCT
iajs-2127	160	13	779–786	779–786	NUM
iajs-2127	160	14	.	.	NOUN
iajs-2127	160	15	4	4	NUM
iajs-2127	160	16	.	.	X
iajs-2127	160	17	fujiwara	fujiwara	PROPN
iajs-2127	160	18	,	,	PUNCT
iajs-2127	160	19	a.	a.	NOUN
iajs-2127	160	20	;	;	PUNCT
iajs-2127	160	21	sakaguchi	sakaguchi	ADV
iajs-2127	160	22	,	,	PUNCT
iajs-2127	160	23	k.	k.	PROPN
iajs-2127	160	24	;	;	PUNCT
iajs-2127	160	25	fujioka	fujioka	PROPN
iajs-2127	160	26	,	,	PUNCT
iajs-2127	160	27	s.	s.	PROPN
iajs-2127	160	28	fibrosis	fibrosis	PROPN
iajs-2127	160	29	progression	progression	NOUN
iajs-2127	160	30	,	,	PUNCT
iajs-2127	160	31	rates	rate	NOUN
iajs-2127	160	32	between	between	ADP
iajs-2127	160	33	chronic	chronic	ADJ
iajs-2127	160	34	hepatitis	hepatitis	NOUN
iajs-2127	160	35	,	,	PUNCT
iajs-2127	160	36	b	b	PROPN
iajs-2127	160	37	and	and	CCONJ
iajs-2127	160	38	c	c	PROPN
iajs-2127	160	39	patients	patient	NOUN
iajs-2127	160	40	with	with	ADP
iajs-2127	160	41	elevated	elevated	ADJ
iajs-2127	160	42	,	,	PUNCT
iajs-2127	160	43	alanine	alanine	NOUN
iajs-2127	160	44	aminotransferase	aminotransferase	PROPN
iajs-2127	160	45	levels	level	NOUN
iajs-2127	160	46	.	.	PUNCT
iajs-2127	161	1	j	j	PROPN
iajs-2127	161	2	gastroenterol	gastroenterol	PROPN
iajs-2127	161	3	.	.	PUNCT
iajs-2127	162	1	2008	2008	NUM
iajs-2127	162	2	,	,	PUNCT
iajs-2127	162	3	43	43	NUM
iajs-2127	162	4	,	,	PUNCT
iajs-2127	162	5	484–491	484–491	NUM
iajs-2127	162	6	.	.	PUNCT
iajs-2127	163	1	5	5	NUM
iajs-2127	163	2	.	.	NOUN
iajs-2127	163	3	8	8	NUM
iajs-2127	163	4	-	-	PUNCT
iajs-2127	163	5	eze	eze	ADJ
iajs-2127	163	6	,	,	PUNCT
iajs-2127	163	7	m.e	m.e	PROPN
iajs-2127	163	8	.	.	PROPN
iajs-2127	163	9	;	;	PUNCT
iajs-2127	164	1	buseri	buseri	PROPN
iajs-2127	164	2	,	,	PUNCT
iajs-2127	164	3	f.i	f.i	PROPN
iajs-2127	164	4	.	.	PROPN
iajs-2127	164	5	effects	effect	NOUN
iajs-2127	164	6	,	,	PUNCT
iajs-2127	164	7	of	of	ADP
iajs-2127	164	8	hepatitis	hepatitis	PROPN
iajs-2127	164	9	b	b	NOUN
iajs-2127	164	10	infection	infection	NOUN
iajs-2127	164	11	,	,	PUNCT
iajs-2127	164	12	on	on	ADP
iajs-2127	164	13	haemtological	haemtological	ADJ
iajs-2127	164	14	parameters	parameter	NOUN
iajs-2127	164	15	in	in	ADP
iajs-2127	164	16	,	,	PUNCT
iajs-2127	164	17	pregnancy	pregnancy	NOUN
iajs-2127	164	18	in	in	ADP
iajs-2127	164	19	port	port	NOUN
iajs-2127	164	20	,	,	PUNCT
iajs-2127	164	21	harcourt	harcourt	PROPN
iajs-2127	164	22	.	.	PUNCT
iajs-2127	165	1	nigeria	nigeria	PROPN
iajs-2127	165	2	research	research	PROPN
iajs-2127	165	3	journal	journal	PROPN
iajs-2127	165	4	,	,	PUNCT
iajs-2127	165	5	of	of	ADP
iajs-2127	165	6	medical	medical	ADJ
iajs-2127	165	7	sciences3	sciences3	PROPN
iajs-2127	165	8	.	.	PUNCT
iajs-2127	166	1	2009	2009	NUM
iajs-2127	166	2	,	,	PUNCT
iajs-2127	166	3	6	6	NUM
iajs-2127	166	4	,	,	PUNCT
iajs-2127	166	5	194	194	NUM
iajs-2127	166	6	-	-	SYM
iajs-2127	166	7	197	197	NUM
iajs-2127	166	8	.	.	NOUN
iajs-2127	167	1	6	6	NUM
iajs-2127	167	2	.	.	NUM
iajs-2127	167	3	drew	draw	VERB
iajs-2127	167	4	,	,	PUNCT
iajs-2127	167	5	p.	p.	NOUN
iajs-2127	167	6	abc	abc	PROPN
iajs-2127	167	7	of	of	ADP
iajs-2127	167	8	clinical	clinical	ADJ
iajs-2127	167	9	haematology	haematology	NOUN
iajs-2127	167	10	,	,	PUNCT
iajs-2127	167	11	2	2	NUM
iajs-2127	167	12	nd	nd	NUM
iajs-2127	167	13	edition	edition	NOUN
iajs-2127	167	14	,	,	PUNCT
iajs-2127	167	15	bmj	bmj	PROPN
iajs-2127	167	16	,	,	PUNCT
iajs-2127	167	17	books	book	NOUN
iajs-2127	167	18	.	.	PUNCT
iajs-2127	168	1	2003	2003	NUM
iajs-2127	168	2	.	.	PUNCT
iajs-2127	169	1	7	7	X
iajs-2127	169	2	.	.	X
iajs-2127	169	3	pan	pan	PROPN
iajs-2127	169	4	,	,	PUNCT
iajs-2127	169	5	c.q	c.q	PROPN
iajs-2127	169	6	.	.	PROPN
iajs-2127	169	7	;	;	PUNCT
iajs-2127	169	8	zhang	zhang	PROPN
iajs-2127	169	9	,	,	PUNCT
iajs-2127	169	10	j.x	j.x	PROPN
iajs-2127	169	11	.	.	PROPN
iajs-2127	169	12	natural	natural	ADJ
iajs-2127	169	13	history	history	NOUN
iajs-2127	169	14	and	and	CCONJ
iajs-2127	169	15	clinical	clinical	ADJ
iajs-2127	169	16	consequences	consequence	NOUN
iajs-2127	169	17	of	of	ADP
iajs-2127	169	18	hepatitis	hepatitis	PROPN
iajs-2127	169	19	b	b	PROPN
iajs-2127	169	20	virus	virus	NOUN
iajs-2127	169	21	infection	infection	NOUN
iajs-2127	169	22	.	.	PUNCT
iajs-2127	170	1	int	int	NOUN
iajs-2127	170	2	.	.	PUNCT
iajs-2127	171	1	j.	j.	PROPN
iajs-2127	171	2	med	med	PROPN
iajs-2127	171	3	sci	sci	PROPN
iajs-2127	171	4	.	.	PROPN
iajs-2127	171	5	2005	2005	NUM
iajs-2127	171	6	,	,	PUNCT
iajs-2127	171	7	2	2	NUM
iajs-2127	171	8	,	,	PUNCT
iajs-2127	171	9	36	36	NUM
iajs-2127	171	10	-	-	SYM
iajs-2127	171	11	40	40	NUM
iajs-2127	171	12	.	.	NOUN
iajs-2127	171	13	8	8	NUM
iajs-2127	171	14	.	.	X
iajs-2127	172	1	park	park	NOUN
iajs-2127	172	2	,	,	PUNCT
iajs-2127	172	3	k.s	k.s	PROPN
iajs-2127	172	4	.	.	PROPN
iajs-2127	172	5	;	;	PUNCT
iajs-2127	172	6	lee	lee	PROPN
iajs-2127	172	7	,	,	PUNCT
iajs-2127	172	8	y.s	y.s	PROPN
iajs-2127	172	9	.	.	PROPN
iajs-2127	172	10	;	;	PUNCT
iajs-2127	172	11	lee	lee	PROPN
iajs-2127	172	12	,	,	PUNCT
iajs-2127	172	13	s.k	s.k	PROPN
iajs-2127	172	14	.	.	PUNCT
iajs-2127	173	1	a	a	DET
iajs-2127	173	2	study	study	NOUN
iajs-2127	173	3	on	on	ADP
iajs-2127	173	4	markers	marker	NOUN
iajs-2127	173	5	nwokediukoa	nwokediukoa	PROPN
iajs-2127	173	6	,	,	PUNCT
iajs-2127	173	7	s.c	s.c	PROPN
iajs-2127	173	8	.	.	PROPN
iajs-2127	173	9	;	;	PUNCT
iajs-2127	173	10	ibegbulam	ibegbulam	NOUN
iajs-2127	173	11	,	,	PUNCT
iajs-2127	173	12	o.	o.	PROPN
iajs-2127	173	13	quantitative	quantitative	ADJ
iajs-2127	173	14	platelet	platelet	NOUN
iajs-2127	173	15	,	,	PUNCT
iajs-2127	173	16	abnormalities	abnormality	NOUN
iajs-2127	173	17	in	in	ADP
iajs-2127	173	18	patients	patient	NOUN
iajs-2127	173	19	with	with	ADP
iajs-2127	173	20	hepatitis	hepatitis	PROPN
iajs-2127	173	21	,	,	PUNCT
iajs-2127	173	22	b	b	NOUN
iajs-2127	173	23	virus	virus	NOUN
iajs-2127	173	24	-	-	PUNCT
iajs-2127	173	25	related	relate	VERB
iajs-2127	173	26	,	,	PUNCT
iajs-2127	173	27	liver	liver	NOUN
iajs-2127	173	28	disease	disease	NOUN
iajs-2127	173	29	.	.	PUNCT
iajs-2127	174	1	gastroenterology	gastroenterology	NOUN
iajs-2127	174	2	,	,	PUNCT
iajs-2127	174	3	research	research	NOUN
iajs-2127	174	4	.	.	PUNCT
iajs-2127	175	1	2009	2009	NUM
iajs-2127	175	2	,	,	PUNCT
iajs-2127	175	3	2	2	NUM
iajs-2127	175	4	,	,	PUNCT
iajs-2127	175	5	6	6	NUM
iajs-2127	175	6	,	,	PUNCT
iajs-2127	175	7	344	344	NUM
iajs-2127	175	8	-	-	SYM
iajs-2127	175	9	349	349	NUM
iajs-2127	175	10	.	.	PUNCT
iajs-2127	176	1	9	9	NUM
iajs-2127	176	2	.	.	X
iajs-2127	176	3	of	of	ADP
iajs-2127	176	4	viral	viral	ADJ
iajs-2127	176	5	hepatitis	hepatitis	NOUN
iajs-2127	176	6	in	in	ADP
iajs-2127	176	7	adults	adult	NOUN
iajs-2127	176	8	living	live	VERB
iajs-2127	176	9	in	in	ADP
iajs-2127	176	10	daegu	daegu	NOUN
iajs-2127	176	11	and	and	CCONJ
iajs-2127	176	12	gyungbuk	gyungbuk	NOUN
iajs-2127	176	13	area	area	NOUN
iajs-2127	176	14	.	.	PUNCT
iajs-2127	177	1	korean	korean	PROPN
iajs-2127	177	2	j	j	PROPN
iajs-2127	177	3	,	,	PUNCT
iajs-2127	177	4	gastroenterol.2003	gastroenterol.2003	PROPN
iajs-2127	177	5	,	,	PUNCT
iajs-2127	177	6	41	41	NUM
iajs-2127	177	7	,	,	PUNCT
iajs-2127	177	8	473	473	NUM
iajs-2127	177	9	-	-	SYM
iajs-2127	177	10	479	479	NUM
iajs-2127	177	11	.	.	PUNCT
iajs-2127	178	1	10	10	NUM
iajs-2127	178	2	.	.	X
iajs-2127	178	3	yoshimura	yoshimura	NOUN
iajs-2127	178	4	,	,	PUNCT
iajs-2127	178	5	m.	m.	NOUN
iajs-2127	178	6	;	;	PUNCT
iajs-2127	178	7	sakurai	sakurai	PROPN
iajs-2127	178	8	,	,	PUNCT
iajs-2127	178	9	i.	i.	PROPN
iajs-2127	178	10	;	;	PUNCT
iajs-2127	178	11	shimoda	shimoda	PROPN
iajs-2127	178	12	,	,	PUNCT
iajs-2127	178	13	t.	t.	NOUN
iajs-2127	178	14	detection	detection	NOUN
iajs-2127	178	15	of	of	ADP
iajs-2127	178	16	hbsag	hbsag	NOUN
iajs-2127	178	17	in	in	ADP
iajs-2127	178	18	the	the	DET
iajs-2127	178	19	pancreas	pancrea	NOUN
iajs-2127	178	20	.	.	PUNCT
iajs-2127	179	1	acta	acta	PROPN
iajs-2127	179	2	,	,	PUNCT
iajs-2127	179	3	pathol	pathol	PROPN
iajs-2127	179	4	jpn	jpn	PROPN
iajs-2127	179	5	.	.	PROPN
iajs-2127	179	6	1981	1981	NUM
iajs-2127	179	7	,	,	PUNCT
iajs-2127	179	8	31	31	NUM
iajs-2127	179	9	,	,	PUNCT
iajs-2127	179	10	4	4	NUM
iajs-2127	179	11	,	,	PUNCT
iajs-2127	179	12	711	711	NOUN
iajs-2127	179	13	-	-	SYM
iajs-2127	179	14	717	717	NUM
iajs-2127	179	15	.	.	PUNCT
iajs-2127	180	1	11	11	NUM
iajs-2127	180	2	.	.	PUNCT
iajs-2127	181	1	shima	shima	PROPN
iajs-2127	181	2	,	,	PUNCT
iajs-2127	181	3	m.	m.	NOUN
iajs-2127	181	4	;	;	PUNCT
iajs-2127	181	5	nakao	nakao	PROPN
iajs-2127	181	6	,	,	PUNCT
iajs-2127	181	7	k.	k.	PROPN
iajs-2127	181	8	;	;	PUNCT
iajs-2127	181	9	kato	kato	PROPN
iajs-2127	181	10	,	,	PUNCT
iajs-2127	181	11	y.	y.	PROPN
iajs-2127	181	12	;	;	PUNCT
iajs-2127	181	13	nakata	nakata	NOUN
iajs-2127	181	14	,	,	PUNCT
iajs-2127	181	15	k.	k.	PROPN
iajs-2127	181	16	;	;	PUNCT
iajs-2127	181	17	ishii	ishii	PROPN
iajs-2127	181	18	,	,	PUNCT
iajs-2127	181	19	n.	n.	NOUN
iajs-2127	181	20	;	;	PUNCT
iajs-2127	181	21	nagataki	nagataki	PROPN
iajs-2127	181	22	,	,	PUNCT
iajs-2127	181	23	s.	s.	PROPN
iajs-2127	181	24	comparative	comparative	PROPN
iajs-2127	181	25	,	,	PUNCT
iajs-2127	181	26	study	study	NOUN
iajs-2127	181	27	of	of	ADP
iajs-2127	181	28	c	c	NOUN
iajs-2127	181	29	-	-	NOUN
iajs-2127	181	30	reactive	reactive	ADJ
iajs-2127	181	31	,	,	PUNCT
iajs-2127	181	32	protein	protein	NOUN
iajs-2127	181	33	in	in	ADP
iajs-2127	181	34	chronic	chronic	ADJ
iajs-2127	181	35	hepatitis	hepatitis	NOUN
iajs-2127	181	36	,	,	PUNCT
iajs-2127	181	37	b	b	NOUN
iajs-2127	181	38	and	and	CCONJ
iajs-2127	181	39	chronic	chronic	ADJ
iajs-2127	181	40	hepatitic	hepatitic	NOUN
iajs-2127	181	41	,	,	PUNCT
iajs-2127	181	42	c.	c.	PROPN
iajs-2127	181	43	tohoku	tohoku	PROPN
iajs-2127	181	44	j.	j.	PROPN
iajs-2127	181	45	exp	exp	PROPN
iajs-2127	181	46	.	.	PROPN
iajs-2127	181	47	,	,	PUNCT
iajs-2127	181	48	med	med	PROPN
iajs-2127	181	49	.	.	PROPN
iajs-2127	181	50	1996	1996	NUM
iajs-2127	181	51	,	,	PUNCT
iajs-2127	181	52	178	178	NUM
iajs-2127	181	53	,	,	PUNCT
iajs-2127	181	54	287	287	NUM
iajs-2127	181	55	-	-	SYM
iajs-2127	181	56	297	297	NUM
iajs-2127	181	57	,	,	PUNCT
iajs-2127	181	58	doi:10.1620	doi:10.1620	NOUN
iajs-2127	181	59	/	/	SYM
iajs-2127	181	60	tjem.178.287	tjem.178.287	PROPN
iajs-2127	181	61	.	.	PUNCT
iajs-2127	182	1	12	12	NUM
iajs-2127	182	2	.	.	PUNCT
iajs-2127	182	3	spinella	spinella	PROPN
iajs-2127	182	4	,	,	PUNCT
iajs-2127	182	5	r.	r.	PROPN
iajs-2127	182	6	;	;	PUNCT
iajs-2127	182	7	sawhney	sawhney	PROPN
iajs-2127	182	8	,	,	PUNCT
iajs-2127	182	9	r.	r.	PROPN
iajs-2127	182	10	;	;	PUNCT
iajs-2127	182	11	jalan	jalan	PROPN
iajs-2127	182	12	,	,	PUNCT
iajs-2127	182	13	r.	r.	PROPN
iajs-2127	182	14	albumin	albumin	PROPN
iajs-2127	182	15	in	in	ADP
iajs-2127	182	16	chronic	chronic	ADJ
iajs-2127	182	17	liver	liver	NOUN
iajs-2127	182	18	disease	disease	NOUN
iajs-2127	182	19	,	,	PUNCT
iajs-2127	182	20	structure	structure	NOUN
iajs-2127	182	21	,	,	PUNCT
iajs-2127	182	22	functions	function	NOUN
iajs-2127	182	23	and	and	CCONJ
iajs-2127	182	24	therapeutic	therapeutic	ADJ
iajs-2127	182	25	implications	implication	NOUN
iajs-2127	182	26	.	.	PUNCT
iajs-2127	183	1	hepatol	hepatol	ADJ
iajs-2127	183	2	.	.	PUNCT
iajs-2127	184	1	int	int	NOUN
iajs-2127	184	2	.	.	PUNCT
iajs-2127	185	1	2016	2016	NUM
iajs-2127	185	2	,	,	PUNCT
iajs-2127	185	3	10	10	NUM
iajs-2127	185	4	,	,	PUNCT
iajs-2127	185	5	124	124	NUM
iajs-2127	185	6	-	-	SYM
iajs-2127	185	7	132	132	NUM
iajs-2127	185	8	,	,	PUNCT
iajs-2127	185	9	doi:10.1007	doi:10.1007	ADJ
iajs-2127	185	10	s12072	s12072	NOUN
iajs-2127	185	11	-	-	PUNCT
iajs-2127	185	12	0159665	0159665	NUM
iajs-2127	185	13	-	-	SYM
iajs-2127	185	14	6	6	NUM
iajs-2127	185	15	.	.	PUNCT
iajs-2127	186	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=pan%20y%5bauthor%5d&cauthor=true&cauthor_uid=27329384	https://www.ncbi.nlm.nih.gov/pubmed/?term=pan%20y%5bauthor%5d&cauthor=true&cauthor_uid=27329384	PROPN
iajs-2127	186	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=muheremu%20a%5bauthor%5d&cauthor=true&cauthor_uid=27329384	https://www.ncbi.nlm.nih.gov/pubmed/?term=muheremu%20a%5bauthor%5d&cauthor=true&cauthor_uid=27329384	PROPN
iajs-2127	186	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=wu%20x%5bauthor%5d&cauthor=true&cauthor_uid=27329384	https://www.ncbi.nlm.nih.gov/pubmed/?term=wu%20x%5bauthor%5d&cauthor=true&cauthor_uid=27329384	PROPN
iajs-2127	186	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20j%5bauthor%5d&cauthor=true&cauthor_uid=27329384	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20j%5bauthor%5d&cauthor=true&cauthor_uid=27329384	PROPN
iajs-2127	186	5	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5536628/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5536628/	PROPN
iajs-2127	186	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=yoshimura%20m%5bauthor%5d&cauthor=true&cauthor_uid=7025575	https://www.ncbi.nlm.nih.gov/pubmed/?term=yoshimura%20m%5bauthor%5d&cauthor=true&cauthor_uid=7025575	PROPN
iajs-2127	186	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=sakurai%20i%5bauthor%5d&cauthor=true&cauthor_uid=7025575	https://www.ncbi.nlm.nih.gov/pubmed/?term=sakurai%20i%5bauthor%5d&cauthor=true&cauthor_uid=7025575	PROPN
iajs-2127	187	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=shimoda%20t%5bauthor%5d&cauthor=true&cauthor_uid=7025575	https://www.ncbi.nlm.nih.gov/pubmed/?term=shimoda%20t%5bauthor%5d&cauthor=true&cauthor_uid=7025575	PROPN
iajs-2127	187	2	https://www.ncbi.nlm.nih.gov/pubmed/7025575	https://www.ncbi.nlm.nih.gov/pubmed/7025575	PROPN
iajs-2127	187	3	https://www.ncbi.nlm.nih.gov/pubmed/7025575	https://www.ncbi.nlm.nih.gov/pubmed/7025575	PROPN
iajs-2127	187	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=nakata%20k%5bauthor%5d&cauthor=true&cauthor_uid=8727711	https://www.ncbi.nlm.nih.gov/pubmed/?term=nakata%20k%5bauthor%5d&cauthor=true&cauthor_uid=8727711	ADP
iajs-2127	187	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=ishii%20n%5bauthor%5d&cauthor=true&cauthor_uid=8727711	https://www.ncbi.nlm.nih.gov/pubmed/?term=ishii%20n%5bauthor%5d&cauthor=true&cauthor_uid=8727711	NOUN
iajs-2127	187	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=nagataki%20s%5bauthor%5d&cauthor=true&cauthor_uid=8727711	https://www.ncbi.nlm.nih.gov/pubmed/?term=nagataki%20s%5bauthor%5d&cauthor=true&cauthor_uid=8727711	NUM
iajs-2127	187	7	17	17	NUM
iajs-2127	187	8	ibn	ibn	PROPN
iajs-2127	187	9	al	al	PROPN
iajs-2127	187	10	-	-	PUNCT
iajs-2127	187	11	haitham	haitham	PROPN
iajs-2127	187	12	jour	jour	X
iajs-2127	187	13	.	.	PROPN
iajs-2127	188	1	for	for	ADP
iajs-2127	188	2	pure	pure	ADJ
iajs-2127	188	3	&	&	CCONJ
iajs-2127	188	4	appl	appl	PROPN
iajs-2127	188	5	.	.	PUNCT
iajs-2127	189	1	sci	sci	PROPN
iajs-2127	189	2	.	.	PROPN
iajs-2127	189	3	32	32	NUM
iajs-2127	189	4	(	(	PUNCT
iajs-2127	189	5	2	2	NUM
iajs-2127	189	6	)	)	PUNCT
iajs-2127	189	7	2019	2019	NUM
iajs-2127	189	8	13	13	NUM
iajs-2127	189	9	.	.	PUNCT
iajs-2127	190	1	yavuz	yavuz	PROPN
iajs-2127	190	2	,	,	PUNCT
iajs-2127	190	3	f.	f.	PROPN
iajs-2127	190	4	;	;	PUNCT
iajs-2127	190	5	biyik	biyik	NOUN
iajs-2127	190	6	,	,	PUNCT
iajs-2127	190	7	m.	m.	NOUN
iajs-2127	190	8	;	;	PUNCT
iajs-2127	190	9	asil	asil	NOUN
iajs-2127	190	10	,	,	PUNCT
iajs-2127	190	11	m.	m.	NOUN
iajs-2127	190	12	;	;	PUNCT
iajs-2127	190	13	dertli	dertli	PROPN
iajs-2127	190	14	,	,	PUNCT
iajs-2127	190	15	r.	r.	PROPN
iajs-2127	190	16	;	;	PUNCT
iajs-2127	190	17	demir	demir	PROPN
iajs-2127	190	18	,	,	PUNCT
iajs-2127	190	19	a.	a.	PROPN
iajs-2127	190	20	;	;	PUNCT
iajs-2127	190	21	polat	polat	NOUN
iajs-2127	190	22	,	,	PUNCT
iajs-2127	190	23	h.	h.	PROPN
iajs-2127	190	24	;	;	PUNCT
iajs-2127	190	25	uysal	uysal	ADJ
iajs-2127	190	26	,	,	PUNCT
iajs-2127	190	27	s.	s.	PROPN
iajs-2127	190	28	;	;	PUNCT
iajs-2127	190	29	ataseven	ataseven	PROPN
iajs-2127	190	30	,	,	PUNCT
iajs-2127	190	31	h.	h.	PROPN
iajs-2127	190	32	serum	serum	PROPN
iajs-2127	190	33	ischemic	ischemic	ADJ
iajs-2127	190	34	modified	modify	VERB
iajs-2127	190	35	,	,	PUNCT
iajs-2127	190	36	albumin	albumin	NOUN
iajs-2127	190	37	(	(	PUNCT
iajs-2127	190	38	i	i	NOUN
iajs-2127	190	39	m	m	PROPN
iajs-2127	190	40	a	a	NOUN
iajs-2127	190	41	)	)	PUNCT
iajs-2127	190	42	concentration	concentration	NOUN
iajs-2127	190	43	,	,	PUNCT
iajs-2127	190	44	and	and	CCONJ
iajs-2127	190	45	ima/,albumin	ima/,albumin	ADJ
iajs-2127	190	46	ratio	ratio	NOUN
iajs-2127	190	47	in	in	ADP
iajs-2127	190	48	patients	patient	NOUN
iajs-2127	190	49	,	,	PUNCT
iajs-2127	190	50	with	with	ADP
iajs-2127	190	51	hepatitis	hepatitis	NOUN
iajs-2127	190	52	,	,	PUNCT
iajs-2127	190	53	b	b	X
iajs-2127	190	54	-	-	PUNCT
iajs-2127	190	55	related	relate	VERB
iajs-2127	190	56	chronic	chronic	ADJ
iajs-2127	190	57	liver	liver	NOUN
iajs-2127	190	58	,	,	PUNCT
iajs-2127	190	59	diseases	disease	NOUN
iajs-2127	190	60	.	.	PUNCT
iajs-2127	191	1	hepatol	hepatol	ADJ
iajs-2127	191	2	.	.	PUNCT
iajs-2127	192	1	int	int	NOUN
iajs-2127	192	2	.	.	PUNCT
iajs-2127	193	1	2017	2017	NUM
iajs-2127	193	2	,	,	PUNCT
iajs-2127	193	3	10	10	NUM
iajs-2127	193	4	,	,	PUNCT
iajs-2127	193	5	124	124	NUM
iajs-2127	193	6	-	-	SYM
iajs-2127	193	7	132	132	NUM
iajs-2127	193	8	,	,	PUNCT
iajs-2127	193	9	doi:10.3906	doi:10.3906	NOUN
iajs-2127	193	10	/	/	SYM
iajs-2127	193	11	sag-1611	sag-1611	NOUN
iajs-2127	193	12	-	-	PUNCT
iajs-2127	193	13	66	66	NUM
iajs-2127	193	14	.	.	PUNCT
iajs-2127	194	1	14	14	NUM
iajs-2127	194	2	.	.	PUNCT
iajs-2127	195	1	khan	khan	PROPN
iajs-2127	195	2	,	,	PUNCT
iajs-2127	195	3	s.	s.	PROPN
iajs-2127	195	4	;	;	PUNCT
iajs-2127	195	5	bhargava	bhargava	PROPN
iajs-2127	195	6	,	,	PUNCT
iajs-2127	195	7	a.	a.	PROPN
iajs-2127	195	8	;	;	PUNCT
iajs-2127	195	9	pathak	pathak	PROPN
iajs-2127	195	10	,	,	PUNCT
iajs-2127	195	11	n.	n.	PROPN
iajs-2127	195	12	;	;	PUNCT
iajs-2127	195	13	maudar	maudar	PROPN
iajs-2127	195	14	,	,	PUNCT
iajs-2127	195	15	k.k	k.k	PROPN
iajs-2127	195	16	.	.	PROPN
iajs-2127	195	17	;	;	PUNCT
iajs-2127	195	18	varshney	varshney	NOUN
iajs-2127	195	19	,	,	PUNCT
iajs-2127	195	20	s.	s.	PROPN
iajs-2127	195	21	;	;	PUNCT
iajs-2127	195	22	mishra	mishra	PROPN
iajs-2127	195	23	,	,	PUNCT
iajs-2127	195	24	p.k	p.k	PROPN
iajs-2127	195	25	.	.	PUNCT
iajs-2127	195	26	circulating	circulate	VERB
iajs-2127	195	27	biomarkers	biomarker	NOUN
iajs-2127	195	28	and	and	CCONJ
iajs-2127	195	29	,	,	PUNCT
iajs-2127	195	30	their	their	PRON
iajs-2127	195	31	possible	possible	ADJ
iajs-2127	195	32	role	role	NOUN
iajs-2127	195	33	,	,	PUNCT
iajs-2127	195	34	in	in	ADP
iajs-2127	195	35	pathogenesis	pathogenesis	NOUN
iajs-2127	195	36	of	of	ADP
iajs-2127	195	37	chronic	chronic	NOUN
iajs-2127	195	38	,	,	PUNCT
iajs-2127	195	39	hepatitis	hepatitis	PROPN
iajs-2127	195	40	b	b	PROPN
iajs-2127	195	41	and	and	CCONJ
iajs-2127	195	42	c	c	PROPN
iajs-2127	195	43	viral	viral	ADJ
iajs-2127	195	44	,	,	PUNCT
iajs-2127	195	45	infections	infection	NOUN
iajs-2127	195	46	.	.	PUNCT
iajs-2127	196	1	ind	ind	PROPN
iajs-2127	196	2	.	.	PUNCT
iajs-2127	197	1	j.	j.	PROPN
iajs-2127	197	2	clin	clin	PROPN
iajs-2127	197	3	.	.	PUNCT
iajs-2127	198	1	biochem	biochem	PROPN
iajs-2127	198	2	.	.	PUNCT
iajs-2127	199	1	2011	2011	NUM
iajs-2127	199	2	,	,	PUNCT
iajs-2127	199	3	26	26	NUM
iajs-2127	199	4	,	,	PUNCT
iajs-2127	199	5	2	2	NUM
iajs-2127	199	6	,	,	PUNCT
iajs-2127	199	7	168	168	NUM
iajs-2127	199	8	,	,	PUNCT
iajs-2127	199	9	doi:10.1007	doi:10.1007	NOUN
iajs-2127	199	10	/	/	SYM
iajs-2127	199	11	s12291	s12291	NUM
iajs-2127	199	12	-	-	PUNCT
iajs-2127	199	13	0100098	0100098	NUM
iajs-2127	199	14	-	-	PUNCT
iajs-2127	199	15	7	7	NUM
iajs-2127	199	16	.	.	NOUN
iajs-2127	199	17	15	15	NUM
iajs-2127	199	18	.	.	PUNCT
iajs-2127	200	1	al	al	PROPN
iajs-2127	200	2	-	-	PUNCT
iajs-2127	200	3	ajeeli	ajeeli	ADJ
iajs-2127	200	4	,	,	PUNCT
iajs-2127	200	5	k.s.a	k.s.a	NOUN
iajs-2127	200	6	.	.	PUNCT
iajs-2127	200	7	assessment	assessment	NOUN
iajs-2127	200	8	,	,	PUNCT
iajs-2127	200	9	of	of	ADP
iajs-2127	200	10	c	c	NOUN
iajs-2127	200	11	-	-	PUNCT
iajs-2127	200	12	reactive	reactive	ADJ
iajs-2127	200	13	protein	protein	NOUN
iajs-2127	200	14	,	,	PUNCT
iajs-2127	200	15	titer	titer	NOUN
iajs-2127	200	16	in	in	ADP
iajs-2127	200	17	patients	patient	NOUN
iajs-2127	200	18	with	with	ADP
iajs-2127	200	19	,	,	PUNCT
iajs-2127	200	20	chronic	chronic	ADJ
iajs-2127	200	21	hepatitis	hepatitis	PROPN
iajs-2127	200	22	b	b	PROPN
iajs-2127	200	23	,	,	PUNCT
iajs-2127	200	24	virus	virus	NOUN
iajs-2127	200	25	infection	infection	NOUN
iajs-2127	200	26	.	.	PUNCT
iajs-2127	201	1	iraqi	iraqi	PROPN
iajs-2127	201	2	.	.	PUNCT
iajs-2127	202	1	j.	j.	PROPN
iajs-2127	202	2	comm	comm	PROPN
iajs-2127	202	3	.	.	PUNCT
iajs-2127	203	1	med	med	PROPN
iajs-2127	203	2	.	.	PROPN
iajs-2127	204	1	2011	2011	NUM
iajs-2127	204	2	,	,	PUNCT
iajs-2127	204	3	24	24	NUM
iajs-2127	204	4	,	,	PUNCT
iajs-2127	204	5	4	4	NUM
iajs-2127	204	6	,	,	PUNCT
iajs-2127	204	7	291	291	NUM
iajs-2127	204	8	-	-	SYM
iajs-2127	204	9	4	4	NUM
iajs-2127	204	10	.	.	NUM
iajs-2127	205	1	16	16	NUM
iajs-2127	205	2	.	.	PUNCT
iajs-2127	206	1	ma	ma	PROPN
iajs-2127	206	2	,	,	PUNCT
iajs-2127	206	3	l.n	l.n	PROPN
iajs-2127	206	4	.	.	PROPN
iajs-2127	206	5	;	;	PUNCT
iajs-2127	207	1	liu	liu	PROPN
iajs-2127	207	2	,	,	PUNCT
iajs-2127	207	3	x.y	x.y	PROPN
iajs-2127	207	4	.	.	PROPN
iajs-2127	207	5	;	;	PUNCT
iajs-2127	207	6	luo	luo	PROPN
iajs-2127	207	7	,	,	PUNCT
iajs-2127	207	8	x.	x.	PROPN
iajs-2127	207	9	;	;	PUNCT
iajs-2127	207	10	hu	hu	PROPN
iajs-2127	207	11	,	,	PUNCT
iajs-2127	207	12	y.c	y.c	PROPN
iajs-2127	207	13	.	.	PROPN
iajs-2127	207	14	;	;	PUNCT
iajs-2127	207	15	liu	liu	PROPN
iajs-2127	207	16	,	,	PUNCT
iajs-2127	207	17	s.w	s.w	PROPN
iajs-2127	207	18	.	.	PROPN
iajs-2127	207	19	;	;	PUNCT
iajs-2127	207	20	tang	tang	PROPN
iajs-2127	207	21	,	,	PUNCT
iajs-2127	207	22	y.y	y.y	PROPN
iajs-2127	207	23	.	.	PROPN
iajs-2127	207	24	;	;	PUNCT
iajs-2127	207	25	pan	pan	PROPN
iajs-2127	207	26	,	,	PUNCT
iajs-2127	207	27	j.l	j.l	PROPN
iajs-2127	207	28	.	.	PROPN
iajs-2127	207	29	;	;	PUNCT
iajs-2127	207	30	ding	ding	PROPN
iajs-2127	207	31	,	,	PUNCT
iajs-2127	207	32	x.c	x.c	PROPN
iajs-2127	207	33	.	.	PROPN
iajs-2127	207	34	serum	serum	VERB
iajs-2127	207	35	high	high	ADJ
iajs-2127	207	36	-	-	PUNCT
iajs-2127	207	37	sensitivity	sensitivity	NOUN
iajs-2127	207	38	,	,	PUNCT
iajs-2127	207	39	c	c	NOUN
iajs-2127	207	40	-	-	PUNCT
iajs-2127	207	41	reactive	reactive	ADJ
iajs-2127	207	42	protein	protein	NOUN
iajs-2127	207	43	,	,	PUNCT
iajs-2127	207	44	are	be	AUX
iajs-2127	207	45	associated	associate	VERB
iajs-2127	207	46	with	with	ADP
iajs-2127	207	47	,	,	PUNCT
iajs-2127	207	48	hbv	hbv	NOUN
iajs-2127	207	49	replication	replication	NOUN
iajs-2127	207	50	,	,	PUNCT
iajs-2127	207	51	liver	liver	NOUN
iajs-2127	207	52	damage	damage	NOUN
iajs-2127	207	53	and	and	CCONJ
iajs-2127	207	54	fibrosis	fibrosis	NOUN
iajs-2127	207	55	in	in	ADP
iajs-2127	207	56	patients	patient	NOUN
iajs-2127	207	57	with	with	ADP
iajs-2127	207	58	chronic	chronic	ADJ
iajs-2127	207	59	hepatitis	hepatitis	PROPN
iajs-2127	207	60	b.	b.	PROPN
iajs-2127	207	61	hepatogastroenterology	hepatogastroenterology	PROPN
iajs-2127	207	62	.	.	PUNCT
iajs-2127	208	1	2015	2015	NUM
iajs-2127	208	2	,	,	PUNCT
iajs-2127	208	3	62	62	NUM
iajs-2127	208	4	,	,	PUNCT
iajs-2127	208	5	138	138	NUM
iajs-2127	208	6	,	,	PUNCT
iajs-2127	208	7	368	368	NUM
iajs-2127	208	8	-	-	SYM
iajs-2127	208	9	372	372	NUM
iajs-2127	208	10	,	,	PUNCT
iajs-2127	208	11	doi:10.5754	doi:10.5754	ADJ
iajs-2127	208	12	/	/	SYM
iajs-2127	208	13	hge14772	hge14772	NOUN
iajs-2127	208	14	17	17	NUM
iajs-2127	208	15	.	.	PUNCT
iajs-2127	209	1	kaur	kaur	PROPN
iajs-2127	209	2	,	,	PUNCT
iajs-2127	209	3	n.	n.	PROPN
iajs-2127	209	4	;	;	PUNCT
iajs-2127	209	5	sharma	sharma	PROPN
iajs-2127	209	6	,	,	PUNCT
iajs-2127	209	7	r.	r.	PROPN
iajs-2127	209	8	;	;	PUNCT
iajs-2127	209	9	mahajan	mahajan	PROPN
iajs-2127	209	10	,	,	PUNCT
iajs-2127	209	11	m.	m.	NOUN
iajs-2127	209	12	serum	serum	NOUN
iajs-2127	209	13	hyperamylasemia	hyperamylasemia	NOUN
iajs-2127	209	14	as	as	ADP
iajs-2127	209	15	a	a	DET
iajs-2127	209	16	prognostic	prognostic	ADJ
iajs-2127	209	17	indicator	indicator	NOUN
iajs-2127	209	18	,	,	PUNCT
iajs-2127	209	19	of	of	ADP
iajs-2127	209	20	acute	acute	ADJ
iajs-2127	209	21	viral	viral	NOUN
iajs-2127	209	22	,	,	PUNCT
iajs-2127	209	23	hepatitis	hepatitis	NOUN
iajs-2127	209	24	and	and	CCONJ
iajs-2127	209	25	cirrhosis	cirrhosis	NOUN
iajs-2127	209	26	,	,	PUNCT
iajs-2127	209	27	of	of	ADP
iajs-2127	209	28	liver	liver	NOUN
iajs-2127	209	29	.	.	PUNCT
iajs-2127	210	1	human	human	NOUN
iajs-2127	210	2	.	.	PUNCT
iajs-2127	210	3	biology	biology	NOUN
iajs-2127	210	4	.	.	PUNCT
iajs-2127	211	1	review	review	NOUN
iajs-2127	211	2	.	.	PUNCT
iajs-2127	212	1	2014	2014	NUM
iajs-2127	212	2	,	,	PUNCT
iajs-2127	212	3	3	3	NUM
iajs-2127	212	4	,	,	PUNCT
iajs-2127	212	5	3	3	NUM
iajs-2127	212	6	,	,	PUNCT
iajs-2127	212	7	233	233	NUM
iajs-2127	212	8	-	-	SYM
iajs-2127	212	9	241	241	NUM
iajs-2127	212	10	.	.	PUNCT
iajs-2127	213	1	18	18	NUM
iajs-2127	213	2	.	.	PUNCT
iajs-2127	214	1	jo	jo	PROPN
iajs-2127	214	2	,	,	PUNCT
iajs-2127	214	3	h.	h.	PROPN
iajs-2127	214	4	j.	j.	PROPN
iajs-2127	214	5	;	;	PUNCT
iajs-2127	214	6	park	park	PROPN
iajs-2127	214	7	,	,	PUNCT
iajs-2127	214	8	g.	g.	PROPN
iajs-2127	214	9	n.	n.	PROPN
iajs-2127	214	10	;	;	PUNCT
iajs-2127	214	11	kim	kim	PROPN
iajs-2127	214	12	,	,	PUNCT
iajs-2127	214	13	h.	h.	PROPN
iajs-2127	214	14	r.	r.	PROPN
iajs-2127	214	15	;	;	PUNCT
iajs-2127	214	16	kim	kim	PROPN
iajs-2127	214	17	,	,	PUNCT
iajs-2127	214	18	m.j	m.j	PROPN
iajs-2127	214	19	.	.	PROPN
iajs-2127	214	20	;	;	PUNCT
iajs-2127	214	21	shin	shin	PROPN
iajs-2127	214	22	,	,	PUNCT
iajs-2127	214	23	k.a	k.a	PROPN
iajs-2127	214	24	.	.	PROPN
iajs-2127	214	25	;	;	PUNCT
iajs-2127	214	26	hong	hong	PROPN
iajs-2127	214	27	,	,	PUNCT
iajs-2127	214	28	s.b	s.b	PROPN
iajs-2127	214	29	.	.	PROPN
iajs-2127	214	30	;	;	PUNCT
iajs-2127	214	31	chang	chang	PROPN
iajs-2127	214	32	,	,	PUNCT
iajs-2127	214	33	k.s	k.s	PROPN
iajs-2127	214	34	.	.	PROPN
iajs-2127	214	35	differences	difference	NOUN
iajs-2127	214	36	,	,	PUNCT
iajs-2127	214	37	in	in	ADP
iajs-2127	214	38	haematological	haematological	ADJ
iajs-2127	214	39	,	,	PUNCT
iajs-2127	214	40	characteristics	characteristic	NOUN
iajs-2127	214	41	,	,	PUNCT
iajs-2127	214	42	including	include	VERB
iajs-2127	214	43	cholesterol	cholesterol	NOUN
iajs-2127	214	44	,	,	PUNCT
iajs-2127	214	45	and	and	CCONJ
iajs-2127	214	46	apolipoprotein	apolipoprotein	ADJ
iajs-2127	214	47	b	b	NUM
iajs-2127	214	48	,	,	PUNCT
iajs-2127	214	49	and	and	CCONJ
iajs-2127	214	50	e	e	NOUN
iajs-2127	214	51	,	,	PUNCT
iajs-2127	214	52	between	between	ADP
iajs-2127	214	53	,	,	PUNCT
iajs-2127	214	54	hepatitis	hepatitis	NOUN
iajs-2127	214	55	b	b	PROPN
iajs-2127	214	56	,	,	PUNCT
iajs-2127	214	57	virus	virus	NOUN
iajs-2127	214	58	and	and	CCONJ
iajs-2127	214	59	hepatitis	hepatitis	NOUN
iajs-2127	214	60	,	,	PUNCT
iajs-2127	214	61	c	c	PROPN
iajs-2127	214	62	virus	virus	NOUN
iajs-2127	214	63	patients	patient	NOUN
iajs-2127	214	64	,	,	PUNCT
iajs-2127	214	65	in	in	ADP
iajs-2127	214	66	korea	korea	PROPN
iajs-2127	214	67	.	.	PUNCT
iajs-2127	215	1	j.	j.	PROPN
iajs-2127	215	2	,	,	PUNCT
iajs-2127	215	3	bact	bact	PROPN
iajs-2127	215	4	.	.	PUNCT
iajs-2127	216	1	viro	viro	PROPN
iajs-2127	216	2	.	.	PROPN
iajs-2127	217	1	2016	2016	NUM
iajs-2127	217	2	,	,	PUNCT
iajs-2127	217	3	46	46	NUM
iajs-2127	217	4	,	,	PUNCT
iajs-2127	217	5	3	3	NUM
iajs-2127	217	6	,	,	PUNCT
iajs-2127	217	7	152–158	152–158	NUM
iajs-2127	217	8	,	,	PUNCT
iajs-2127	217	9	doi.org/10.4167/jbv.2016.46.3.152	doi.org/10.4167/jbv.2016.46.3.152	NOUN
iajs-2127	217	10	.	.	PROPN
iajs-2127	218	1	19	19	NUM
iajs-2127	218	2	.	.	X
iajs-2127	218	3	wang	wang	PROPN
iajs-2127	218	4	,	,	PUNCT
iajs-2127	218	5	x.	x.	PROPN
iajs-2127	218	6	;	;	PUNCT
iajs-2127	218	7	cheng	cheng	PROPN
iajs-2127	218	8	,	,	PUNCT
iajs-2127	218	9	p.	p.	PROPN
iajs-2127	218	10	;	;	PUNCT
iajs-2127	218	11	jiang	jiang	PROPN
iajs-2127	218	12	,	,	PUNCT
iajs-2127	218	13	f.	f.	PROPN
iajs-2127	218	14	;	;	PUNCT
iajs-2127	218	15	jiao	jiao	PROPN
iajs-2127	218	16	,	,	PUNCT
iajs-2127	218	17	x.y	x.y	PROPN
iajs-2127	218	18	.	.	PROPN
iajs-2127	219	1	the	the	DET
iajs-2127	219	2	effect	effect	NOUN
iajs-2127	219	3	of	of	ADP
iajs-2127	219	4	hepatitis	hepatitis	NOUN
iajs-2127	219	5	,	,	PUNCT
iajs-2127	219	6	b	b	PROPN
iajs-2127	219	7	virus	virus	NOUN
iajs-2127	219	8	infection	infection	NOUN
iajs-2127	219	9	,	,	PUNCT
iajs-2127	219	10	on	on	ADP
iajs-2127	219	11	hepcidin	hepcidin	VERB
iajs-2127	219	12	expression	expression	NOUN
iajs-2127	219	13	,	,	PUNCT
iajs-2127	219	14	in	in	ADP
iajs-2127	219	15	hepatitis	hepatitis	PROPN
iajs-2127	219	16	b	b	PROPN
iajs-2127	219	17	,	,	PUNCT
iajs-2127	219	18	patients	patient	NOUN
iajs-2127	219	19	.	.	PUNCT
iajs-2127	220	1	annal	annal	ADJ
iajs-2127	220	2	.	.	PUNCT
iajs-2127	221	1	clin	clin	PROPN
iajs-2127	221	2	.	.	PROPN
iajs-2127	221	3	,	,	PUNCT
iajs-2127	221	4	lab	lab	PROPN
iajs-2127	221	5	.	.	PUNCT
iajs-2127	222	1	sci	sci	PROPN
iajs-2127	222	2	.	.	PROPN
iajs-2127	222	3	2013	2013	NUM
iajs-2127	222	4	,	,	PUNCT
iajs-2127	222	5	43	43	NUM
iajs-2127	222	6	,	,	PUNCT
iajs-2127	222	7	2	2	NUM
iajs-2127	222	8	,	,	PUNCT
iajs-2127	222	9	126134	126134	NUM
iajs-2127	222	10	,	,	PUNCT
iajs-2127	222	11	available	available	ADJ
iajs-2127	222	12	online	online	ADV
iajs-2127	222	13	at	at	ADP
iajs-2127	222	14	www.annclinlabsci.org	www.annclinlabsci.org	PROPN
iajs-2127	222	15	.	.	PUNCT
iajs-2127	223	1	20	20	NUM
iajs-2127	223	2	.	.	X
iajs-2127	223	3	nascimento	nascimento	PROPN
iajs-2127	223	4	,	,	PUNCT
iajs-2127	223	5	m.m	m.m	PROPN
iajs-2127	223	6	.	.	PROPN
iajs-2127	223	7	;	;	PUNCT
iajs-2127	223	8	suliman	suliman	NOUN
iajs-2127	223	9	,	,	PUNCT
iajs-2127	223	10	m.e	m.e	PROPN
iajs-2127	223	11	.	.	PROPN
iajs-2127	223	12	;	;	PUNCT
iajs-2127	223	13	bruchfeld	bruchfeld	NOUN
iajs-2127	223	14	,	,	PUNCT
iajs-2127	223	15	a.	a.	NOUN
iajs-2127	223	16	;	;	PUNCT
iajs-2127	223	17	hayashi	hayashi	PROPN
iajs-2127	223	18	,	,	PUNCT
iajs-2127	223	19	s.y	s.y	PROPN
iajs-2127	223	20	.	.	PROPN
iajs-2127	223	21	;	;	PUNCT
iajs-2127	223	22	manfro	manfro	PROPN
iajs-2127	223	23	,	,	PUNCT
iajs-2127	223	24	r.c	r.c	PROPN
iajs-2127	223	25	.	.	PROPN
iajs-2127	223	26	;	;	PUNCT
iajs-2127	223	27	qureshi	qureshi	PROPN
iajs-2127	223	28	,	,	PUNCT
iajs-2127	223	29	a.r	a.r	PROPN
iajs-2127	223	30	.	.	PROPN
iajs-2127	223	31	;	;	PUNCT
iajs-2127	223	32	pecoits	pecoit	NOUN
iajs-2127	223	33	-	-	PUNCT
iajs-2127	223	34	filho	filho	PROPN
iajs-2127	223	35	,	,	PUNCT
iajs-2127	223	36	r.	r.	PROPN
iajs-2127	223	37	;	;	PUNCT
iajs-2127	223	38	pachaly	pachaly	PROPN
iajs-2127	223	39	,	,	PUNCT
iajs-2127	223	40	m.a	m.a	PROPN
iajs-2127	223	41	.	.	PROPN
iajs-2127	223	42	;	;	PUNCT
iajs-2127	223	43	renner	renner	PROPN
iajs-2127	223	44	,	,	PUNCT
iajs-2127	223	45	l.	l.	PROPN
iajs-2127	223	46	;	;	PUNCT
iajs-2127	223	47	stenvinkel	stenvinkel	PROPN
iajs-2127	223	48	,	,	PUNCT
iajs-2127	223	49	p.	p.	NOUN
iajs-2127	223	50	;	;	PUNCT
iajs-2127	223	51	riella	riella	PROPN
iajs-2127	223	52	,	,	PUNCT
iajs-2127	223	53	m.c	m.c	PROPN
iajs-2127	223	54	.	.	PROPN
iajs-2127	223	55	;	;	PUNCT
iajs-2127	224	1	lindholm	lindholm	PROPN
iajs-2127	224	2	,	,	PUNCT
iajs-2127	224	3	b.	b.	PROPN
iajs-2127	224	4	the	the	DET
iajs-2127	224	5	influence	influence	NOUN
iajs-2127	224	6	,	,	PUNCT
iajs-2127	224	7	of	of	ADP
iajs-2127	224	8	hepatitis	hepatitis	PROPN
iajs-2127	224	9	c	c	PROPN
iajs-2127	224	10	and	and	CCONJ
iajs-2127	224	11	,	,	PUNCT
iajs-2127	224	12	iron	iron	NOUN
iajs-2127	224	13	replacement	replacement	NOUN
iajs-2127	224	14	therapy	therapy	NOUN
iajs-2127	224	15	on	on	ADP
iajs-2127	224	16	plasma	plasma	NOUN
iajs-2127	224	17	,	,	PUNCT
iajs-2127	224	18	pentosidine	pentosidine	NOUN
iajs-2127	224	19	levels	level	NOUN
iajs-2127	224	20	in	in	ADP
iajs-2127	224	21	,	,	PUNCT
iajs-2127	224	22	haemo	haemo	NOUN
iajs-2127	224	23	dialysis	dialysis	NOUN
iajs-2127	224	24	patients	patient	NOUN
iajs-2127	224	25	.	.	PUNCT
iajs-2127	225	1	nephrol	nephrol	NOUN
iajs-2127	225	2	.	.	PUNCT
iajs-2127	226	1	dial	dial	NOUN
iajs-2127	226	2	.	.	PUNCT
iajs-2127	227	1	transplant	transplant	NOUN
iajs-2127	227	2	.	.	PUNCT
iajs-2127	228	1	2004	2004	NUM
iajs-2127	228	2	,	,	PUNCT
iajs-2127	228	3	19	19	NUM
iajs-2127	228	4	,	,	PUNCT
iajs-2127	228	5	3112	3112	NUM
iajs-2127	228	6	-	-	SYM
iajs-2127	228	7	3116	3116	NUM
iajs-2127	228	8	,	,	PUNCT
iajs-2127	228	9	doi:10.1093	doi:10.1093	NOUN
iajs-2127	228	10	/	/	SYM
iajs-2127	228	11	ndt	ndt	PROPN
iajs-2127	228	12	/	/	SYM
iajs-2127	228	13	gfh508	gfh508	PROPN
iajs-2127	228	14	.	.	PUNCT
iajs-2127	229	1	21	21	NUM
iajs-2127	229	2	.	.	PUNCT
iajs-2127	230	1	das	das	PROPN
iajs-2127	230	2	,	,	PUNCT
iajs-2127	230	3	s.k	s.k	PROPN
iajs-2127	230	4	.	.	PROPN
iajs-2127	230	5	;	;	PUNCT
iajs-2127	230	6	mukherjee	mukherjee	PROPN
iajs-2127	230	7	,	,	PUNCT
iajs-2127	230	8	s.	s.	PROPN
iajs-2127	230	9	;	;	PUNCT
iajs-2127	230	10	vasudevan	vasudevan	PROPN
iajs-2127	230	11	,	,	PUNCT
iajs-2127	230	12	d.m	d.m	PROPN
iajs-2127	230	13	.	.	PUNCT
iajs-2127	230	14	;	;	PUNCT
iajs-2127	231	1	balakrishnan	balakrishnan	PROPN
iajs-2127	231	2	,	,	PUNCT
iajs-2127	231	3	v.	v.	ADP
iajs-2127	231	4	comparison	comparison	NOUN
iajs-2127	231	5	of	of	ADP
iajs-2127	231	6	haematological	haematological	ADJ
iajs-2127	231	7	parameters	parameter	NOUN
iajs-2127	231	8	in	in	ADP
iajs-2127	231	9	patients	patient	NOUN
iajs-2127	231	10	with	with	ADP
iajs-2127	231	11	non	non	ADJ
iajs-2127	231	12	-	-	ADJ
iajs-2127	231	13	alcoholic	alcoholic	ADJ
iajs-2127	231	14	fatty	fatty	NOUN
iajs-2127	231	15	liver	liver	NOUN
iajs-2127	231	16	disease	disease	NOUN
iajs-2127	231	17	and	and	CCONJ
iajs-2127	231	18	alcoholic	alcoholic	ADJ
iajs-2127	231	19	liver	liver	NOUN
iajs-2127	231	20	disease	disease	NOUN
iajs-2127	231	21	.	.	PUNCT
iajs-2127	232	1	singapore	singapore	PROPN
iajs-2127	232	2	.	.	PUNCT
iajs-2127	232	3	med	med	PROPN
iajs-2127	232	4	.	.	PUNCT
iajs-2127	233	1	j.	j.	PROPN
iajs-2127	233	2	2011	2011	PROPN
iajs-2127	233	3	,	,	PUNCT
iajs-2127	233	4	52	52	NUM
iajs-2127	233	5	,	,	PUNCT
iajs-2127	233	6	3	3	NUM
iajs-2127	233	7	,	,	PUNCT
iajs-2127	233	8	175	175	NUM
iajs-2127	233	9	-	-	SYM
iajs-2127	233	10	180	180	NUM
iajs-2127	233	11	.	.	PUNCT
iajs-2127	234	1	22	22	NUM
iajs-2127	234	2	.	.	PUNCT
iajs-2127	235	1	liaskou	liaskou	PROPN
iajs-2127	235	2	,	,	PUNCT
iajs-2127	235	3	e.	e.	PROPN
iajs-2127	235	4	;	;	PUNCT
iajs-2127	235	5	wilson	wilson	PROPN
iajs-2127	235	6	,	,	PUNCT
iajs-2127	235	7	d.v	d.v	PROPN
iajs-2127	235	8	.	.	PROPN
iajs-2127	235	9	;	;	PUNCT
iajs-2127	235	10	oo	oo	INTJ
iajs-2127	235	11	,	,	PUNCT
iajs-2127	235	12	y.h	y.h	PROPN
iajs-2127	235	13	.	.	PROPN
iajs-2127	235	14	innate	innate	ADJ
iajs-2127	235	15	immune	immune	NOUN
iajs-2127	235	16	,	,	PUNCT
iajs-2127	235	17	cells	cell	NOUN
iajs-2127	235	18	in	in	ADP
iajs-2127	235	19	liver	liver	NOUN
iajs-2127	235	20	,	,	PUNCT
iajs-2127	235	21	inflammation	inflammation	NOUN
iajs-2127	235	22	.	.	PUNCT
iajs-2127	236	1	media	medium	NOUN
iajs-2127	236	2	.	.	PUNCT
iajs-2127	237	1	inflam	inflam	PROPN
iajs-2127	237	2	.	.	PUNCT
iajs-2127	238	1	2012	2012	NUM
iajs-2127	238	2	,	,	PUNCT
iajs-2127	238	3	2012	2012	NUM
iajs-2127	238	4	,	,	PUNCT
iajs-2127	238	5	1	1	NUM
iajs-2127	238	6	,	,	PUNCT
iajs-2127	238	7	1	1	NUM
iajs-2127	238	8	-	-	SYM
iajs-2127	238	9	21	21	NUM
iajs-2127	238	10	,	,	PUNCT
iajs-2127	238	11	doi	doi	NOUN
iajs-2127	238	12	.	.	PUNCT
iajs-2127	239	1	org/10.1155/2012,/949157	org/10.1155/2012,/949157	PROPN
iajs-2127	239	2	.	.	PROPN
iajs-2127	239	3	23	23	NUM
iajs-2127	239	4	.	.	PUNCT
iajs-2127	240	1	xu	xu	PROPN
iajs-2127	240	2	,	,	PUNCT
iajs-2127	240	3	r.	r.	PROPN
iajs-2127	240	4	;	;	PUNCT
iajs-2127	240	5	huang	huang	PROPN
iajs-2127	240	6	,	,	PUNCT
iajs-2127	240	7	h.	h.	PROPN
iajs-2127	240	8	;	;	PUNCT
iajs-2127	240	9	zhang	zhang	PROPN
iajs-2127	240	10	,	,	PUNCT
iajs-2127	240	11	z.	z.	PROPN
iajs-2127	240	12	;	;	PUNCT
iajs-2127	240	13	wang	wang	PROPN
iajs-2127	240	14	,	,	PUNCT
iajs-2127	240	15	f.s	f.s	PROPN
iajs-2127	240	16	.	.	PUNCT
iajs-2127	241	1	the	the	DET
iajs-2127	241	2	role	role	NOUN
iajs-2127	241	3	of	of	ADP
iajs-2127	241	4	neutrophils	neutrophil	NOUN
iajs-2127	241	5	in	in	ADP
iajs-2127	241	6	the	the	DET
iajs-2127	241	7	development	development	NOUN
iajs-2127	241	8	of	of	ADP
iajs-2127	241	9	liver	liver	NOUN
iajs-2127	241	10	diseases	disease	NOUN
iajs-2127	241	11	.	.	PUNCT
iajs-2127	242	1	cell	cell	NOUN
iajs-2127	242	2	.	.	PUNCT
iajs-2127	243	1	mol	mol	PROPN
iajs-2127	243	2	.	.	PUNCT
iajs-2127	243	3	immunol	immunol	NOUN
iajs-2127	243	4	.	.	PUNCT
iajs-2127	244	1	2014	2014	NUM
iajs-2127	244	2	,	,	PUNCT
iajs-2127	244	3	11	11	NUM
iajs-2127	244	4	,	,	PUNCT
iajs-2127	244	5	224–231	224–231	NUM
iajs-2127	244	6	,	,	PUNCT
iajs-2127	244	7	doi:10.1038	doi:10.1038	NOUN
iajs-2127	244	8	/	/	SYM
iajs-2127	244	9	cmi.2014.2	cmi.2014.2	PROPN
iajs-2127	244	10	.	.	PUNCT
iajs-2127	245	1	epub	epub	PROPN
iajs-2127	245	2	2014	2014	NUM
iajs-2127	245	3	mar	mar	PROPN
iajs-2127	245	4	17	17	NUM
iajs-2127	245	5	.	.	PUNCT
iajs-2127	246	1	24	24	NUM
iajs-2127	246	2	.	.	PUNCT
iajs-2127	247	1	tritto	tritto	NOUN
iajs-2127	247	2	,	,	PUNCT
iajs-2127	247	3	g.	g.	PROPN
iajs-2127	247	4	;	;	PUNCT
iajs-2127	247	5	bechlis	bechlis	PROPN
iajs-2127	247	6	,	,	PUNCT
iajs-2127	247	7	z.	z.	PROPN
iajs-2127	247	8	;	;	PUNCT
iajs-2127	247	9	stadlbauer	stadlbauer	PROPN
iajs-2127	247	10	,	,	PUNCT
iajs-2127	247	11	v.	v.	PROPN
iajs-2127	247	12	;	;	PUNCT
iajs-2127	247	13	davies	davy	NOUN
iajs-2127	247	14	,	,	PUNCT
iajs-2127	247	15	n.	n.	NOUN
iajs-2127	247	16	;	;	PUNCT
iajs-2127	247	17	francés	francés	PROPN
iajs-2127	247	18	,	,	PUNCT
iajs-2127	247	19	r.	r.	PROPN
iajs-2127	247	20	;	;	PUNCT
iajs-2127	247	21	shah	shah	NOUN
iajs-2127	247	22	,	,	PUNCT
iajs-2127	247	23	n.	n.	NOUN
iajs-2127	247	24	;	;	PUNCT
iajs-2127	247	25	mookerjee	mookerjee	PROPN
iajs-2127	247	26	,	,	PUNCT
iajs-2127	247	27	r.p	r.p	PROPN
iajs-2127	247	28	.	.	PROPN
iajs-2127	247	29	;	;	PUNCT
iajs-2127	247	30	such	such	ADJ
iajs-2127	247	31	,	,	PUNCT
iajs-2127	247	32	j.	j.	PROPN
iajs-2127	247	33	;	;	PUNCT
iajs-2127	247	34	jalan	jalan	PROPN
iajs-2127	247	35	,	,	PUNCT
iajs-2127	247	36	r.	r.	PROPN
iajs-2127	247	37	evidence	evidence	NOUN
iajs-2127	247	38	,	,	PUNCT
iajs-2127	247	39	of	of	ADP
iajs-2127	247	40	neutrophil	neutrophil	ADJ
iajs-2127	247	41	functional	functional	ADJ
iajs-2127	247	42	,	,	PUNCT
iajs-2127	247	43	defect	defect	VERB
iajs-2127	247	44	despite	despite	SCONJ
iajs-2127	247	45	inflammation	inflammation	NOUN
iajs-2127	247	46	,	,	PUNCT
iajs-2127	247	47	in	in	ADP
iajs-2127	247	48	stable	stable	ADJ
iajs-2127	247	49	cirrhosis	cirrhosis	NOUN
iajs-2127	247	50	,	,	PUNCT
iajs-2127	247	51	.	.	PUNCT
iajs-2127	248	1	j.	j.	PROPN
iajs-2127	248	2	hepatol	hepatol	PROPN
iajs-2127	248	3	.	.	PUNCT
iajs-2127	249	1	2011	2011	NUM
iajs-2127	249	2	,	,	PUNCT
iajs-2127	249	3	55	55	NUM
iajs-2127	249	4	,	,	PUNCT
iajs-2127	249	5	574–581	574–581	NUM
iajs-2127	249	6	,	,	PUNCT
iajs-2127	249	7	doi	doi	NOUN
iajs-2127	249	8	:	:	PUNCT
iajs-2127	249	9	10.1016	10.1016	NUM
iajs-2127	249	10	/	/	SYM
iajs-2127	249	11	j.jhep.2010.11.034	j.jhep.2010.11.034	NOUN
iajs-2127	249	12	.	.	PUNCT
iajs-2127	250	1	25	25	NUM
iajs-2127	250	2	.	.	X
iajs-2127	251	1	zhang	zhang	PROPN
iajs-2127	251	2	,	,	PUNCT
iajs-2127	251	3	j.	j.	PROPN
iajs-2127	251	4	;	;	PUNCT
iajs-2127	251	5	feng	feng	PROPN
iajs-2127	251	6	,	,	PUNCT
iajs-2127	251	7	g.	g.	PROPN
iajs-2127	251	8	;	;	PUNCT
iajs-2127	251	9	zhao	zhao	PROPN
iajs-2127	251	10	,	,	PUNCT
iajs-2127	251	11	y.	y.	PROPN
iajs-2127	251	12	;	;	PUNCT
iajs-2127	251	13	zhang	zhang	PROPN
iajs-2127	251	14	,	,	PUNCT
iajs-2127	251	15	j.	j.	PROPN
iajs-2127	251	16	;	;	PUNCT
iajs-2127	251	17	feng	feng	PROPN
iajs-2127	251	18	,	,	PUNCT
iajs-2127	251	19	l.	l.	PROPN
iajs-2127	251	20	;	;	PUNCT
iajs-2127	251	21	yang	yang	PROPN
iajs-2127	251	22	,	,	PUNCT
iajs-2127	251	23	j.	j.	PROPN
iajs-2127	251	24	association	association	PROPN
iajs-2127	251	25	,	,	PUNCT
iajs-2127	251	26	between	between	ADP
iajs-2127	251	27	lymphocyte	lymphocyte	ADJ
iajs-2127	251	28	,	,	PUNCT
iajs-2127	251	29	tomonocyte	tomonocyte	NOUN
iajs-2127	251	30	ratio	ratio	NOUN
iajs-2127	251	31	(	(	PUNCT
iajs-2127	251	32	lmr),and	lmr),and	NOUN
iajs-2127	251	33	the	the	DET
iajs-2127	251	34	mortality	mortality	NOUN
iajs-2127	251	35	,	,	PUNCT
iajs-2127	251	36	of	of	ADP
iajs-2127	251	37	hbv	hbv	NOUN
iajs-2127	251	38	-	-	PUNCT
iajs-2127	251	39	related	relate	VERB
iajs-2127	251	40	,	,	PUNCT
iajs-2127	251	41	liver	liver	NOUN
iajs-2127	251	42	cirrhosis	cirrhosis	NOUN
iajs-2127	251	43	:	:	PUNCT
iajs-2127	251	44	a	a	DET
iajs-2127	251	45	retrospective	retrospective	ADJ
iajs-2127	251	46	cohort	cohort	NOUN
iajs-2127	251	47	study	study	NOUN
iajs-2127	251	48	.	.	PUNCT
iajs-2127	252	1	bmj	bmj	PROPN
iajs-2127	252	2	open	open	ADJ
iajs-2127	252	3	.	.	PUNCT
iajs-2127	253	1	2015	2015	NUM
iajs-2127	253	2	,	,	PUNCT
iajs-2127	253	3	5	5	NUM
iajs-2127	253	4	,	,	PUNCT
iajs-2127	253	5	1	1	NUM
iajs-2127	253	6	-	-	SYM
iajs-2127	253	7	7	7	NUM
iajs-2127	253	8	,	,	PUNCT
iajs-2127	253	9	doi:10.1136	doi:10.1136	NOUN
iajs-2127	253	10	/	/	SYM
iajs-2127	253	11	bmjopen-2015	bmjopen-2015	PROPN
iajs-2127	253	12	-	-	PUNCT
iajs-2127	253	13	008033	008033	NUM
iajs-2127	253	14	.	.	PUNCT
iajs-2127	254	1	26	26	NUM
iajs-2127	254	2	.	.	X
iajs-2127	255	1	francisca	francisca	PROPN
iajs-2127	255	2	,	,	PUNCT
iajs-2127	255	3	o.u	o.u	PROPN
iajs-2127	255	4	.	.	PROPN
iajs-2127	255	5	;	;	PUNCT
iajs-2127	255	6	ihongbe	ihongbe	NOUN
iajs-2127	255	7	,	,	PUNCT
iajs-2127	255	8	j.c	j.c	PROPN
iajs-2127	255	9	.	.	PROPN
iajs-2127	255	10	;	;	PUNCT
iajs-2127	255	11	ifeanyi	ifeanyi	PROPN
iajs-2127	255	12	,	,	PUNCT
iajs-2127	255	13	o.e	o.e	PROPN
iajs-2127	255	14	.	.	PUNCT
iajs-2127	255	15	;	;	PUNCT
iajs-2127	255	16	martin	martin	PROPN
iajs-2127	255	17	,	,	PUNCT
iajs-2127	255	18	i.	i.	PROPN
iajs-2127	255	19	;	;	PUNCT
iajs-2127	255	20	ebele	ebele	PROPN
iajs-2127	255	21	,	,	PUNCT
iajs-2127	255	22	n.p	n.p	PROPN
iajs-2127	255	23	.	.	PROPN
iajs-2127	255	24	;	;	PUNCT
iajs-2127	255	25	ogochukwu	ogochukwu	ADJ
iajs-2127	255	26	,	,	PUNCT
iajs-2127	255	27	o.	o.	PROPN
iajs-2127	255	28	haematological	haematological	ADJ
iajs-2127	255	29	indices	index	NOUN
iajs-2127	255	30	of	of	ADP
iajs-2127	255	31	hepatitis	hepatitis	NOUN
iajs-2127	255	32	,	,	PUNCT
iajs-2127	255	33	b	b	NOUN
iajs-2127	255	34	infected	infected	ADJ
iajs-2127	255	35	subjects	subject	NOUN
iajs-2127	255	36	,	,	PUNCT
iajs-2127	255	37	in	in	ADP
iajs-2127	255	38	nnamdi	nnamdi	PROPN
iajs-2127	255	39	azikiwe	azikiwe	NOUN
iajs-2127	255	40	,	,	PUNCT
iajs-2127	255	41	university	university	NOUN
iajs-2127	255	42	teaching	teaching	NOUN
iajs-2127	255	43	hospital	hospital	NOUN
iajs-2127	255	44	,	,	PUNCT
iajs-2127	255	45	nnewi	nnewi	PROPN
iajs-2127	255	46	,	,	PUNCT
iajs-2127	255	47	anambra	anambra	PROPN
iajs-2127	255	48	state	state	PROPN
iajs-2127	255	49	,	,	PUNCT
iajs-2127	255	50	nigeria	nigeria	PROPN
iajs-2127	255	51	.	.	PUNCT
iajs-2127	256	1	jbc	jbc	PROPN
iajs-2127	256	2	.	.	PROPN
iajs-2127	256	3	2017	2017	NUM
iajs-2127	256	4	,	,	PUNCT
iajs-2127	256	5	6	6	NUM
iajs-2127	256	6	,	,	PUNCT
iajs-2127	256	7	3	3	NUM
iajs-2127	256	8	,	,	PUNCT
iajs-2127	256	9	17	17	NUM
iajs-2127	256	10	-	-	SYM
iajs-2127	256	11	24	24	NUM
iajs-2127	256	12	,	,	PUNCT
iajs-2127	256	13	doi:10.4172/2254	doi:10.4172/2254	NOUN
iajs-2127	256	14	-609x.100061	-609x.100061	PROPN
iajs-2127	256	15	.	.	PUNCT
iajs-2127	257	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=dertli%20r%5bauthor%5d&cauthor=true&cauthor_uid=28618749	https://www.ncbi.nlm.nih.gov/pubmed/?term=dertli%20r%5bauthor%5d&cauthor=true&cauthor_uid=28618749	NUM
iajs-2127	258	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=demir%20a%5bauthor%5d&cauthor=true&cauthor_uid=28618749	https://www.ncbi.nlm.nih.gov/pubmed/?term=demir%20a%5bauthor%5d&cauthor=true&cauthor_uid=28618749	NOUN
iajs-2127	258	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=polat%20h%5bauthor%5d&cauthor=true&cauthor_uid=28618749	https://www.ncbi.nlm.nih.gov/pubmed/?term=polat%20h%5bauthor%5d&cauthor=true&cauthor_uid=28618749	NUM
iajs-2127	259	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=uysal%20s%5bauthor%5d&cauthor=true&cauthor_uid=28618749	https://www.ncbi.nlm.nih.gov/pubmed/?term=uysal%20s%5bauthor%5d&cauthor=true&cauthor_uid=28618749	NUM
iajs-2127	259	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=ataseven%20h%5bauthor%5d&cauthor=true&cauthor_uid=28618749	https://www.ncbi.nlm.nih.gov/pubmed/?term=ataseven%20h%5bauthor%5d&cauthor=true&cauthor_uid=28618749	VERB
iajs-2127	259	3	https://doi.org/10.3906/sag-1611-66	https://doi.org/10.3906/sag-1611-66	ADP
iajs-2127	260	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=maudar%20kk%5bauthor%5d&cauthor=true&cauthor_uid=22468043	https://www.ncbi.nlm.nih.gov/pubmed/?term=maudar%20kk%5bauthor%5d&cauthor=true&cauthor_uid=22468043	ADJ
iajs-2127	260	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=varshney%20s%5bauthor%5d&cauthor=true&cauthor_uid=22468043	https://www.ncbi.nlm.nih.gov/pubmed/?term=varshney%20s%5bauthor%5d&cauthor=true&cauthor_uid=22468043	ADJ
iajs-2127	260	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=mishra%20pk%5bauthor%5d&cauthor=true&cauthor_uid=22468043	https://www.ncbi.nlm.nih.gov/pubmed/?term=mishra%20pk%5bauthor%5d&cauthor=true&cauthor_uid=22468043	NOUN
iajs-2127	260	4	https://dx.doi.org/10.1007%2fs12291-010-0098-7	https://dx.doi.org/10.1007%2fs12291-010-0098-7	NOUN
iajs-2127	260	5	https://dx.doi.org/10.1007%2fs12291-010-0098-7	https://dx.doi.org/10.1007%2fs12291-010-0098-7	PROPN
iajs-2127	260	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=ma%20ln%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=ma%20ln%5bauthor%5d&cauthor=true&cauthor_uid=25916065	NOUN
iajs-2127	260	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20xy%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20xy%5bauthor%5d&cauthor=true&cauthor_uid=25916065	PROPN
iajs-2127	261	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=luo%20x%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=luo%20x%5bauthor%5d&cauthor=true&cauthor_uid=25916065	PROPN
iajs-2127	261	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=hu%20yc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=hu%20yc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	PROPN
iajs-2127	262	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20sw%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20sw%5bauthor%5d&cauthor=true&cauthor_uid=25916065	INTJ
iajs-2127	263	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=tang%20yy%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=tang%20yy%5bauthor%5d&cauthor=true&cauthor_uid=25916065	NOUN
iajs-2127	264	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=pan%20jl%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=pan%20jl%5bauthor%5d&cauthor=true&cauthor_uid=25916065	INTJ
iajs-2127	265	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=ding%20xc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=ding%20xc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	INTJ
iajs-2127	265	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=ding%20xc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	https://www.ncbi.nlm.nih.gov/pubmed/?term=ding%20xc%5bauthor%5d&cauthor=true&cauthor_uid=25916065	PROPN
iajs-2127	265	3	https://www.ncbi.nlm.nih.gov/pubmed/25916065	https://www.ncbi.nlm.nih.gov/pubmed/25916065	NUM
iajs-2127	266	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=jiao%20xy%5bauthor%5d&cauthor=true&cauthor_uid=23694786	https://www.ncbi.nlm.nih.gov/pubmed/?term=jiao%20xy%5bauthor%5d&cauthor=true&cauthor_uid=23694786	ADV
iajs-2127	266	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=hayashi%20sy%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=hayashi%20sy%5bauthor%5d&cauthor=true&cauthor_uid=15466879	VERB
iajs-2127	266	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=manfro%20rc%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=manfro%20rc%5bauthor%5d&cauthor=true&cauthor_uid=15466879	AUX
iajs-2127	266	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=qureshi%20ar%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=qureshi%20ar%5bauthor%5d&cauthor=true&cauthor_uid=15466879	PROPN
iajs-2127	266	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=qureshi%20ar%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=qureshi%20ar%5bauthor%5d&cauthor=true&cauthor_uid=15466879	PROPN
iajs-2127	266	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=pecoits-filho%20r%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=pecoits-filho%20r%5bauthor%5d&cauthor=true&cauthor_uid=15466879	PROPN
iajs-2127	266	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=pachaly%20ma%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=pachaly%20ma%5bauthor%5d&cauthor=true&cauthor_uid=15466879	ADJ
iajs-2127	266	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=renner%20l%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=renner%20l%5bauthor%5d&cauthor=true&cauthor_uid=15466879	PROPN
iajs-2127	266	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=stenvinkel%20p%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=stenvinkel%20p%5bauthor%5d&cauthor=true&cauthor_uid=15466879	VERB
iajs-2127	266	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=riella%20mc%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=riella%20mc%5bauthor%5d&cauthor=true&cauthor_uid=15466879	PROPN
iajs-2127	266	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=lindholm%20b%5bauthor%5d&cauthor=true&cauthor_uid=15466879	https://www.ncbi.nlm.nih.gov/pubmed/?term=lindholm%20b%5bauthor%5d&cauthor=true&cauthor_uid=15466879	NOUN
iajs-2127	266	12	https://doi.org/10.1093/ndt/gfh508	https://doi.org/10.1093/ndt/gfh508	PROPN
iajs-2127	266	13	http://dx.doi	http://dx.doi	NOUN
iajs-2127	266	14	.	.	PUNCT
iajs-2127	266	15	,org/10.1155/2012,/949157	,org/10.1155/2012,/949157	X
iajs-2127	267	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=wang%20fs%5bauthor%5d&cauthor=true&cauthor_uid=24633014	https://www.ncbi.nlm.nih.gov/pubmed/?term=wang%20fs%5bauthor%5d&cauthor=true&cauthor_uid=24633014	PROPN
iajs-2127	267	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=davies%20n%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=davies%20n%5bauthor%5d&cauthor=true&cauthor_uid=21236309	PROPN
iajs-2127	267	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=franc%c3%a9s%20r%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=franc%c3%a9s%20r%5bauthor%5d&cauthor=true&cauthor_uid=21236309	PROPN
iajs-2127	267	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=shah%20n%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=shah%20n%5bauthor%5d&cauthor=true&cauthor_uid=21236309	PROPN
iajs-2127	267	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=mookerjee%20rp%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=mookerjee%20rp%5bauthor%5d&cauthor=true&cauthor_uid=21236309	NOUN
iajs-2127	267	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=such%20j%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=such%20j%5bauthor%5d&cauthor=true&cauthor_uid=21236309	PROPN
iajs-2127	267	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=jalan%20r%5bauthor%5d&cauthor=true&cauthor_uid=21236309	https://www.ncbi.nlm.nih.gov/pubmed/?term=jalan%20r%5bauthor%5d&cauthor=true&cauthor_uid=21236309	PROPN
iajs-2127	267	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20j%5bauthor%5d&cauthor=true&cauthor_uid=26297362	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20j%5bauthor%5d&cauthor=true&cauthor_uid=26297362	PROPN
iajs-2127	267	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=feng%20l%5bauthor%5d&cauthor=true&cauthor_uid=26297362	https://www.ncbi.nlm.nih.gov/pubmed/?term=feng%20l%5bauthor%5d&cauthor=true&cauthor_uid=26297362	NUM
iajs-2127	267	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=yang%20j%5bauthor%5d&cauthor=true&cauthor_uid=26297362	https://www.ncbi.nlm.nih.gov/pubmed/?term=yang%20j%5bauthor%5d&cauthor=true&cauthor_uid=26297362	PROPN
iajs-2127	267	11	https://dx.doi.org/10.1136%2fbmjopen-2015-008033	https://dx.doi.org/10.1136%2fbmjopen-2015-008033	PROPN
iajs-2127	267	12	18	18	NUM
iajs-2127	267	13	ibn	ibn	PROPN
iajs-2127	267	14	al	al	PROPN
iajs-2127	267	15	-	-	PUNCT
iajs-2127	267	16	haitham	haitham	PROPN
iajs-2127	267	17	jour	jour	X
iajs-2127	267	18	.	.	PROPN
iajs-2127	268	1	for	for	ADP
iajs-2127	268	2	pure	pure	ADJ
iajs-2127	268	3	&	&	CCONJ
iajs-2127	268	4	appl	appl	PROPN
iajs-2127	268	5	.	.	PUNCT
iajs-2127	269	1	sci	sci	PROPN
iajs-2127	269	2	.	.	PROPN
iajs-2127	269	3	32	32	NUM
iajs-2127	269	4	(	(	PUNCT
iajs-2127	269	5	2	2	NUM
iajs-2127	269	6	)	)	PUNCT
iajs-2127	269	7	2019	2019	NUM
iajs-2127	269	8	27	27	NUM
iajs-2127	269	9	.	.	PUNCT
iajs-2127	270	1	kucukazman	kucukazman	NOUN
iajs-2127	270	2	,	,	PUNCT
iajs-2127	270	3	m.	m.	NOUN
iajs-2127	270	4	;	;	PUNCT
iajs-2127	270	5	ata	ata	INTJ
iajs-2127	270	6	,	,	PUNCT
iajs-2127	270	7	n.	n.	PROPN
iajs-2127	270	8	;	;	PUNCT
iajs-2127	270	9	yavuz	yavuz	PROPN
iajs-2127	270	10	,	,	PUNCT
iajs-2127	270	11	b.	b.	PROPN
iajs-2127	270	12	;	;	PUNCT
iajs-2127	270	13	dal	dal	PROPN
iajs-2127	270	14	,	,	PUNCT
iajs-2127	270	15	k.	k.	PROPN
iajs-2127	270	16	;	;	PUNCT
iajs-2127	270	17	ertugrul	ertugrul	NOUN
iajs-2127	270	18	,	,	PUNCT
iajs-2127	270	19	d.t	d.t	PROPN
iajs-2127	270	20	.	.	PROPN
iajs-2127	270	21	;	;	PUNCT
iajs-2127	270	22	yalcin	yalcin	PROPN
iajs-2127	270	23	,	,	PUNCT
iajs-2127	270	24	a.a	a.a	PROPN
iajs-2127	270	25	.	.	PROPN
iajs-2127	270	26	;	;	PUNCT
iajs-2127	270	27	deveci	deveci	PROPN
iajs-2127	270	28	,	,	PUNCT
iajs-2127	270	29	o.s	o.s	PROPN
iajs-2127	270	30	.	.	PROPN
iajs-2127	270	31	;	;	PUNCT
iajs-2127	270	32	sen	sen	PROPN
iajs-2127	270	33	,	,	PUNCT
iajs-2127	270	34	o.	o.	PROPN
iajs-2127	270	35	;	;	PUNCT
iajs-2127	270	36	akin	akin	ADJ
iajs-2127	270	37	,	,	PUNCT
iajs-2127	270	38	k.o	k.o	PROPN
iajs-2127	270	39	.	.	PROPN
iajs-2127	270	40	;	;	PUNCT
iajs-2127	270	41	cizmeci	cizmeci	PROPN
iajs-2127	270	42	,	,	PUNCT
iajs-2127	270	43	z.	z.	PROPN
iajs-2127	270	44	;	;	PUNCT
iajs-2127	270	45	sacikara	sacikara	PROPN
iajs-2127	270	46	,	,	PUNCT
iajs-2127	270	47	m.	m.	NOUN
iajs-2127	270	48	;	;	PUNCT
iajs-2127	270	49	nazligul	nazligul	PROPN
iajs-2127	270	50	,	,	PUNCT
iajs-2127	270	51	y.	y.	PROPN
iajs-2127	270	52	elevation	elevation	NOUN
iajs-2127	270	53	of	of	ADP
iajs-2127	270	54	b	b	NOUN
iajs-2127	270	55	-	-	PUNCT
iajs-2127	270	56	type	type	NOUN
iajs-2127	270	57	,	,	PUNCT
iajs-2127	270	58	natriuretic	natriuretic	ADJ
iajs-2127	270	59	peptide	peptide	NOUN
iajs-2127	270	60	level	level	NOUN
iajs-2127	270	61	,	,	PUNCT
iajs-2127	270	62	in	in	ADP
iajs-2127	270	63	asymptomatic	asymptomatic	ADJ
iajs-2127	270	64	hepatitis	hepatitis	NOUN
iajs-2127	270	65	,	,	PUNCT
iajs-2127	270	66	b	b	NOUN
iajs-2127	270	67	virus	virus	NOUN
iajs-2127	270	68	-	-	PUNCT
iajs-2127	270	69	positive	positive	ADJ
iajs-2127	270	70	,	,	PUNCT
iajs-2127	270	71	patients	patient	NOUN
iajs-2127	270	72	is	be	AUX
iajs-2127	270	73	not	not	PART
iajs-2127	270	74	,	,	PUNCT
iajs-2127	270	75	associated	associate	VERB
iajs-2127	270	76	with	with	ADP
iajs-2127	270	77	abnormalities	abnormality	NOUN
iajs-2127	270	78	,	,	PUNCT
iajs-2127	270	79	of	of	ADP
iajs-2127	270	80	cardiac	cardiac	ADJ
iajs-2127	270	81	function	function	NOUN
iajs-2127	270	82	,	,	PUNCT
iajs-2127	270	83	.	.	PUNCT
iajs-2127	271	1	med	med	PROPN
iajs-2127	271	2	.	.	PUNCT
iajs-2127	271	3	princ	princ	PROPN
iajs-2127	271	4	.	.	PUNCT
iajs-2127	271	5	pract	pract	PROPN
iajs-2127	271	6	.	.	PUNCT
iajs-2127	272	1	2012	2012	NUM
iajs-2127	272	2	,	,	PUNCT
iajs-2127	272	3	21	21	NUM
iajs-2127	272	4	,	,	PUNCT
iajs-2127	272	5	150–155	150–155	NUM
iajs-2127	272	6	,	,	PUNCT
iajs-2127	272	7	doi	doi	NOUN
iajs-2127	272	8	:	:	PUNCT
iajs-2127	272	9	org/	org/	NOUN
iajs-2127	272	10	10.1159/	10.1159/	NUM
iajs-2127	272	11	000332440	000332440	NUM
iajs-2127	272	12	.	.	PUNCT
iajs-2127	273	1	28	28	NUM
iajs-2127	273	2	.	.	PUNCT
iajs-2127	274	1	xiao	xiao	PROPN
iajs-2127	274	2	,	,	PUNCT
iajs-2127	274	3	l.	l.	PROPN
iajs-2127	274	4	;	;	PUNCT
iajs-2127	274	5	xian	xian	PROPN
iajs-2127	274	6	,	,	PUNCT
iajs-2127	274	7	j.	j.	PROPN
iajs-2127	274	8	;	;	PUNCT
iajs-2127	274	9	li	li	PROPN
iajs-2127	274	10	,	,	PUNCT
iajs-2127	274	11	y.	y.	PROPN
iajs-2127	274	12	;	;	PUNCT
iajs-2127	274	13	geng	geng	PROPN
iajs-2127	274	14	,	,	PUNCT
iajs-2127	274	15	a.	a.	PROPN
iajs-2127	274	16	;	;	PUNCT
iajs-2127	274	17	yang	yang	PROPN
iajs-2127	274	18	,	,	PUNCT
iajs-2127	274	19	x.	x.	PROPN
iajs-2127	274	20	;	;	PUNCT
iajs-2127	274	21	han	han	PROPN
iajs-2127	274	22	,	,	PUNCT
iajs-2127	274	23	l.	l.	PROPN
iajs-2127	274	24	;	;	PUNCT
iajs-2127	274	25	xu	xu	PROPN
iajs-2127	274	26	,	,	PUNCT
iajs-2127	274	27	h.	h.	PROPN
iajs-2127	274	28	parameters	parameter	NOUN
iajs-2127	274	29	associated	associate	VERB
iajs-2127	274	30	with	with	ADP
iajs-2127	274	31	significant	significant	ADJ
iajs-2127	274	32	,	,	PUNCT
iajs-2127	274	33	liver	liver	ADJ
iajs-2127	274	34	histological	histological	ADJ
iajs-2127	274	35	changes	change	NOUN
iajs-2127	274	36	,	,	PUNCT
iajs-2127	274	37	,	,	PUNCT
iajs-2127	274	38	in	in	ADP
iajs-2127	274	39	patients	patient	NOUN
iajs-2127	274	40	with	with	ADP
iajs-2127	274	41	,	,	PUNCT
iajs-2127	274	42	,	,	PUNCT
iajs-2127	274	43	chronic	chronic	ADJ
iajs-2127	274	44	hepatitis	hepatitis	PROPN
iajs-2127	274	45	b.	b.	PROPN
iajs-2127	274	46	isrn	isrn	PROPN
iajs-2127	274	47	gastroenterology	gastroenterology	PROPN
iajs-2127	274	48	.	.	PUNCT
iajs-2127	274	49	2014	2014	NUM
iajs-2127	274	50	,	,	PUNCT
iajs-2127	274	51	2014,doi.org/10.1155/2014/913890	2014,doi.org/10.1155/2014/913890	NUM
iajs-2127	274	52	.	.	NOUN
iajs-2127	274	53	29	29	NUM
iajs-2127	274	54	.	.	PUNCT
iajs-2127	275	1	pan	pan	PROPN
iajs-2127	275	2	,	,	PUNCT
iajs-2127	275	3	y.	y.	PROPN
iajs-2127	275	4	;	;	PUNCT
iajs-2127	275	5	muheremu	muheremu	NOUN
iajs-2127	275	6	,	,	PUNCT
iajs-2127	275	7	a.	a.	NOUN
iajs-2127	275	8	;	;	PUNCT
iajs-2127	275	9	wu	wu	PROPN
iajs-2127	275	10	,	,	PUNCT
iajs-2127	275	11	x.	x.	PROPN
iajs-2127	275	12	;	;	PUNCT
iajs-2127	275	13	liu	liu	PROPN
iajs-2127	275	14	,	,	PUNCT
iajs-2127	275	15	j.	j.	PROPN
iajs-2127	275	16	relationship	relationship	NOUN
iajs-2127	275	17	between	between	ADP
iajs-2127	275	18	platelet	platelet	NOUN
iajs-2127	275	19	parameters	parameter	NOUN
iajs-2127	275	20	,	,	PUNCT
iajs-2127	275	21	and	and	CCONJ
iajs-2127	275	22	hepatic	hepatic	ADJ
iajs-2127	275	23	pathology	pathology	NOUN
iajs-2127	275	24	,	,	PUNCT
iajs-2127	275	25	in	in	ADP
iajs-2127	275	26	patientswith	patientswith	NOUN
iajs-2127	275	27	chronic	chronic	NOUN
iajs-2127	275	28	,	,	PUNCT
iajs-2127	275	29	hepatitis	hepatitis	PROPN
iajs-2127	275	30	b	b	NOUN
iajs-2127	275	31	infection	infection	NOUN
iajs-2127	275	32	,	,	PUNCT
iajs-2127	275	33	–	–	PUNCT
iajs-2127	275	34	a	a	DET
iajs-2127	275	35	retrospective	retrospective	ADJ
iajs-2127	275	36	cohort	cohort	NOUN
iajs-2127	275	37	study	study	NOUN
iajs-2127	275	38	,	,	PUNCT
iajs-2127	275	39	of	of	ADP
iajs-2127	275	40	677	677	NUM
iajs-2127	275	41	patients	patient	NOUN
iajs-2127	275	42	,	,	PUNCT
iajs-2127	275	43	.	.	PUNCT
iajs-2127	276	1	j.	j.	PROPN
iajs-2127	276	2	inter	inter	PROPN
iajs-2127	276	3	.	.	PROPN
iajs-2127	276	4	med	med	PROPN
iajs-2127	276	5	.	.	PROPN
iajs-2127	276	6	,	,	PUNCT
iajs-2127	276	7	res	re	NOUN
iajs-2127	276	8	.	.	PROPN
iajs-2127	276	9	2016	2016	NUM
iajs-2127	276	10	,	,	PUNCT
iajs-2127	276	11	44	44	NUM
iajs-2127	276	12	,	,	PUNCT
iajs-2127	276	13	4	4	NUM
iajs-2127	276	14	,	,	PUNCT
iajs-2127	276	15	779–786	779–786	NUM
iajs-2127	276	16	,	,	PUNCT
iajs-2127	276	17	doi:10.1177/0300060516650076	doi:10.1177/0300060516650076	ADJ
iajs-2127	276	18	.	.	PUNCT
iajs-2127	277	1	30	30	NUM
iajs-2127	277	2	.	.	PUNCT
iajs-2127	277	3	elefsiniotisa	elefsiniotisa	NOUN
iajs-2127	277	4	,	,	PUNCT
iajs-2127	277	5	i.s	i.s	PROPN
iajs-2127	277	6	.	.	PROPN
iajs-2127	277	7	;	;	PUNCT
iajs-2127	277	8	brokalakia	brokalakia	NOUN
iajs-2127	277	9	,	,	PUNCT
iajs-2127	277	10	h.	h.	PROPN
iajs-2127	277	11	;	;	PUNCT
iajs-2127	277	12	argyropoulosa	argyropoulosa	PROPN
iajs-2127	277	13	,	,	PUNCT
iajs-2127	277	14	e.	e.	PROPN
iajs-2127	277	15	;	;	PUNCT
iajs-2127	277	16	magaziotou	magaziotou	PROPN
iajs-2127	277	17	,	,	PUNCT
iajs-2127	277	18	i.	i.	NOUN
iajs-2127	277	19	;	;	PUNCT
iajs-2127	277	20	derdemezib	derdemezib	PROPN
iajs-2127	277	21	,	,	PUNCT
iajs-2127	277	22	a.	a.	NOUN
iajs-2127	277	23	;	;	PUNCT
iajs-2127	277	24	mihasa	mihasa	PROPN
iajs-2127	277	25	.	.	PUNCT
iajs-2127	278	1	c.	c.	PROPN
iajs-2127	278	2	;	;	PUNCT
iajs-2127	278	3	tsoumakasb	tsoumakasb	NOUN
iajs-2127	278	4	,	,	PUNCT
iajs-2127	278	5	k.	k.	NOUN
iajs-2127	278	6	evaluation	evaluation	NOUN
iajs-2127	278	7	of	of	ADP
iajs-2127	278	8	liver	liver	NOUN
iajs-2127	278	9	,	,	PUNCT
iajs-2127	278	10	enzymes	enzyme	NOUN
iajs-2127	278	11	in	in	ADP
iajs-2127	278	12	asymptomatic	asymptomatic	ADJ
iajs-2127	278	13	,	,	PUNCT
iajs-2127	278	14	chronic	chronic	ADJ
iajs-2127	278	15	hepatitis	hepatitis	PROPN
iajs-2127	278	16	b	b	PROPN
iajs-2127	278	17	,	,	PUNCT
iajs-2127	278	18	virus	virus	NOUN
iajs-2127	278	19	infected	infect	VERB
iajs-2127	278	20	pregnant	pregnant	ADJ
iajs-2127	278	21	,	,	PUNCT
iajs-2127	278	22	women	woman	NOUN
iajs-2127	278	23	.	.	PUNCT
iajs-2127	279	1	ann	ann	PROPN
iajs-2127	279	2	gastro.2013,26,59	gastro.2013,26,59	PROPN
iajs-2127	279	3	-	-	PUNCT
iajs-2127	279	4	65	65	NUM
iajs-2127	279	5	,	,	PUNCT
iajs-2127	279	6	download	download	VERB
iajs-2127	279	7	from	from	ADP
iajs-2127	279	8	:	:	PUNCT
iajs-2127	279	9	http://	http://	PROPN
iajs-2127	279	10	www	www	PROPN
iajs-2127	279	11	.	.	PROPN
iajs-2127	279	12	annalsgastro	annalsgastro	PROPN
iajs-2127	279	13	.gr/	.gr/	PUNCT
iajs-2127	279	14	index	index	NOUN
iajs-2127	279	15	.	.	PUNCT
iajs-2127	280	1	php/	php/	NOUN
iajs-2127	280	2	annalsgastro/	annalsgastro/	NUM
iajs-2127	280	3	article	article	NOUN
iajs-2127	280	4	/	/	SYM
iajs-2127	280	5	view/1094/971	view/1094/971	NOUN
iajs-2127	280	6	.	.	PROPN
iajs-2127	280	7	31	31	NUM
iajs-2127	280	8	.	.	PUNCT
iajs-2127	281	1	thapa	thapa	PROPN
iajs-2127	281	2	,	,	PUNCT
iajs-2127	281	3	b.r	b.r	PROPN
iajs-2127	281	4	.	.	PROPN
iajs-2127	281	5	;	;	PUNCT
iajs-2127	281	6	walia	walia	PROPN
iajs-2127	281	7	,	,	PUNCT
iajs-2127	281	8	a.	a.	NOUN
iajs-2127	281	9	liver	liver	NOUN
iajs-2127	281	10	function	function	NOUN
iajs-2127	281	11	tests	test	NOUN
iajs-2127	281	12	,	,	PUNCT
iajs-2127	281	13	and	and	CCONJ
iajs-2127	281	14	their	their	PRON
iajs-2127	281	15	interpretation	interpretation	NOUN
iajs-2127	281	16	.	.	PUNCT
iajs-2127	282	1	indian	indian	PROPN
iajs-2127	282	2	j.	j.	PROPN
iajs-2127	282	3	pediatr.2007	pediatr.2007	PROPN
iajs-2127	282	4	,	,	PUNCT
iajs-2127	282	5	74	74	NUM
iajs-2127	282	6	,	,	PUNCT
iajs-2127	282	7	7	7	NUM
iajs-2127	282	8	,	,	PUNCT
iajs-2127	282	9	663	663	NUM
iajs-2127	282	10	-	-	SYM
iajs-2127	282	11	671	671	NUM
iajs-2127	282	12	,	,	PUNCT
iajs-2127	282	13	doi	doi	NOUN
iajs-2127	282	14	:	:	PUNCT
iajs-2127	282	15	doi.org/10.1007/s12098-007-0118-7	doi.org/10.1007/s12098-007-0118-7	PROPN
iajs-2127	282	16	.	.	PUNCT
iajs-2127	283	1	32	32	NUM
iajs-2127	283	2	.	.	PUNCT
iajs-2127	284	1	hernaez	hernaez	PROPN
iajs-2127	284	2	,	,	PUNCT
iajs-2127	284	3	r.	r.	PROPN
iajs-2127	284	4	;	;	PUNCT
iajs-2127	284	5	yeh	yeh	PROPN
iajs-2127	284	6	,	,	PUNCT
iajs-2127	284	7	h.c	h.c	PROPN
iajs-2127	284	8	.	.	PROPN
iajs-2127	284	9	;	;	PUNCT
iajs-2127	284	10	lazo	lazo	PROPN
iajs-2127	284	11	,	,	PUNCT
iajs-2127	284	12	m.	m.	NOUN
iajs-2127	284	13	;	;	PUNCT
iajs-2127	284	14	chung	chung	PROPN
iajs-2127	284	15	,	,	PUNCT
iajs-2127	284	16	h.m	h.m	PROPN
iajs-2127	284	17	.	.	PROPN
iajs-2127	284	18	;	;	PUNCT
iajs-2127	284	19	hamilton	hamilton	PROPN
iajs-2127	284	20	,	,	PUNCT
iajs-2127	284	21	j.p	j.p	PROPN
iajs-2127	284	22	.	.	PROPN
iajs-2127	284	23	;	;	PUNCT
iajs-2127	284	24	koteish	koteish	PROPN
iajs-2127	284	25	,	,	PUNCT
iajs-2127	284	26	a.	a.	NOUN
iajs-2127	284	27	;	;	PUNCT
iajs-2127	284	28	potter	potter	PROPN
iajs-2127	284	29	,	,	PUNCT
iajs-2127	284	30	j.j	j.j	PROPN
iajs-2127	284	31	.	.	PROPN
iajs-2127	284	32	;	;	PUNCT
iajs-2127	284	33	brancati	brancati	PROPN
iajs-2127	284	34	,	,	PUNCT
iajs-2127	284	35	f.l	f.l	PROPN
iajs-2127	284	36	.	.	PROPN
iajs-2127	284	37	;	;	PUNCT
iajs-2127	284	38	clark	clark	PROPN
iajs-2127	284	39	,	,	PUNCT
iajs-2127	284	40	j.m	j.m	PROPN
iajs-2127	284	41	.	.	PROPN
iajs-2127	284	42	elevated	elevated	ADJ
iajs-2127	284	43	,	,	PUNCT
iajs-2127	284	44	alt	alt	VERB
iajs-2127	284	45	and	and	CCONJ
iajs-2127	284	46	ggt	ggt	NOUN
iajs-2127	284	47	,	,	PUNCT
iajs-2127	284	48	predict	predict	VERB
iajs-2127	284	49	all	all	DET
iajs-2127	284	50	-	-	PUNCT
iajs-2127	284	51	cause	cause	NOUN
iajs-2127	284	52	,	,	PUNCT
iajs-2127	284	53	mortality	mortality	NOUN
iajs-2127	284	54	and	and	CCONJ
iajs-2127	284	55	hepatocellular	hepatocellular	NOUN
iajs-2127	284	56	,	,	PUNCT
iajs-2127	284	57	carcinoma	carcinoma	NOUN
iajs-2127	284	58	in	in	ADP
iajs-2127	284	59	taiwanese	taiwanese	ADJ
iajs-2127	284	60	,	,	PUNCT
iajs-2127	284	61	male	male	NOUN
iajs-2127	284	62	:	:	PUNCT
iajs-2127	284	63	a	a	DET
iajs-2127	284	64	case	case	NOUN
iajs-2127	284	65	-	-	PUNCT
iajs-2127	284	66	cohort	cohort	NOUN
iajs-2127	284	67	study	study	NOUN
iajs-2127	284	68	.	.	PUNCT
iajs-2127	285	1	hepatol	hepatol	ADJ
iajs-2127	285	2	.	.	PUNCT
iajs-2127	285	3	,	,	PUNCT
iajs-2127	286	1	int.2013	int.2013	X
iajs-2127	286	2	,	,	PUNCT
iajs-2127	286	3	7	7	NUM
iajs-2127	286	4	,	,	PUNCT
iajs-2127	286	5	1040–1049	1040–1049	NUM
iajs-2127	286	6	,	,	PUNCT
iajs-2127	286	7	doi:10.1007	doi:10.1007	NOUN
iajs-2127	286	8	/	/	SYM
iajs-2127	286	9	s12072	s12072	NOUN
iajs-2127	286	10	-	-	PUNCT
iajs-2127	286	11	013	013	NUM
iajs-2127	286	12	-	-	PUNCT
iajs-2127	286	13	9476	9476	NUM
iajs-2127	286	14	-	-	PUNCT
iajs-2127	286	15	6	6	NUM
iajs-2127	286	16	.	.	NOUN
iajs-2127	286	17	33	33	NUM
iajs-2127	286	18	.	.	PUNCT
iajs-2127	287	1	eminler	eminler	NOUN
iajs-2127	287	2	,	,	PUNCT
iajs-2127	287	3	a.t	a.t	PROPN
iajs-2127	287	4	.	.	PROPN
iajs-2127	287	5	;	;	PUNCT
iajs-2127	287	6	irak	irak	PROPN
iajs-2127	287	7	,	,	PUNCT
iajs-2127	287	8	k.	k.	PROPN
iajs-2127	287	9	;	;	PUNCT
iajs-2127	287	10	ayyildiz	ayyildiz	PROPN
iajs-2127	287	11	,	,	PUNCT
iajs-2127	287	12	t.	t.	PROPN
iajs-2127	287	13	;	;	PUNCT
iajs-2127	287	14	keskin	keskin	X
iajs-2127	287	15	,	,	PUNCT
iajs-2127	287	16	m.	m.	NOUN
iajs-2127	287	17	;	;	PUNCT
iajs-2127	287	18	kiyici	kiyici	PROPN
iajs-2127	287	19	,	,	PUNCT
iajs-2127	287	20	m.	m.	NOUN
iajs-2127	287	21	;	;	PUNCT
iajs-2127	287	22	gurel	gurel	NOUN
iajs-2127	287	23	,	,	PUNCT
iajs-2127	287	24	s.	s.	PROPN
iajs-2127	287	25	;	;	PUNCT
iajs-2127	287	26	gulten	gulten	VERB
iajs-2127	287	27	,	,	PUNCT
iajs-2127	287	28	m.	m.	NOUN
iajs-2127	287	29	;	;	PUNCT
iajs-2127	287	30	dolar	dolar	NOUN
iajs-2127	287	31	,	,	PUNCT
iajs-2127	287	32	e.	e.	PROPN
iajs-2127	287	33	;	;	PUNCT
iajs-2127	287	34	nak	nak	PROPN
iajs-2127	287	35	,	,	PUNCT
iajs-2127	287	36	s.g	s.g	PROPN
iajs-2127	287	37	.	.	PROPN
iajs-2127	288	1	the	the	DET
iajs-2127	288	2	relation	relation	NOUN
iajs-2127	288	3	between	between	ADP
iajs-2127	288	4	,	,	PUNCT
iajs-2127	288	5	liver	liver	NOUN
iajs-2127	288	6	histopathology	histopathology	NOUN
iajs-2127	288	7	and	and	CCONJ
iajs-2127	288	8	,	,	PUNCT
iajs-2127	288	9	ggt	ggt	PROPN
iajs-2127	288	10	levels	level	NOUN
iajs-2127	288	11	in	in	ADP
iajs-2127	288	12	,	,	PUNCT
iajs-2127	288	13	viral	viral	ADJ
iajs-2127	288	14	hepatitis	hepatitis	NOUN
iajs-2127	288	15	:	:	PUNCT
iajs-2127	288	16	more	more	ADJ
iajs-2127	288	17	,	,	PUNCT
iajs-2127	288	18	important	important	ADJ
iajs-2127	288	19	in	in	ADP
iajs-2127	288	20	hepatitis	hepatitis	PROPN
iajs-2127	288	21	,	,	PUNCT
iajs-2127	288	22	b.	b.	PROPN
iajs-2127	288	23	turk	turk	PROPN
iajs-2127	288	24	j	j	PROPN
iajs-2127	288	25	,	,	PUNCT
iajs-2127	288	26	gastroenterol	gastroenterol	PROPN
iajs-2127	288	27	.	.	PUNCT
iajs-2127	288	28	2014	2014	NUM
iajs-2127	288	29	,	,	PUNCT
iajs-2127	288	30	25	25	NUM
iajs-2127	288	31	,	,	PUNCT
iajs-2127	288	32	411	411	NUM
iajs-2127	288	33	-	-	SYM
iajs-2127	288	34	5	5	NUM
iajs-2127	288	35	,	,	PUNCT
iajs-2127	288	36	doi:10.5152	doi:10.5152	PRON
iajs-2127	288	37	/	/	SYM
iajs-2127	288	38	tjg.2014.3693	tjg.2014.3693	PROPN
iajs-2127	288	39	.	.	PUNCT
iajs-2127	289	1	34	34	NUM
iajs-2127	289	2	.	.	PUNCT
iajs-2127	289	3	katakura	katakura	PROPN
iajs-2127	289	4	,	,	PUNCT
iajs-2127	289	5	y.	y.	PROPN
iajs-2127	289	6	;	;	PUNCT
iajs-2127	289	7	yotsuyanagi	yotsuyanagi	PROPN
iajs-2127	289	8	,	,	PUNCT
iajs-2127	289	9	h.	h.	PROPN
iajs-2127	289	10	;	;	PUNCT
iajs-2127	289	11	hashizume	hashizume	PROPN
iajs-2127	289	12	,	,	PUNCT
iajs-2127	289	13	k.	k.	PROPN
iajs-2127	289	14	;	;	PUNCT
iajs-2127	289	15	okuse	okuse	NOUN
iajs-2127	289	16	,	,	PUNCT
iajs-2127	289	17	c.	c.	NOUN
iajs-2127	289	18	;	;	PUNCT
iajs-2127	289	19	okuse	okuse	NOUN
iajs-2127	289	20	,	,	PUNCT
iajs-2127	289	21	n.	n.	NOUN
iajs-2127	289	22	;	;	PUNCT
iajs-2127	289	23	nishikawa	nishikawa	PROPN
iajs-2127	289	24	,	,	PUNCT
iajs-2127	289	25	k.	k.	PROPN
iajs-2127	289	26	;	;	PUNCT
iajs-2127	289	27	suzuki	suzuki	PROPN
iajs-2127	289	28	,	,	PUNCT
iajs-2127	289	29	m.	m.	NOUN
iajs-2127	289	30	;	;	PUNCT
iajs-2127	289	31	iino	iino	PROPN
iajs-2127	289	32	,	,	PUNCT
iajs-2127	289	33	s.	s.	PROPN
iajs-2127	289	34	;	;	PUNCT
iajs-2127	289	35	itoh	itoh	PROPN
iajs-2127	289	36	,	,	PUNCT
iajs-2127	289	37	f.	f.	PROPN
iajs-2127	289	38	pancreatic	pancreatic	PROPN
iajs-2127	289	39	,	,	PUNCT
iajs-2127	289	40	function	function	NOUN
iajs-2127	289	41	in	in	ADP
iajs-2127	289	42	chronic	chronic	NOUN
iajs-2127	289	43	,	,	PUNCT
iajs-2127	289	44	viral	viral	ADJ
iajs-2127	289	45	hepatitis	hepatitis	NOUN
iajs-2127	289	46	.	.	PUNCT
iajs-2127	290	1	world	world	NOUN
iajs-2127	290	2	.	.	PUNCT
iajs-2127	291	1	j.	j.	PROPN
iajs-2127	291	2	gastroenterol	gastroenterol	PROPN
iajs-2127	291	3	.	.	PUNCT
iajs-2127	292	1	2005	2005	NUM
iajs-2127	292	2	,	,	PUNCT
iajs-2127	292	3	11	11	NUM
iajs-2127	292	4	,	,	PUNCT
iajs-2127	292	5	23	23	NUM
iajs-2127	292	6	,	,	PUNCT
iajs-2127	292	7	3508	3508	NUM
iajs-2127	292	8	-	-	SYM
iajs-2127	292	9	3513	3513	NUM
iajs-2127	292	10	,	,	PUNCT
iajs-2127	292	11	doi:10.3748/	doi:10.3748/	PROPN
iajs-2127	292	12	wjg	wjg	VERB
iajs-2127	292	13	.	.	PUNCT
iajs-2127	292	14	v11.i23.3508	v11.i23.3508	PROPN
iajs-2127	292	15	.	.	PUNCT
iajs-2127	293	1	35	35	NUM
iajs-2127	293	2	.	.	PUNCT
iajs-2127	293	3	ayelagbe	ayelagbe	NOUN
iajs-2127	293	4	,	,	PUNCT
iajs-2127	293	5	o.g	o.g	PROPN
iajs-2127	293	6	.	.	PROPN
iajs-2127	293	7	;	;	PUNCT
iajs-2127	293	8	oladipo	oladipo	PROPN
iajs-2127	293	9	,	,	PUNCT
iajs-2127	293	10	t.s	t.s	PROPN
iajs-2127	293	11	.	.	PROPN
iajs-2127	293	12	renal	renal	ADJ
iajs-2127	293	13	function	function	NOUN
iajs-2127	293	14	status	status	NOUN
iajs-2127	293	15	,	,	PUNCT
iajs-2127	293	16	of	of	ADP
iajs-2127	293	17	nigerian	nigerian	ADJ
iajs-2127	293	18	patients	patient	NOUN
iajs-2127	293	19	,	,	PUNCT
iajs-2127	293	20	infected	infect	VERB
iajs-2127	293	21	with	with	ADP
iajs-2127	293	22	hepatitis	hepatitis	PROPN
iajs-2127	293	23	,	,	PUNCT
iajs-2127	293	24	b	b	PROPN
iajs-2127	293	25	virus	virus	NOUN
iajs-2127	293	26	.	.	PUNCT
iajs-2127	294	1	biokemistri	biokemistri	ADJ
iajs-2127	294	2	.	.	PROPN
iajs-2127	295	1	2012	2012	NUM
iajs-2127	295	2	,	,	PUNCT
iajs-2127	295	3	24	24	NUM
iajs-2127	295	4	,	,	PUNCT
iajs-2127	295	5	2	2	NUM
iajs-2127	295	6	,	,	PUNCT
iajs-2127	295	7	77	77	NUM
iajs-2127	295	8	-	-	SYM
iajs-2127	295	9	81	81	NUM
iajs-2127	295	10	.	.	PUNCT
iajs-2127	296	1	36	36	NUM
iajs-2127	296	2	.	.	PUNCT
iajs-2127	297	1	shahid	shahid	PROPN
iajs-2127	297	2	,	,	PUNCT
iajs-2127	297	3	a.	a.	NOUN
iajs-2127	297	4	;	;	PUNCT
iajs-2127	297	5	quresbi	quresbi	PROPN
iajs-2127	297	6	,	,	PUNCT
iajs-2127	297	7	h.	h.	PROPN
iajs-2127	297	8	;	;	PUNCT
iajs-2127	297	9	nizami	nizami	PROPN
iajs-2127	297	10	,	,	PUNCT
iajs-2127	297	11	f.	f.	PROPN
iajs-2127	297	12	;	;	PUNCT
iajs-2127	297	13	zuberi	zuberi	PROPN
iajs-2127	297	14	,	,	PUNCT
iajs-2127	297	15	s.j	s.j	PROPN
iajs-2127	297	16	.	.	PROPN
iajs-2127	297	17	electrolytes	electrolyte	NOUN
iajs-2127	297	18	,	,	PUNCT
iajs-2127	297	19	in	in	ADP
iajs-2127	297	20	liver	liver	NOUN
iajs-2127	297	21	disease	disease	NOUN
iajs-2127	297	22	,	,	PUNCT
iajs-2127	297	23	-a	-a	X
iajs-2127	297	24	preliminary	preliminary	ADJ
iajs-2127	297	25	study	study	NOUN
iajs-2127	297	26	.	.	PUNCT
iajs-2127	298	1	j.	j.	PROPN
iajs-2127	298	2	pak	pak	PROPN
iajs-2127	298	3	.	.	PROPN
iajs-2127	298	4	med	med	PROPN
iajs-2127	298	5	.	.	PROPN
iajs-2127	298	6	assoc	assoc	PROPN
iajs-2127	298	7	.	.	PUNCT
iajs-2127	299	1	1983	1983	NUM
iajs-2127	299	2	,	,	PUNCT
iajs-2127	299	3	33	33	NUM
iajs-2127	299	4	,	,	PUNCT
iajs-2127	299	5	289	289	NUM
iajs-2127	299	6	-	-	SYM
iajs-2127	299	7	293	293	NUM
iajs-2127	299	8	.	.	PUNCT
iajs-2127	300	1	37	37	NUM
iajs-2127	300	2	.	.	PUNCT
iajs-2127	301	1	ryder	ryder	PROPN
iajs-2127	301	2	,	,	PUNCT
iajs-2127	301	3	s.d	s.d	PROPN
iajs-2127	301	4	.	.	PROPN
iajs-2127	301	5	;	;	PUNCT
iajs-2127	301	6	beckingham	beckingham	NOUN
iajs-2127	301	7	,	,	PUNCT
iajs-2127	301	8	i.j	i.j	PROPN
iajs-2127	301	9	.	.	PROPN
iajs-2127	301	10	abc	abc	PROPN
iajs-2127	301	11	of	of	ADP
iajs-2127	301	12	diseases	disease	NOUN
iajs-2127	301	13	,	,	PUNCT
iajs-2127	301	14	of	of	ADP
iajs-2127	301	15	liver	liver	NOUN
iajs-2127	301	16	,	,	PUNCT
iajs-2127	301	17	pancreas	pancrea	NOUN
iajs-2127	301	18	,	,	PUNCT
iajs-2127	301	19	and	and	CCONJ
iajs-2127	301	20	biliary	biliary	NOUN
iajs-2127	301	21	system	system	NOUN
iajs-2127	301	22	,	,	PUNCT
iajs-2127	301	23	acute	acute	ADJ
iajs-2127	301	24	hepatitis	hepatitis	NOUN
iajs-2127	301	25	.	.	PUNCT
iajs-2127	302	1	bmj	bmj	PROPN
iajs-2127	302	2	.	.	PUNCT
iajs-2127	302	3	2001	2001	NUM
iajs-2127	302	4	,	,	PUNCT
iajs-2127	302	5	322	322	NUM
iajs-2127	302	6	,	,	PUNCT
iajs-2127	302	7	7279	7279	NUM
iajs-2127	302	8	,	,	PUNCT
iajs-2127	302	9	151	151	NUM
iajs-2127	302	10	-	-	SYM
iajs-2127	302	11	153	153	NUM
iajs-2127	302	12	,	,	PUNCT
iajs-2127	302	13	doi	doi	NOUN
iajs-2127	302	14	:	:	PUNCT
iajs-2127	302	15	doi.org/	doi.org/	NOUN
iajs-2127	302	16	10.1136	10.1136	NUM
iajs-2127	302	17	/	/	SYM
iajs-2127	302	18	bmj.322.7279.151	bmj.322.7279.151	NOUN
iajs-2127	302	19	.	.	PUNCT
iajs-2127	303	1	38	38	NUM
iajs-2127	303	2	.	.	PUNCT
iajs-2127	304	1	asghar	asghar	PROPN
iajs-2127	304	2	,	,	PUNCT
iajs-2127	304	3	s.	s.	PROPN
iajs-2127	304	4	;	;	PUNCT
iajs-2127	304	5	zia	zia	PROPN
iajs-2127	304	6	,	,	PUNCT
iajs-2127	304	7	m.a	m.a	PROPN
iajs-2127	304	8	.	.	PROPN
iajs-2127	304	9	;	;	PUNCT
iajs-2127	304	10	jafri	jafri	PROPN
iajs-2127	304	11	,	,	PUNCT
iajs-2127	304	12	s.a	s.a	PROPN
iajs-2127	304	13	.	.	PROPN
iajs-2127	304	14	;	;	PUNCT
iajs-2127	304	15	ahmed	ahmed	PROPN
iajs-2127	304	16	,	,	PUNCT
iajs-2127	304	17	i.	i.	PROPN
iajs-2127	304	18	;	;	PUNCT
iajs-2127	304	19	amjad	amjad	PROPN
iajs-2127	304	20	,	,	PUNCT
iajs-2127	304	21	m.a	m.a	PROPN
iajs-2127	304	22	.	.	PROPN
iajs-2127	304	23	correlative	correlative	ADJ
iajs-2127	304	24	study	study	NOUN
iajs-2127	304	25	between	between	ADP
iajs-2127	304	26	,	,	PUNCT
iajs-2127	304	27	biochemical	biochemical	ADJ
iajs-2127	304	28	and	and	CCONJ
iajs-2127	304	29	hematological	hematological	ADJ
iajs-2127	304	30	,	,	PUNCT
iajs-2127	304	31	parameters	parameter	NOUN
iajs-2127	304	32	and	and	CCONJ
iajs-2127	304	33	hepatitis	hepatitis	NOUN
iajs-2127	304	34	,	,	PUNCT
iajs-2127	304	35	c	c	NOUN
iajs-2127	304	36	prevalence	prevalence	NOUN
iajs-2127	304	37	in	in	ADP
iajs-2127	304	38	,	,	PUNCT
iajs-2127	304	39	the	the	DET
iajs-2127	304	40	premises	premise	NOUN
iajs-2127	304	41	of	of	ADP
iajs-2127	304	42	,	,	PUNCT
iajs-2127	304	43	faisalabad	faisalabad	PROPN
iajs-2127	304	44	.	.	PROPN
iajs-2127	304	45	midlle	midlle	PROPN
iajs-2127	304	46	-	-	PUNCT
iajs-2127	304	47	east	east	PROPN
iajs-2127	304	48	,	,	PUNCT
iajs-2127	304	49	j.	j.	PROPN
iajs-2127	304	50	sci	sci	PROPN
iajs-2127	304	51	.	.	PUNCT
iajs-2127	305	1	res	re	NOUN
iajs-2127	305	2	.	.	PUNCT
iajs-2127	305	3	2011,7	2011,7	NUM
iajs-2127	305	4	,	,	PUNCT
iajs-2127	305	5	4	4	NUM
iajs-2127	305	6	,	,	PUNCT
iajs-2127	305	7	538	538	NUM
iajs-2127	305	8	-	-	SYM
iajs-2127	305	9	542	542	NUM
iajs-2127	305	10	.	.	PUNCT
iajs-2127	306	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=geng%20a%5bauthor%5d&cauthor=true&cauthor_uid=24616815	https://www.ncbi.nlm.nih.gov/pubmed/?term=geng%20a%5bauthor%5d&cauthor=true&cauthor_uid=24616815	NOUN
iajs-2127	306	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=yang%20x%5bauthor%5d&cauthor=true&cauthor_uid=24616815	https://www.ncbi.nlm.nih.gov/pubmed/?term=yang%20x%5bauthor%5d&cauthor=true&cauthor_uid=24616815	NOUN
iajs-2127	306	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=han%20l%5bauthor%5d&cauthor=true&cauthor_uid=24616815	https://www.ncbi.nlm.nih.gov/pubmed/?term=han%20l%5bauthor%5d&cauthor=true&cauthor_uid=24616815	NOUN
iajs-2127	306	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=xu%20h%5bauthor%5d&cauthor=true&cauthor_uid=24616815	https://www.ncbi.nlm.nih.gov/pubmed/?term=xu%20h%5bauthor%5d&cauthor=true&cauthor_uid=24616815	NOUN
iajs-2127	306	5	http://dx.doi.org/10.1155/2014/913890	http://dx.doi.org/10.1155/2014/913890	VERB
iajs-2127	306	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20j%5bauthor%5d&cauthor=true&cauthor_uid=27329384	https://www.ncbi.nlm.nih.gov/pubmed/?term=liu%20j%5bauthor%5d&cauthor=true&cauthor_uid=27329384	PROPN
iajs-2127	306	7	https://dx.doi.org/10.1177%2f0300060516650076	https://dx.doi.org/10.1177%2f0300060516650076	PROPN
iajs-2127	306	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=magaziotou%20i%5bauthor%5d&cauthor=true&cauthor_uid=24714311	https://www.ncbi.nlm.nih.gov/pubmed/?term=magaziotou%20i%5bauthor%5d&cauthor=true&cauthor_uid=24714311	NOUN
iajs-2127	306	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=derdemezib%20a%5bauthor%5d&cauthor=true&cauthor_uid=24714311	https://www.ncbi.nlm.nih.gov/pubmed/?term=derdemezib%20a%5bauthor%5d&cauthor=true&cauthor_uid=24714311	NOUN
iajs-2127	306	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=mihasa%20c%5bauthor%5d&cauthor=true&cauthor_uid=24714311	https://www.ncbi.nlm.nih.gov/pubmed/?term=mihasa%20c%5bauthor%5d&cauthor=true&cauthor_uid=24714311	NOUN
iajs-2127	306	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=tsoumakasb%20k%5bauthor%5d&cauthor=true&cauthor_uid=24714311	https://www.ncbi.nlm.nih.gov/pubmed/?term=tsoumakasb%20k%5bauthor%5d&cauthor=true&cauthor_uid=24714311	PROPN
iajs-2127	306	12	https://www.ncbi.nlm.nih.gov/pubmed/?term=chung%20hm%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=chung%20hm%5bauthor%5d&cauthor=true&cauthor_uid=26202033	NOUN
iajs-2127	306	13	https://www.ncbi.nlm.nih.gov/pubmed/?term=hamilton%20jp%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=hamilton%20jp%5bauthor%5d&cauthor=true&cauthor_uid=26202033	PROPN
iajs-2127	306	14	https://www.ncbi.nlm.nih.gov/pubmed/?term=koteish%20a%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=koteish%20a%5bauthor%5d&cauthor=true&cauthor_uid=26202033	PROPN
iajs-2127	306	15	https://www.ncbi.nlm.nih.gov/pubmed/?term=potter%20jj%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=potter%20jj%5bauthor%5d&cauthor=true&cauthor_uid=26202033	VERB
iajs-2127	306	16	https://www.ncbi.nlm.nih.gov/pubmed/?term=potter%20jj%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=potter%20jj%5bauthor%5d&cauthor=true&cauthor_uid=26202033	NOUN
iajs-2127	306	17	https://www.ncbi.nlm.nih.gov/pubmed/?term=brancati%20fl%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=brancati%20fl%5bauthor%5d&cauthor=true&cauthor_uid=26202033	VERB
iajs-2127	306	18	https://www.ncbi.nlm.nih.gov/pubmed/?term=clark%20jm%5bauthor%5d&cauthor=true&cauthor_uid=26202033	https://www.ncbi.nlm.nih.gov/pubmed/?term=clark%20jm%5bauthor%5d&cauthor=true&cauthor_uid=26202033	NOUN
iajs-2127	306	19	https://www.ncbi.nlm.nih.gov/pubmed/?term=keskin%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=keskin%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	20	https://www.ncbi.nlm.nih.gov/pubmed/?term=kiyici%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=kiyici%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	21	https://www.ncbi.nlm.nih.gov/pubmed/?term=gurel%20s%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=gurel%20s%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	22	https://www.ncbi.nlm.nih.gov/pubmed/?term=gulten%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=gulten%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	23	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolar%20e%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolar%20e%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	24	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolar%20e%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolar%20e%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	25	https://www.ncbi.nlm.nih.gov/pubmed/?term=nak%20sg%5bauthor%5d&cauthor=true&cauthor_uid=25254524	https://www.ncbi.nlm.nih.gov/pubmed/?term=nak%20sg%5bauthor%5d&cauthor=true&cauthor_uid=25254524	PROPN
iajs-2127	306	26	https://www.ncbi.nlm.nih.gov/pubmed/?term=okuse%20c%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=okuse%20c%5bauthor%5d&cauthor=true&cauthor_uid=15962364	PROPN
iajs-2127	306	27	https://www.ncbi.nlm.nih.gov/pubmed/?term=okuse%20n%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=okuse%20n%5bauthor%5d&cauthor=true&cauthor_uid=15962364	PROPN
iajs-2127	306	28	https://www.ncbi.nlm.nih.gov/pubmed/?term=nishikawa%20k%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=nishikawa%20k%5bauthor%5d&cauthor=true&cauthor_uid=15962364	NOUN
iajs-2127	306	29	https://www.ncbi.nlm.nih.gov/pubmed/?term=suzuki%20m%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=suzuki%20m%5bauthor%5d&cauthor=true&cauthor_uid=15962364	VERB
iajs-2127	306	30	https://www.ncbi.nlm.nih.gov/pubmed/?term=iino%20s%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=iino%20s%5bauthor%5d&cauthor=true&cauthor_uid=15962364	PROPN
iajs-2127	306	31	https://www.ncbi.nlm.nih.gov/pubmed/?term=itoh%20f%5bauthor%5d&cauthor=true&cauthor_uid=15962364	https://www.ncbi.nlm.nih.gov/pubmed/?term=itoh%20f%5bauthor%5d&cauthor=true&cauthor_uid=15962364	NUM
iajs-2127	306	32	https://doi.org/10.3748/wjg.v11.i23.3508	https://doi.org/10.3748/wjg.v11.i23.3508	NOUN
iajs-2127	307	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=zuberi%20sj%5bauthor%5d&cauthor=true&cauthor_uid=6418927	https://www.ncbi.nlm.nih.gov/pubmed/?term=zuberi%20sj%5bauthor%5d&cauthor=true&cauthor_uid=6418927	ADJ
iajs-2127	307	2	https://www.ncbi.nlm.nih.gov/pubmed/6418927	https://www.ncbi.nlm.nih.gov/pubmed/6418927	ADP